[{"symbol": "ABT", "publishedDate": "2021-03-29 12:06:03", "title": "Has Abbott Laboratories (ABT) Outpaced Other Medical Stocks This Year?", "image": "https://cdn.snapi.dev/images/v1/e/v/medical19-743335.jpg", "site": "Zacks Investment Research", "text": "Is (ABT) Outperforming Other Medical Stocks This Year?", "url": "https://www.zacks.com/stock/news/1313813/has-abbott-laboratories-abt-outpaced-other-medical-stocks-this-year"}, {"symbol": "ABT", "publishedDate": "2021-03-29 10:30:00", "title": "Abbott Hosts Conference Call for First-Quarter Earnings", "image": "https://cdn.snapi.dev/images/v1/x/o/conf4-743143.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., March 29, 2021 /PRNewswire/ --\u00a0Abbott (NYSE: ABT) will announce its first-quarter 2021 financial results on Tuesday, April 20, 2021, before the market opens.", "url": "https://www.prnewswire.com/news-releases/abbott-hosts-conference-call-for-first-quarter-earnings-301257585.html"}, {"symbol": "ABT", "publishedDate": "2021-03-28 07:31:30", "title": "EOS: An Attractive CEF With Stellar Performance", "image": "https://cdn.snapi.dev/images/v1/a/w/medical13-742132.jpg", "site": "Seeking Alpha", "text": "EOS: An Attractive CEF With Stellar Performance", "url": "https://seekingalpha.com/article/4416450-eos-cef-should-you-buy-for-stellar-performance"}, {"symbol": "ABT", "publishedDate": "2021-03-28 06:15:00", "title": "3 Stocks for the 2020s", "image": "https://cdn.snapi.dev/images/v1/t/o/top-dividend-stocks-for-august-742153.jpg", "site": "The Motley Fool", "text": "The next decade is poised to be one of the most influential in history.", "url": "https://www.fool.com/investing/2021/03/28/3-stocks-for-the-2020s/"}, {"symbol": "ABT", "publishedDate": "2021-03-28 06:08:00", "title": "3 High-Yield Dividend Stocks With Solid Growth Prospects", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5938142fgettyimages-1194732144jpgw700opresize-742148.jpg", "site": "The Motley Fool", "text": "You don't have to sacrifice growth for great dividend yields with these stocks.", "url": "https://www.fool.com/investing/2021/03/28/3-high-yield-dividend-stocks-with-solid-growth-pro/"}, {"symbol": "ABT", "publishedDate": "2021-03-25 09:51:23", "title": "5 MedTech Growth Stocks Gaining Ground in 2021 Amid Pandemic", "image": "https://cdn.snapi.dev/images/v1/f/0/f0p222-739280.", "site": "Zacks Investment Research", "text": "Here are a few MedTech stocks, ABT, HOLX, HRC, IDXX, LMAT, which have held their ground amid the pandemic and can turn out to be wise investment choices for 2021.", "url": "https://www.zacks.com/stock/news/1293672/5-medtech-growth-stocks-gaining-ground-in-2021-amid-pandemic"}, {"symbol": "ABT", "publishedDate": "2021-03-25 08:20:18", "title": "MedTech to Gain From Economic Stimulus Bill: 3 Stocks to Buy", "image": "https://cdn.snapi.dev/images/v1/6/n/medical6-738905.jpg", "site": "Zacks Investment Research", "text": "Grab these three top stocks - ABT, HOLX and BIO - that continue to show tremendous promise and stand to benefit from the historic stimulus package.", "url": "https://www.zacks.com/stock/news/1293375/medtech-to-gain-from-economic-stimulus-bill-3-stocks-to-buy"}, {"symbol": "ABT", "publishedDate": "2021-03-24 10:42:28", "title": "Abbott (ABT) Nutrition Shows Robust Momentum Amid Pandemic", "image": "https://cdn.snapi.dev/images/v1/b/l/medical9-737537.jpg", "site": "Zacks Investment Research", "text": "Within Medical Device, Abbott (ABT) Diabetes Care business has been in the limelight for developments in its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.", "url": "https://www.zacks.com/stock/news/1288621/abbott-abt-nutrition-shows-robust-momentum-amid-pandemic"}, {"symbol": "ABT", "publishedDate": "2021-03-23 18:56:05", "title": "Abbott (ABT) Dips More Than Broader Markets: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/i/k/medical29-736476.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) closed at $120.49 in the latest trading session, marking a -0.81% move from the prior day.", "url": "https://www.zacks.com/stock/news/1285131/abbott-abt-dips-more-than-broader-markets-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2021-03-21 07:52:28", "title": "Abbott: Super-Bullish FY21 Forecasts Add To Already Strong Investment Case", "image": "https://cdn.snapi.dev/images/v1/m/f/medical9-732547.jpg", "site": "Seeking Alpha", "text": "Abbott Laboratories is a >$200bn market cap blue chip stock with a strong record of delivering share price growth. The company surprised analysts and the market with exceptionally bullish growth forecasts for 2021 based on its COVID testing opportunity.", "url": "https://seekingalpha.com/article/4415190-abbott-super-bullish-fy21-forecasts-add-to-already-strong-investment-case"}, {"symbol": "ABT", "publishedDate": "2021-03-19 09:39:18", "title": "4 Stocks in Focus as Diabetes Sector Grows Amid Pandemic", "image": "https://cdn.snapi.dev/images/v1/s/s/ss2222-731383.", "site": "Zacks Investment Research", "text": "Here are a few diabetes-centric MedTech stocks, ABT, NVO, MDT, PODD and TNDM, which investors can focus on to reap profits in the new normal.", "url": "https://www.zacks.com/stock/news/1282566/4-stocks-in-focus-as-diabetes-sector-grows-amid-pandemic"}, {"symbol": "ABT", "publishedDate": "2021-03-19 07:19:00", "title": "Could Abbott Laboratories Be a Millionaire-Maker Stock?", "image": "https://cdn.snapi.dev/images/v1/p/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6181962fdoctor-reviewing-test-results-with-a-patientjpgw700opresize-731088.jpg", "site": "The Motley Fool", "text": "The medical device company's stock generated 49% returns over just the past year.", "url": "https://www.fool.com/investing/2021/03/19/could-abbott-laboratories-be-a-millionaire-maker-s/"}, {"symbol": "ABT", "publishedDate": "2021-03-19 06:00:00", "title": "This Is Why Abbott Labs Is a Great Stock to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/j/6/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6184322fgettyimages-638638994jpgw700opresize-730996.jpg", "site": "The Motley Fool", "text": "The key words are \"growth\" and \"recovery.\"", "url": "https://www.fool.com/investing/2021/03/19/this-is-why-abbott-labs-is-a-great-stock-to-buy-ri/"}, {"symbol": "ABT", "publishedDate": "2021-03-17 18:56:08", "title": "Abbott (ABT) Stock Sinks As Market Gains: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/y/g/medical16-728716.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Abbott (ABT) closed at $117.62, marking a -0.51% move from the previous day.", "url": "https://www.zacks.com/stock/news/1281651/abbott-abt-stock-sinks-as-market-gains-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2021-03-12 12:32:01", "title": "Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?", "image": "https://cdn.snapi.dev/images/v1/z/7/medical29-721715.jpg", "site": "Zacks Investment Research", "text": "Is (ABT) Outperforming Other Medical Stocks This Year?", "url": "https://www.zacks.com/stock/news/1278364/is-abbott-laboratories-abt-stock-outpacing-its-medical-peers-this-year"}, {"symbol": "ABT", "publishedDate": "2021-03-12 11:01:09", "title": "Tandem (TNDM) Grows on Abbott, Dexcom Pacts Amid COVID-19 Woes", "image": "https://cdn.snapi.dev/images/v1/n/d/medical25-721493.jpg", "site": "Zacks Investment Research", "text": "Tandem Diabetes (TNDM) is expects t:sport to be a major growth catalyst for 2022.", "url": "https://www.zacks.com/stock/news/1278268/tandem-tndm-grows-on-abbott-dexcom-pacts-amid-covid-19-woes"}, {"symbol": "ABT", "publishedDate": "2021-03-11 18:56:20", "title": "Abbott (ABT) Outpaces Stock Market Gains: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/6/0/medical18-720492.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) closed the most recent trading day at $117.52, moving +1.42% from the previous trading session.", "url": "https://www.zacks.com/stock/news/1277802/abbott-abt-outpaces-stock-market-gains-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2021-03-11 09:00:00", "title": "Abbott Announces its Pandemic Defense Coalition: A Global Network of Expert Collaborators Designed To Help Prevent Future Pandemics, Currently Searching for COVID-19 Variants", "image": "https://cdn.snapi.dev/images/v1/a/h/press7-718984.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., March 11, 2021 /PRNewswire/ --\u00a0Abbott (NYSE: ABT) today announced the formation of the Abbott Pandemic Defense Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.", "url": "https://www.prnewswire.com/news-releases/abbott-announces-its-pandemic-defense-coalition-a-global-network-of-expert-collaborators-designed-to-help-prevent-future-pandemics-currently-searching-for-covid-19-variants-301245394.html"}, {"symbol": "ABT", "publishedDate": "2021-03-08 09:51:14", "title": "Abbott's (ABT) Diagnostics Arm to Gain From New & Updated EUAs", "image": "https://cdn.snapi.dev/images/v1/2/z/medical24-712712.jpg", "site": "Zacks Investment Research", "text": "Abbott's (ABT) Alinity m SARS-CoV-2 test set to detect COVID-19 in individuals who do not have symptoms.", "url": "https://www.zacks.com/stock/news/1275100/abbotts-abt-diagnostics-arm-to-gain-from-new-updated-euas"}, {"symbol": "ABT", "publishedDate": "2021-03-05 18:59:07", "title": "Abbott (ABT) Gains But Lags Market: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/h/v/medical6-711362.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Abbott (ABT) closed at $117.25, marking a +1.07% move from the previous day.", "url": "https://www.zacks.com/stock/news/1274527/abbott-abt-gains-but-lags-market-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2021-03-05 11:09:47", "title": "Abbott's Molecular Assay Gets FDA EUA Approval To Detect SARS-CoV-2 And Flu In One Test", "image": "https://cdn.snapi.dev/images/v1/c/2/medical26-710611.jpg", "site": "Benzinga", "text": "The\u00a0FDA has granted Emergency Use Authorization\u00a0(EUA) for\u00a0Abbott Laboratories' (NYSE:\u00a0ABT) Alinity m Resp-4-Plex molecular assay to detect and differentiate SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) in one test. The Alinity m Resp-4-Plex test can be conducted with one swab specimen.", "url": "https://www.benzinga.com/general/biotech/21/03/20031329/abbotts-molecular-assay-gets-fda-eua-approval-to-detect-sars-cov-2-and-flu-in-one-test"}, {"symbol": "ABT", "publishedDate": "2021-03-05 09:54:26", "title": "4 Stocks to Watch as FDA Action Plan Stresses MedTech Digitization", "image": "https://cdn.snapi.dev/images/v1/5/u/medical19-710418.jpg", "site": "Zacks Investment Research", "text": "These four MedTech stocks -- ABT, JNJ, MDT and MASI -- are expected to gain enormously from FDA's SaMD Action Plan 2021.", "url": "https://www.zacks.com/stock/news/1274037/4-stocks-to-watch-as-fda-action-plan-stresses-medtech-digitization"}, {"symbol": "ABT", "publishedDate": "2021-03-04 09:53:24", "title": "Abbott (ABT) Gets Canadian Nod for FreeStyle Libre Expanded Use", "image": "https://cdn.snapi.dev/images/v1/t/d/medical9-708217.jpg", "site": "Zacks Investment Research", "text": "Abbott's (ABT) FreeStyle Libre is the only glucose sensing technology available in Canada to remotely monitor glucose status in an expectant mother to reduce exposure to COVID-19.", "url": "https://www.zacks.com/stock/news/1273152/abbott-abt-gets-canadian-nod-for-freestyle-libre-expanded-use"}, {"symbol": "ABT", "publishedDate": "2021-03-04 08:01:04", "title": "The Pandemic is a Long-Term Factor (NASDAQ: QDEL) (NYSEAMERICAN: APT) (OTC US: BNOW) (NYSE: ABT)", "image": "https://cdn.snapi.dev/images/v1/p/r/press16-707839.jpg", "site": "OTC PR Wire", "text": "The pandemic won't always be a pandemic, but the virus is going to with us as an endemic part of life. That's the message from a new piece on Reuters.", "url": "https://otcprwire.com/the-pandemic-is-a-long-term-factor-nasdaq-qdel-nyseamerican-apt-otc-us-bnow-nyse-abt/"}, {"symbol": "ABT", "publishedDate": "2021-03-02 16:35:46", "title": "Abbott Announces HIV Vaccine Research Findings: 'Another Step Toward Unlocking A Cure'", "image": "https://cdn.snapi.dev/images/v1/p/r/hiv-704588.jpg", "site": "Benzinga", "text": "Abbott\u00a0Laboratories (NYSE: ABT) has announced a potential research breakthrough that could lead to advancements and potential vaccines for the treatment of HIV. What Happened:\u00a0Abbott's researchers have joined a team of scientists from Johns Hopkins University, the National Institute of Allergy and Infectious Diseases, the University of Missouri-Kansas City and the Universit\u00e9 Protestante au Congo in studying approximately 10,000 people in the Democratic Republic of Congo who have tested positive for HIV antibodies but have low to non-detectable viral load counts that occurred without the use of\u00a0antiretroviral treatment.", "url": "https://www.benzinga.com/general/biotech/21/03/19942357/abbott-announces-hiv-vaccine-research-findings-another-step-toward-unlocking-a-cure"}, {"symbol": "ABT", "publishedDate": "2021-03-02 08:11:10", "title": "Abbott Labs: Congo research findings could lead to HIV vaccine", "image": "https://cdn.snapi.dev/images/v1/x/3/medical2-703180.jpg", "site": "Market Watch", "text": "Abbott Labs: Congo research findings could lead to HIV vaccine", "url": "https://www.marketwatch.com/story/abbott-says-researchers-in-the-democratic-republic-of-congo-have-made-findings-that-could-lead-to-hiv-vaccine-2021-03-02"}, {"symbol": "ABT", "publishedDate": "2021-03-01 13:39:05", "title": "Is Abbott (ABT) a Solid Growth Stock? 3 Reasons to Think \" Yes \"", "image": "https://cdn.snapi.dev/images/v1/l/x/medical26-701592.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) possesses solid growth attributes, which could help it handily outperform the market.", "url": "https://www.zacks.com/stock/news/1271351/is-abbott-abt-a-solid-growth-stock-3-reasons-to-think-yes-"}, {"symbol": "ABT", "publishedDate": "2021-03-01 11:23:09", "title": "Here's Why You Should Add Abbott (ABT) to Your Portfolio", "image": "https://cdn.snapi.dev/images/v1/w/2/medical19-701236.jpg", "site": "Zacks Investment Research", "text": "Investors continue to be optimistic about Abbott (ABT) due to a slew of product launches and regulatory approvals.", "url": "https://www.zacks.com/stock/news/1271197/heres-why-you-should-add-abbott-abt-to-your-portfolio"}, {"symbol": "ABT", "publishedDate": "2021-03-01 08:21:03", "title": "5 Dividend Growth Stocks Poised for Outperformance", "image": "https://cdn.snapi.dev/images/v1/m/6/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5805032fcoronavirus-stock-market-xaoojydjpgw700opresize-700607.jpg", "site": "Zacks Investment Research", "text": "Dividend growth stocks like Skyworks Solutions (SWKS), ParkerHannifin (PH), Toll Brothers (TOL), Abbott Laboratories (ABT) and FedEx (FDX) seems poised to outperform.", "url": "https://www.zacks.com/stock/news/1270989/5-dividend-growth-stocks-poised-for-outperformance"}, {"symbol": "ABT", "publishedDate": "2021-03-01 07:36:04", "title": "February Ends in Green Amid Extreme Volatility: 5 Top Picks", "image": "https://cdn.snapi.dev/images/v1/g/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6049832fstock-up-glowing-green-arrow-climbs-on-a-stock-screenjpgw700opresize-700482.jpg", "site": "Zacks Investment Research", "text": "We have narrowed down our search to five corporate behemoths that suffered a blow in last month's turmoil. These are AAPL, MSFT, FB, ABT and DHR.", "url": "https://www.zacks.com/stock/news/1270938/february-ends-in-green-amid-extreme-volatility-5-top-picks"}, {"symbol": "ABT", "publishedDate": "2021-02-28 06:22:00", "title": "3 Great Stocks for Low-Risk Investors", "image": "https://cdn.snapi.dev/images/v1/1/6/16stre-1-699911.jpg", "site": "The Motley Fool", "text": "These companies with low-risk businesses will hold up over the long run.", "url": "https://www.fool.com/investing/2021/02/28/3-great-stocks-for-low-risk-investors/"}, {"symbol": "ABT", "publishedDate": "2021-02-27 18:30:35", "title": "Traders Look to Buy Global Health Care Stocks", "image": "https://cdn.snapi.dev/images/v1/b/s/healthcare-stock-istock-504307232-8b949300f82945e98e67a659171de0eb-699786.jpg", "site": "Investopedia", "text": "The patterns forming on the long-term charts suggest that the global health care sector could be poised for a prolonged move higher.", "url": "https://www.investopedia.com/traders-look-to-buy-global-health-care-stocks-4690339"}, {"symbol": "ABT", "publishedDate": "2021-02-26 12:08:04", "title": "Why Is Abbott (ABT) Up 1% Since Last Earnings Report?", "image": "https://cdn.snapi.dev/images/v1/3/y/medical9-698627.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/1270344/why-is-abbott-abt-up-1-since-last-earnings-report"}, {"symbol": "ABT", "publishedDate": "2021-02-25 18:58:15", "title": "Abbott (ABT) Stock Moves -0.65%: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/i/h/medical30-697312.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) closed the most recent trading day at $121.58, moving -0.65% from the previous trading session.", "url": "https://www.zacks.com/stock/news/1269775/abbott-abt-stock-moves-065-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2021-02-24 12:09:00", "title": "Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year?", "image": "https://cdn.snapi.dev/images/v1/h/e/medical22.jpg", "site": "Zacks Investment Research", "text": "Is (ABT) Outperforming Other Medical Stocks This Year?", "url": "https://www.zacks.com/stock/news/1268857/is-abbott-laboratories-abt-outperforming-other-medical-stocks-this-year"}, {"symbol": "ABT", "publishedDate": "2021-02-22 11:49:29", "title": "Daily Dividend Report: Allstate, Abbott, Westlake Chemical, Chemed, Leidos Holdings", "image": "https://cdn.snapi.dev/images/v1/d/a/daily-dividend-report-allstate-abbott-westlake-chemical-chemed-leidos-holdings.jpg", "site": "Forbes", "text": "The Allstate board of directors has approved a quarterly dividend of $0.81 cents on each outstanding share of the corporation's common stock, payable in cash on April 1, 2021, to stockholders of record at the close of business on March 4, 2021. This represents a 50% increase from the dividend declared in the previous quarter.", "url": "https://www.forbes.com/sites/dividendchannel/2021/02/22/daily-dividend-report-allstate-abbott-westlake-chemical-chemed-leidos-holdings/"}, {"symbol": "ABT", "publishedDate": "2021-02-22 09:07:31", "title": "CEO Confidence of U.S. Corporates Hits 17-Year High: 5 Picks", "image": "https://cdn.snapi.dev/images/v1/d/k/medical30.jpg", "site": "Zacks Investment Research", "text": "It will be prudent to invest in stocks of U.S. corporate giants as these companies have robust business model and a powerful brand value. These are: GS, AMAT, SCHW, CAT and ABT.", "url": "https://www.zacks.com/stock/news/1267077/ceo-confidence-of-us-corporates-hits-17-year-high-5-picks"}, {"symbol": "ABT", "publishedDate": "2021-02-20 11:05:00", "title": "Which Stocks Could Win if the U.S. Requires COVID Tests for Domestic Flights?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc7---7pwssjapu2.jpg", "site": "The Motley Fool", "text": "It's possible that some stocks could fly higher with the policy change being considered by the Biden administration.", "url": "https://www.fool.com/investing/2021/02/20/which-stocks-could-win-if-the-us-requires-covid-te/"}, {"symbol": "ABT", "publishedDate": "2021-02-19 18:54:25", "title": "Abbott (ABT) Dips More Than Broader Markets: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/k/q/medical24.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) closed at $123.04 in the latest trading session, marking a -1.89% move from the prior day.", "url": "https://www.zacks.com/stock/news/1266501/abbott-abt-dips-more-than-broader-markets-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2021-02-19 13:26:00", "title": "Abbott Declares 389th Consecutive Quarterly Dividend", "image": "https://cdn.snapi.dev/images/v1/s/r/press16---zbcwinyroa.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., Feb. 19, 2021 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 45 cents per share. This marks the 389th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable May 17, 2021,...", "url": "https://www.prnewswire.com/news-releases/abbott-declares-389th-consecutive-quarterly-dividend-301231830.html"}, {"symbol": "ABT", "publishedDate": "2021-02-19 09:50:35", "title": "Protect Your Portfolio From Volatility With 5 Low-Beta Picks", "image": "https://cdn.snapi.dev/images/v1/a/l/stocks1-un7lybpde9.jpg", "site": "Zacks Investment Research", "text": "At this stage, it is prudent to invest in low-beta stocks with a favorable Zacks Rank as these will be less volatile than the broader market. These are: ABT, CAT, CNA, GOLF and SAFM.", "url": "https://www.zacks.com/stock/news/1266097/protect-your-portfolio-from-volatility-with-5-low-beta-picks"}, {"symbol": "ABT", "publishedDate": "2021-02-16 16:09:39", "title": "Abbott Laboratories: The Definition of a Premium Company", "image": "https://cdn.snapi.dev/images/v1/3/6/medical3.jpg", "site": "GuruFocus", "text": "Abbott Laboratories (NYSE:ABT) recently reported earnings results that easily topped Wall Street analysts' estimates and issued guidance that shows the company is expecting to perform very well in 2021.", "url": "https://www.gurufocus.com/news/1360606/abbott-laboratories-the-definition-of-a-premium-company"}, {"symbol": "ABT", "publishedDate": "2021-02-16 09:13:10", "title": "5 Top Ranked Stocks With Solid Sales Growth to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/w/4/top-dividend-stocks-for-august.jpg", "site": "Zacks Investment Research", "text": "Sales growth is an important indicator of a company's health and ability to sustain its business. Let's check Abbott (ABT), Facebook (FB), Stanley Black & Decker (SWK), Leidos (LDOS) & Euronet (EEFT) as these might witness solid sales growth.", "url": "https://www.zacks.com/stock/news/1263696/5-top-ranked-stocks-with-solid-sales-growth-to-buy-right-now"}, {"symbol": "ABT", "publishedDate": "2021-02-12 18:01:27", "title": "Diamond Hill Capital Trades Citigroup for Bank of America", "image": "https://cdn.snapi.dev/images/v1/d/g/medical10---j8usaqukl0.jpg", "site": "GuruFocus", "text": "Diamond Hill Capital (Trades, Portfolio) recently disclosed its portfolio updates for the fourth quarter of 2020, which ended on Dec. 31.", "url": "https://www.gurufocus.com/news/1358398/diamond-hill-capital-trades-citigroup-for-bank-of-america"}, {"symbol": "ABT", "publishedDate": "2021-02-12 06:40:00", "title": "3 Top Healthcare Stocks to Buy in February", "image": "https://cdn.snapi.dev/images/v1/s/t/stocks101-12---agevb9vm8d.jpg", "site": "The Motley Fool", "text": "Want to play it safe in a volatile market? Go for these three top-notch healthcare picks.", "url": "https://www.fool.com/investing/2021/02/12/3-top-healthcare-stocks-to-buy-in-february/"}, {"symbol": "ABT", "publishedDate": "2021-02-10 13:14:37", "title": "Here's Why Abbott (ABT) is a Great Momentum Stock to Buy", "image": "https://cdn.snapi.dev/images/v1/2/p/medical22.jpg", "site": "Zacks Investment Research", "text": "Does Abbott (ABT) have what it takes to be a top stock pick for momentum investors? Let's find out.", "url": "https://www.zacks.com/stock/news/1260949/heres-why-abbott-abt-is-a-great-momentum-stock-to-buy"}, {"symbol": "ABT", "publishedDate": "2021-02-09 06:50:00", "title": "This Stock Could Be a Surprise Growth Pick", "image": "https://cdn.snapi.dev/images/v1/e/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6118652fgettyimages-1154691032jpgw700opresize.jpg", "site": "The Motley Fool", "text": "This well-established company offers revenue growth many newer players would envy.", "url": "https://www.fool.com/investing/2021/02/09/this-stock-could-be-a-surprise-growth-pick/"}, {"symbol": "ABT", "publishedDate": "2021-02-09 06:11:00", "title": "Here's Why Investors Should Remember These 2 Healthcare Lessons in 2021", "image": "https://cdn.snapi.dev/images/v1/p/o/podc1---wu124pzpxl.jpg", "site": "The Motley Fool", "text": "If you're thinking about investing in healthcare stocks this year, remember these two things.", "url": "https://www.fool.com/investing/2021/02/09/heres-why-investors-should-remember-these-2-health/"}, {"symbol": "ABT", "publishedDate": "2021-02-07 05:58:00", "title": "2 Green Flags for Abbott Labs and 1 Red Flag", "image": "https://cdn.snapi.dev/images/v1/p/o/podc4---3878qknmnf.jpg", "site": "The Motley Fool", "text": "Coronavirus testing won't last forever, but the future still looks bright for Abbott Labs.", "url": "https://www.fool.com/investing/2021/02/07/2-green-flags-for-abbott-labs-and-1-red-flag/"}, {"symbol": "ABT", "publishedDate": "2021-02-06 10:59:00", "title": "Is Abbott Labs a Good Stock to Buy Now?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc15---rzfhxfdl6n.jpg", "site": "The Motley Fool", "text": "Luckily, coronavirus tests aren't this company's only rising source of revenue.", "url": "https://www.fool.com/investing/2021/02/06/is-abbott-labs-a-good-stock-to-buy-now/"}, {"symbol": "ABT", "publishedDate": "2021-02-05 06:01:00", "title": "Here's the Best Dividend Aristocrat on the Market Right Now", "image": "https://cdn.snapi.dev/images/v1/s/6/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6107222fcrown-on-top-of-cashjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Its dividend track record, reputation, and unshakeable growth prospects set it apart from the rest.", "url": "https://www.fool.com/investing/2021/02/05/heres-the-best-dividend-aristocrat-on-the-market-r/"}, {"symbol": "ABT", "publishedDate": "2021-02-04 12:06:08", "title": "Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year?", "image": "https://cdn.snapi.dev/images/v1/i/n/medical26.jpg", "site": "Zacks Investment Research", "text": "Is (ABT) Outperforming Other Medical Stocks This Year?", "url": "https://www.zacks.com/stock/news/1257652/is-abbott-laboratories-abt-outperforming-other-medical-stocks-this-year"}, {"symbol": "ABT", "publishedDate": "2021-02-02 11:22:08", "title": "Abbott's (ABT) Nutrition & Diabetes Care Beat COVID-19 Woes", "image": "https://cdn.snapi.dev/images/v1/g/z/medical13.jpg", "site": "Zacks Investment Research", "text": "Within pediatric nutrition, Abbott (ABT) registers U.S. sales growth led by increased market share of Similac infant formula brand.", "url": "https://www.zacks.com/stock/news/1255988/abbotts-abt-nutrition-diabetes-care-beat-covid-19-woes"}, {"symbol": "ABT", "publishedDate": "2021-02-01 12:53:13", "title": "Abbott (ABT) Moves to Buy: Rationale Behind the Upgrade", "image": "https://cdn.snapi.dev/images/v1/c/t/medical1.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.", "url": "https://www.zacks.com/stock/news/1255378/abbott-abt-moves-to-buy-rationale-behind-the-upgrade"}, {"symbol": "ABT", "publishedDate": "2021-02-01 06:15:00", "title": "3 Mega-Trends Healthcare Investors Should Watch Right Now", "image": "https://cdn.snapi.dev/images/v1/p/o/podc12---e9tn5vozmv.jpg", "site": "The Motley Fool", "text": "Companies working to bring us to the other side of the pandemic might be the biggest winners.", "url": "https://www.fool.com/investing/2021/02/01/3-mega-trends-healthcare-investors-should-watch-ri/"}, {"symbol": "ABT", "publishedDate": "2021-01-31 06:25:00", "title": "3 Silver Linings for the Healthcare Sector in 2020", "image": "https://cdn.snapi.dev/images/v1/p/o/podc3---yrwfajg3bc.jpg", "site": "The Motley Fool", "text": "In every crisis and challenge rests great opportunity.", "url": "https://www.fool.com/investing/2021/01/31/3-silver-linings-for-the-healthcare-sector-in-2020/"}, {"symbol": "ABT", "publishedDate": "2021-01-29 08:30:00", "title": "Abbott: Ballast Your Portfolio - Q4 2020 Earnings Edition", "image": "https://cdn.snapi.dev/images/v1/p/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5769272fgettyimages-1205966780jpgw700opresize.jpg", "site": "Seeking Alpha", "text": "Abbott's recent Q4 2020 was a thing of beauty with strong forward guidance. The company's COVID-19 tests will serve the company well, even as/if the pandemic eases.", "url": "https://seekingalpha.com/article/4401902-abbott-ballast-your-portfolio-q4-2020-earnings-edition"}, {"symbol": "ABT", "publishedDate": "2021-01-28 12:17:09", "title": "ABT Stock Price: $140 Target (Up From $113) By Cowen", "image": "https://cdn.snapi.dev/images/v1/p/p/medical30.jpg", "site": "Pulse2", "text": "The shares of Abbott Laboratories (NYSE: ABT) have received a price target increase from $113 to $140 by Cowen. These are the details.", "url": "https://pulse2.com/abt-stock-price-140-nyse-abbott-laboratories-target-up-from-113-by-cowen/"}, {"symbol": "ABT", "publishedDate": "2021-01-28 06:20:00", "title": "Better Buy: Abbott Laboratories vs. Intuitive Surgical", "image": "https://cdn.snapi.dev/images/v1/1/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6096772fgettyimages-1220059380jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These two stalwarts are selling at dramatically different valuations.", "url": "https://www.fool.com/investing/2021/01/28/better-buy-abbott-laboratories-vs-intuitive-surgic/"}, {"symbol": "ABT", "publishedDate": "2021-01-27 15:00:00", "title": "Here's How Abbott Labs Hit a Home Run With Its Q4 Results", "image": "https://cdn.snapi.dev/images/v1/e/s/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6100232fcovid-testjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Two words tell the story: coronavirus testing.", "url": "https://www.fool.com/investing/2021/01/27/heres-how-abbott-labs-hit-a-home-run-with-its-q4-r/"}, {"symbol": "ABT", "publishedDate": "2021-01-27 12:57:03", "title": "Abbott Laboratories (ABT) CEO, Robert Ford on Q4 2020 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/j/y/transcript30.jpg", "site": "Seeking Alpha", "text": "Abbott Laboratories (ABT) CEO, Robert Ford on Q4 2020 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4401351-abbott-laboratories-abt-ceo-robert-ford-on-q4-2020-results-earnings-call-transcript"}, {"symbol": "ABT", "publishedDate": "2021-01-27 12:02:22", "title": "Durable Goods Orders For December Rose Lower-than-Expected", "image": "https://cdn.snapi.dev/images/v1/s/z/computer-electronic24.jpg", "site": "Zacks Investment Research", "text": "Durable Goods Orders For December Rose Lower-than-Expected", "url": "https://www.zacks.com/stock/news/1252557/durable-goods-orders-for-december-rose-lower-than-expected"}, {"symbol": "ABT", "publishedDate": "2021-01-27 11:17:06", "title": "Pre-Markets Sell Off Ahead of Big Q4 Earnings", "image": "https://cdn.snapi.dev/images/v1/a/z/computer-electronic17.jpg", "site": "Zacks Investment Research", "text": "It seems a new round of profit-taking is manifesting itself ahead of what will be the single-most consequential day of earnings season so far.", "url": "https://www.zacks.com/stock/news/1252528/pre-markets-sell-off-ahead-of-big-q4-earnings"}, {"symbol": "ABT", "publishedDate": "2021-01-27 11:17:04", "title": "Abbott (ABT) Q4 Earnings Top, Diagnostic Test Sales Solid", "image": "https://cdn.snapi.dev/images/v1/w/j/medical2.jpg", "site": "Zacks Investment Research", "text": "Within Diabetes Care, Abbott (ABT) reports strong sales banking on growing demand for sensor-based continuous glucose monitoring system, FreeStyle Libre.", "url": "https://www.zacks.com/stock/news/1252545/abbott-abt-q4-earnings-top-diagnostic-test-sales-solid"}, {"symbol": "ABT", "publishedDate": "2021-01-27 09:47:16", "title": "Abbott (ABT) Beats Q4 Earnings and Revenue Estimates", "image": "https://cdn.snapi.dev/images/v1/w/h/medical8.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) delivered earnings and revenue surprises of 6.62% and 8.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/1252399/abbott-abt-beats-q4-earnings-and-revenue-estimates"}, {"symbol": "ABT", "publishedDate": "2021-01-27 09:19:11", "title": "Abbott Laboratories beats Wall Street estimates in the fourth quarter", "image": "https://cdn.snapi.dev/images/v1/v/q/132249930-s-740x416.jpg", "site": "Invezz", "text": "Abbott Laboratories (NYSE: ABT) published its earnings report for the fiscal fourth quarter on Wednesday that came in better than what analysts had anticipated. The company attributed its hawkish performance to robust demand for its COVID-19 tests amidst the pandemic that has so far infected more than 26 million people in the United States and [\u2026] The post Abbott Laboratories beats Wall Street estimates in the fourth quarter appeared first on Invezz.", "url": "https://invezz.com/news/2021/01/27/abbott-laboratories-beats-wall-street-estimates-in-the-fourth-quarter/"}, {"symbol": "ABT", "publishedDate": "2021-01-27 08:21:28", "title": "The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF", "image": "https://cdn.snapi.dev/images/v1/v/l/medical4.jpg", "site": "InvestorPlace", "text": "One aspect of the ANEW ETF is focused on the bleeding edge of medical advances. Here's what you need to know if you're considering investing.", "url": "https://investorplace.com/genomics-telehealth-and-the-future-of-healthcare-with-the-anew-etf/"}, {"symbol": "ABT", "publishedDate": "2021-01-27 08:15:35", "title": "Abbott Laboratories: Q4 Earnings Insights", "image": "https://cdn.snapi.dev/images/v1/q/u/medical3.jpg", "site": "Benzinga", "text": "Shares of Abbott Laboratories (NYSE:ABT) moved lower\u00a0by 0.8% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 52.63% year over year to $1.45, which beat the estimate of $1.35.", "url": "https://www.benzinga.com/news/earnings/21/01/19341417/abbott-laboratories-q4-earnings-insights"}, {"symbol": "ABT", "publishedDate": "2021-01-27 08:10:14", "title": "Abbott beats sales estimates as rapid diagnostics business now generates one-fourth of revenue", "image": "https://cdn.snapi.dev/images/v1/c/k/medical2.jpg", "site": "Market Watch", "text": "Shares of Abbott Laboratories were down 0.8% in premarket trading on Wednesday as surging revenue for its COVID-19 tests carried the company past earnings and sales estimates. Abbott had earnings of $2.1 billion, or $1.20 per share, in the fourth quarter of 2020, up from $1.0 billion, or 59 cents per share, in the same quarter a year ago.", "url": "https://www.marketwatch.com/story/abbott-beats-sales-estimates-as-rapid-diagnostics-business-now-generates-one-fourth-of-revenue-2021-01-27"}, {"symbol": "ABT", "publishedDate": "2021-01-26 15:03:03", "title": "5 Incredible Perfect Earnings Charts", "image": "https://cdn.snapi.dev/images/v1/5/m/etf31-10.jpg", "site": "Zacks Investment Research", "text": "It's not easy to beat every quarter on earnings for five years, including during a global pandemic. These companies have done it.", "url": "https://www.zacks.com/stock/news/1252035/5-incredible-perfect-earnings-charts"}, {"symbol": "ABT", "publishedDate": "2021-01-26 12:00:00", "title": "Can Abbott Stock Trade Higher Post Q4 Results?", "image": "https://cdn.snapi.dev/images/v1/q/c/can-abbott-stock-trade-higher-post-q4-results.jpg", "site": "Forbes", "text": "Abbott stock (NYSE: ABT) is scheduled to report its Q4 2020 results on Wednesday, January 27. We expect Abbott to likely report mixed results with revenues slightly below and earnings in-line with the consensus estimates, driven by a rebound in demand for medical devices.", "url": "https://www.forbes.com/sites/greatspeculations/2021/01/26/can-abbott-stock-trade-higher-post-q4-results/"}, {"symbol": "ABT", "publishedDate": "2021-01-26 07:45:00", "title": "Abbott's Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab", "image": "https://cdn.snapi.dev/images/v1/3/b/press11---btcsjzxdlt.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., Jan. 26, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Mark for two new uses of its Panbio\u2122 COVID-19 Ag Rapid Test Device for the detection of the SARS-CoV-2 virus: asymptomatic testing and self-swabbing. Panbio COVID-19 Ag's label has been...", "url": "https://www.prnewswire.com/news-releases/abbotts-panbio-rapid-antigen-test-receives-ce-mark-for-asymptomatic-screening-and-self-administered-sample-collection-with-nasal-swab-301214566.html"}, {"symbol": "ABT", "publishedDate": "2021-01-26 07:16:00", "title": "2 Stocks I'll Hold Forever", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5805032fcoronavirus-stock-market-xaoojydjpgw700opresize.jpg", "site": "The Motley Fool", "text": "You'll get richer if you hold them too.", "url": "https://www.fool.com/investing/2021/01/26/2-stocks-ill-hold-forever/"}, {"symbol": "ABT", "publishedDate": "2021-01-26 07:07:00", "title": "3 Stocks to Bankroll Your Retirement", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5964742fgettyimages-1133472008jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These three stocks all have solid dividend yields for income and expected growth -- just what you need to help fund your retirement.", "url": "https://www.fool.com/investing/2021/01/26/3-stocks-to-bankroll-your-retirement/"}, {"symbol": "ABT", "publishedDate": "2021-01-21 06:09:00", "title": "3 COVID Stocks to Buy if You're Not a Big Risk-Taker", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6079162fsticky-note-showing-coronavirus-with-dollar-signjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These stocks won't keep you up at night.", "url": "https://www.fool.com/investing/2021/01/21/3-covid-stocks-to-buy-if-youre-not-a-big-risk-take/"}, {"symbol": "ABT", "publishedDate": "2021-01-21 04:30:00", "title": "Medical Device Aristocrats For A High Class Dividend Portfolio", "image": "https://cdn.snapi.dev/images/v1/h/n/medical7---vqgqnxiobq.jpg", "site": "Seeking Alpha", "text": "Healthcare aristocrats benefit from significant medical device contributions. By and large these healthcare aristocrats share favorable quant metrics on Seeking Alpha, albeit with significant variations among the five.", "url": "https://seekingalpha.com/article/4400093-medical-device-aristocrats-for-high-class-dividend-portfolio"}, {"symbol": "ABT", "publishedDate": "2021-01-20 09:02:10", "title": "Demand for COVID-19 Tests to Drive Abbott (ABT) Q4 Earnings", "image": "https://cdn.snapi.dev/images/v1/j/s/medical15.jpg", "site": "Zacks Investment Research", "text": "Within EPD, Abbott (ABT) is expected to have witnessed visible signs of rebound through Q4.", "url": "https://www.zacks.com/stock/news/1249061/demand-for-covid-19-tests-to-drive-abbott-abt-q4-earnings"}, {"symbol": "ABT", "publishedDate": "2021-01-20 07:45:00", "title": "Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip\u2122 Device", "image": "https://cdn.snapi.dev/images/v1/n/y/press4---sydbuoyz4e.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., Jan. 20, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) revised its National Coverage Determination (NCD) to expand coverage for transcatheter edge-to-edge repair (TEER), also referred to as...", "url": "https://www.prnewswire.com/news-releases/abbott-receives-expanded-medicare-reimbursement-for-first-of-its-kind-mitraclip-device-301211473.html"}, {"symbol": "ABT", "publishedDate": "2021-01-19 13:17:36", "title": "Healthcare Stocks Appear Set to Move Higher", "image": "https://cdn.snapi.dev/images/v1/h/e/healthcare-costs-and-fees-concept-hand-of-smart-doctor-used-a-calculator-for-medical-costs-in-modern-hospital-917307132-4999a2259bf345f7a695108d514ccc1a.jpg", "site": "Investopedia", "text": "Nearby levels of support and recent closes beyond key resistance are creating lucrative risk/reward setups in the healthcare sector.", "url": "https://www.investopedia.com/healthcare-stocks-appear-set-to-move-higher-5095993"}, {"symbol": "ABT", "publishedDate": "2021-01-19 11:17:11", "title": "Federal, Private Tie-Ups Boost COVID-19 Testing Volume", "image": "https://cdn.snapi.dev/images/v1/h/g/medical9.jpg", "site": "Zacks Investment Research", "text": "The Department of Health and Human Services (HHS) promises over $22 billion of funding.", "url": "https://www.zacks.com/stock/news/1248683/federal-private-tie-ups-boost-covid-19-testing-volume"}, {"symbol": "ABT", "publishedDate": "2021-01-14 15:00:27", "title": "The 2021 Market Outlook And Some New Stock Picks - Ryan Detrick And Eddy Elfenbein Join Alpha Trader (Podcast Transcript)", "image": "https://cdn.snapi.dev/images/v1/n/x/podc1.jpg", "site": "Seeking Alpha", "text": "Welcome to Alpha Trader. We have a special double bill today in honor of wildcard weekend coming up on the show. Eddy Elfenbein of Crossing Wall Street giving us his top five new stocks for 2021. But first we are pleased to welcome back to the show, Ryan Detrick. He is Chief Market Strategist for LPL Financial. Ryan, welcome back to Alpha Trader.", "url": "https://seekingalpha.com/article/4398988-2021-market-outlook-and-new-stock-picks-ryan-detrick-and-eddy-elfenbein-join-alpha-trader"}, {"symbol": "ABT", "publishedDate": "2021-01-14 07:08:00", "title": "My Best Growth Stock for 2021", "image": "https://cdn.snapi.dev/images/v1/e/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6079202fperson-administering-a-covid-19-test-in-a-drive-throughjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The need for frequent and quick COVID-19 testing ensures that demand for its products won't slow down anytime soon.", "url": "https://www.fool.com/investing/2021/01/14/my-best-growth-stock-for-2021/"}, {"symbol": "ABT", "publishedDate": "2021-01-14 07:01:00", "title": "2 Healthcare Stocks to Buy in 2021 and Hold for the Next Decade", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6081152fgettyimages-1147909462jpgw700opresize.jpg", "site": "The Motley Fool", "text": "If you sell too quickly, you'll miss out on billions of dollars in product revenue -- and share performance.", "url": "https://www.fool.com/investing/2021/01/14/2-healthcare-stocks-to-buy-in-2021-and-hold-for-th/"}, {"symbol": "ABT", "publishedDate": "2021-01-14 06:40:00", "title": "My Top 3 Large-Cap Stocks to Own in 2021", "image": "https://cdn.snapi.dev/images/v1/s/t/stocks1---un7lybpde9.jpg", "site": "The Motley Fool", "text": "Dividends and increasing revenue mean you can count on these companies for safety and growth.", "url": "https://www.fool.com/investing/2021/01/14/my-top-3-large-cap-stocks-to-own-in-2021/"}, {"symbol": "ABT", "publishedDate": "2021-01-13 10:32:05", "title": "Testing Space in Focus Again Thanks to New Wave of Coronavirus", "image": "https://cdn.snapi.dev/images/v1/p/f/medical4.jpg", "site": "Zacks Investment Research", "text": "The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.", "url": "https://www.zacks.com/stock/news/1245874/testing-space-in-focus-again-thanks-to-new-wave-of-coronavirus"}, {"symbol": "ABT", "publishedDate": "2021-01-13 06:03:00", "title": "3 Dividend Aristocrats to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6079032f3-gold-eggs-in-money-basketjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These stocks are as solid as they come.", "url": "https://www.fool.com/investing/2021/01/13/3-dividend-aristocrats-to-buy-right-now/"}, {"symbol": "ABT", "publishedDate": "2021-01-12 10:32:13", "title": "Abbott (ABT) to Expand in Booming TBI Space on New Approval", "image": "https://cdn.snapi.dev/images/v1/m/l/medical5.jpg", "site": "Zacks Investment Research", "text": "If positive, Abbott's (ABT) TBI blood test result complements CT scans to help evaluate whether a suspected patient has a TBI.", "url": "https://www.zacks.com/stock/news/1245109/abbott-abt-to-expand-in-booming-tbi-space-on-new-approval"}, {"symbol": "ABT", "publishedDate": "2021-01-12 09:00:11", "title": "Abbott Labs rolls out its BinaxNOW rapid Covid-19 test to schools and workplaces nationwide", "image": "https://cdn.snapi.dev/images/v1/2/t/106680727-1598535895724-abbott-binaxnow-kit-002.png", "site": "CNBC", "text": "Abbott Labs is making its rapid Covid-19 antigen test available to schools, pharmacies and workplaces that require frequent and affordable testing.", "url": "https://www.cnbc.com/2021/01/12/abbott-labs-rolls-out-rapid-covid-test-to-us-schools-and-workplaces.html"}, {"symbol": "ABT", "publishedDate": "2021-01-12 08:00:00", "title": "The 2021 Market Outlook And Some New Stock Picks - Ryan Detrick And Eddy Elfenbein Join Alpha Trader", "image": "https://cdn.snapi.dev/images/v1/w/b/podc13.jpg", "site": "Seeking Alpha", "text": "This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher speaking with LPL Financial's Ryan Detrick and Eddy Elfenbein, editor of the Crossing Wall Street blog and portfolio manager of the AdvisorShares Focused Equity ETF (CWS).", "url": "https://seekingalpha.com/article/4398485-2021-market-outlook-and-new-stock-picks-ryan-detrick-and-eddy-elfenbein-join-alpha-trader"}, {"symbol": "ABT", "publishedDate": "2021-01-07 18:48:18", "title": "Abbott (ABT) Gains But Lags Market: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/m/g/medical8.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) closed the most recent trading day at $111.30, moving +0.97% from the previous trading session.", "url": "https://www.zacks.com/stock/news/1242835/abbott-abt-gains-but-lags-market-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2021-01-07 13:38:11", "title": "8 Dividend Increases To Start 2021", "image": "https://cdn.snapi.dev/images/v1/o/i/asset-management27-v1uayxzxlp.jpg", "site": "Seeking Alpha", "text": "All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. An average increase of 8.4% and a median increase of 6.6%.", "url": "https://seekingalpha.com/article/4397775-8-dividend-increases-to-start-2021"}, {"symbol": "ABT", "publishedDate": "2021-01-06 08:30:00", "title": "2 Coronavirus Stocks That Will Keep Winning in 2021", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6070832fgettyimages-586733088jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The U.S. is focusing on coronavirus testing and vaccination. And that's exactly where these companies excel.", "url": "https://www.fool.com/investing/2021/01/06/2-coronavirus-stocks-that-will-keep-winning-in-202/"}, {"symbol": "ABT", "publishedDate": "2021-01-06 06:33:00", "title": "3 Top Coronavirus Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6071122fgettyimages-1223509804jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These companies are developing highly competitive vaccines and diagnostics.", "url": "https://www.fool.com/investing/2021/01/06/3-top-coronavirus-stocks-to-buy-right-now/"}, {"symbol": "ABT", "publishedDate": "2021-01-05 12:47:04", "title": "Why Abbott (ABT) is Poised to Beat Earnings Estimates Again", "image": "https://cdn.snapi.dev/images/v1/r/t/medical5---03k7cdnk1w.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.", "url": "https://www.zacks.com/stock/news/1241385/why-abbott-abt-is-poised-to-beat-earnings-estimates-again"}, {"symbol": "ABT", "publishedDate": "2021-01-03 15:08:37", "title": "BD Is Just Another Great Addition To Your Dividend Growth Portfolio", "image": "https://cdn.snapi.dev/images/v1/6/f/medical11.jpg", "site": "Seeking Alpha", "text": "BD Is Just Another Great Addition To Your Dividend Growth Portfolio", "url": "https://seekingalpha.com/article/4397057-bd-is-just-another-great-addition-to-your-dividend-growth-portfolio"}, {"symbol": "ABT", "publishedDate": "2021-01-02 10:20:00", "title": "This 3-Pack Grows Dividends By 28% Each Year", "image": "https://cdn.snapi.dev/images/v1/t/h/this-3-pack-grows-dividends-by-28-each-year.jpg", "site": "Forbes", "text": "Everyone loves the dividend, but investors usually don't give enough love to the dividend hike.", "url": "https://www.forbes.com/sites/brettowens/2021/01/02/this-3-pack-grows-dividends-by-28-each-year/"}, {"symbol": "ABT", "publishedDate": "2020-12-31 18:48:15", "title": "Abbott (ABT) Outpaces Stock Market Gains: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/q/q/medical6---obcc8793vt.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) closed at $109.49 in the latest trading session, marking a +0.97% move from the prior day.", "url": "https://www.zacks.com/stock/news/1240004/abbott-abt-outpaces-stock-market-gains-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2020-12-30 10:32:15", "title": "5 Soaring MedTech Stocks to Buy for More Growth in 2021", "image": "https://cdn.snapi.dev/images/v1/s/5/medical4.jpg", "site": "Zacks Investment Research", "text": "We have selected five MedTech growth stocks with further rooms for improvement in 2021.", "url": "https://www.zacks.com/stock/news/1235349/5-soaring-medtech-stocks-to-buy-for-more-growth-in-2021"}, {"symbol": "ABT", "publishedDate": "2020-12-30 09:47:21", "title": "3 Soaring MedTech Stocks That Might Lose Ground in 2021", "image": "https://cdn.snapi.dev/images/v1/u/w/medical30.jpg", "site": "Zacks Investment Research", "text": "Despite MedTech industry's bright prospects in 2021, investors should be wary of stocks like BLFS, STAA and TGTX, given their unfavorable Zacks Rank and weak fundamentals.", "url": "https://www.zacks.com/stock/news/1235104/3-soaring-medtech-stocks-that-might-lose-ground-in-2021"}, {"symbol": "ABT", "publishedDate": "2020-12-30 07:26:00", "title": "The 3 Safest Stocks to Buy With Your Stimulus Money", "image": "https://cdn.snapi.dev/images/v1/p/6/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5938142fgettyimages-1194732144jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These companies are heavyweights, and they're only getting stronger.", "url": "https://www.fool.com/investing/2020/12/30/the-3-safest-stocks-to-buy-with-600-in-stimulus-mo/"}, {"symbol": "ABT", "publishedDate": "2020-12-27 14:30:00", "title": "2 Perfect Stocks For Low-Risk Investors in 2021", "image": "https://cdn.snapi.dev/images/v1/w/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6058882fare-you-diversified-written-in-a-notebookjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These companies are in different industries, pay dividends, and their businesses have continued to do well this year despite the coronavirus pandemic.", "url": "https://www.fool.com/investing/2020/12/27/2-perfect-stocks-for-low-risk-investors-in-2021/"}, {"symbol": "ABT", "publishedDate": "2020-12-24 06:45:00", "title": "The 3 Best Stocks for 2021", "image": "https://cdn.snapi.dev/images/v1/i/h/stocks101-12.jpg", "site": "The Motley Fool", "text": "A beaten-down biotech, a streaming star, and a coronavirus testing giant could be well-rounded additions to your portfolio.", "url": "https://www.fool.com/investing/2020/12/24/the-3-best-stocks-for-2021/"}, {"symbol": "ABT", "publishedDate": "2020-12-22 16:11:11", "title": "5 Health Care Stocks Outperforming the Benchmark", "image": "https://cdn.snapi.dev/images/v1/d/s/drugs3.jpg", "site": "GuruFocus", "text": "According to the GuruFocus All-in-One Screener, a Premium feature, the following guru-owned health care stocks have outperformed the S&P 500 Index over the past 12 months through Dec. 22.", "url": "https://www.gurufocus.com/news/1317010/5-health-care-stocks-outperforming-the-benchmark"}, {"symbol": "ABT", "publishedDate": "2020-12-22 06:21:00", "title": "Got $1,000? 3 Smart Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/e/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6055702fgettyimages-1185208109jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These are three winning stocks to put under your Christmas tree.", "url": "https://www.fool.com/investing/2020/12/22/got-1000-3-smart-stocks-to-buy-right-now/"}, {"symbol": "ABT", "publishedDate": "2020-12-21 18:49:21", "title": "Abbott (ABT) Dips More Than Broader Markets: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/2/k/medical20.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Abbott (ABT) closed at $108.09, marking a -0.81% move from the previous day.", "url": "https://www.zacks.com/stock/news/1193084/abbott-abt-dips-more-than-broader-markets-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2020-12-18 12:02:15", "title": "4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2021", "image": "https://cdn.snapi.dev/images/v1/3/m/medical29.jpg", "site": "Zacks Investment Research", "text": "Four large-cap MedTech stocks are currently flourishing on the back of several positive developments", "url": "https://www.zacks.com/stock/news/1180935/4-large-cap-medtech-stocks-to-keep-winning-streaks-alive-in-2021"}, {"symbol": "ABT", "publishedDate": "2020-12-18 09:47:21", "title": "Abbott (ABT) Broadens Pediatric Client Base With New Labeling", "image": "https://cdn.snapi.dev/images/v1/a/0/medical26.jpg", "site": "Zacks Investment Research", "text": "Abbott's (ABT) HeartMate 3 LVAD or heart pump is an implantable device that pumps blood through the body in people whose hearts are too weak to do so naturally.", "url": "https://www.zacks.com/stock/news/1180271/abbott-abt-broadens-pediatric-client-base-with-new-labeling"}, {"symbol": "ABT", "publishedDate": "2020-12-17 16:52:00", "title": "FDA Approves Labeling Update for Abbott's HeartMate 3 Heart Pump for use in Pediatric Patients", "image": "https://cdn.snapi.dev/images/v1/j/s/press5---bl7mx7pyro.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., Dec. 17, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved updated labeling for the company's HeartMate 3\u2122 heart pump to be used in pediatric patients with advanced refractory left ventricular heart failure....", "url": "https://www.prnewswire.com/news-releases/fda-approves-labeling-update-for-abbotts-heartmate-3-heart-pump-for-use-in-pediatric-patients-301195626.html"}, {"symbol": "ABT", "publishedDate": "2020-12-17 14:43:14", "title": "9 Stocks to Buy With $5,000 in Starter Money", "image": "https://cdn.snapi.dev/images/v1/z/f/top-dividend-stocks-for-august.jpg", "site": "InvestorPlace", "text": "If you have a stack of Benjamins lying around and collecting dust, put them to good use with these stocks to buy with $5,000. The post 9 Stocks to Buy With $5,000 in Starter Money appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/12/9-stocks-to-buy-with-5000-in-starter-money/"}, {"symbol": "ABT", "publishedDate": "2020-12-17 10:32:17", "title": "5 MedTech Stocks That Have Outperformed the Industry in 2020", "image": "https://cdn.snapi.dev/images/v1/h/s/medical16---86xtvarxrq.jpg", "site": "Zacks Investment Research", "text": "Here are a few MedTech stocks which continued to outperform their respective industries amid the pandemic and can turn out to be wise investment choices.", "url": "https://www.zacks.com/stock/news/1176373/5-medtech-stocks-that-have-outperformed-the-industry-in-2020"}, {"symbol": "ABT", "publishedDate": "2020-12-16 23:37:08", "title": "Abbott: Thanks For The 25% Raise, But It's Simply Not Enough", "image": "https://cdn.snapi.dev/images/v1/i/h/medical13.jpg", "site": "Seeking Alpha", "text": "Abbott Laboratories is a great company that rewarded its shareholders with great returns. The company has recently rewarded shareholders with a massive 25% dividend raise.", "url": "https://seekingalpha.com/article/4395104-abbott-thanks-for-25-raise-simply-not-enough"}, {"symbol": "ABT", "publishedDate": "2020-12-16 16:08:21", "title": "FDA authorizes Abbott's rapid $25 Covid test for at-home use", "image": "https://cdn.snapi.dev/images/v1/3/s/106680727-1598535895724-abbott-binaxnow-kit-002.png", "site": "CNBC", "text": "\"FDA continues to authorize COVID-19 tests that will give more Americans access to greater testing flexibility and options,\" FDA Commissioner Dr. Stephen Hahn said.", "url": "https://www.cnbc.com/2020/12/16/fda-authorizes-abbotts-rapid-25-covid-test-for-at-home-use.html"}, {"symbol": "ABT", "publishedDate": "2020-12-16 15:52:08", "title": "FDA Gives Abbott's At-Home Coronavirus Test Emergency Use Authorization", "image": "https://cdn.snapi.dev/images/v1/3/z/fda-gives-abbotts-at-home-coronavirus-test-emergency-use-authorization.jpg", "site": "Forbes", "text": "The sample does not need to be sent to a lab to be processed.", "url": "https://www.forbes.com/sites/elanagross/2020/12/16/fda-gives-abbotts-at-home-coronavirus-test-emergency-use-authorization/"}, {"symbol": "ABT", "publishedDate": "2020-12-16 13:13:00", "title": "Abbott Labs' at-home, $25 rapid COVID-19 test gets EUA from FDA", "image": "https://cdn.snapi.dev/images/v1/b/q/medical7---wttvjo207e.jpg", "site": "Market Watch", "text": "Abbott Laboratories said Wednesday that its at-home BinaxNOW COVID-19 rapid COVID-19 test has been issued Emergency Use Authorization by the Food and Drug Administration. The company said BinaxNOW, which it says is the first at-home, virtually guided rapid test, can provide results in about 20 minutes, and will cost $25.", "url": "https://www.marketwatch.com/story/abbott-labs-at-home-25-rapid-covid-19-test-gets-eua-from-fda-2020-12-16"}, {"symbol": "ABT", "publishedDate": "2020-12-16 05:00:00", "title": "Despite A 70% Rally Abbott Stock Can Continue Higher", "image": "https://cdn.snapi.dev/images/v1/i/j/despite-a-70-rally-abbott-stock-can-continue-higher.jpg", "site": "Forbes", "text": "Abbott stock is up 23% since the start of the year and it has gained around 70% from its March lows. We believe that Abbott could offer an upside in the near term, as the company's revenues in the last three quarters have actually grown by 1%, despite the impact of the pandemic on its sales.", "url": "https://www.forbes.com/sites/greatspeculations/2020/12/16/despite-a-70-rally-abbott-stock-can-continue-higher/"}, {"symbol": "ABT", "publishedDate": "2020-12-15 18:48:08", "title": "Abbott (ABT) Stock Moves -0.23%: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/w/h/medical28.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) closed at $106.79 in the latest trading session, marking a -0.23% move from the prior day.", "url": "https://www.zacks.com/stock/news/1169778/abbott-abt-stock-moves-023-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2020-12-15 16:35:21", "title": "November Buys: 3 Monthly Paying CEFs, Plus Some Dividend Growth Opportunities", "image": "https://cdn.snapi.dev/images/v1/s/k/sk2ff2.", "site": "Seeking Alpha", "text": "November started out with a bang due to the election. Besides some early buying last month, it was another month of light buying throughout the remainder of November.", "url": "https://seekingalpha.com/article/4394921-november-buys-3-monthly-paying-cefs-plus-dividend-growth-opportunities"}, {"symbol": "ABT", "publishedDate": "2020-12-15 09:47:13", "title": "Abbott (ABT) Launches Immunity Boosting Hydration Solution", "image": "https://cdn.snapi.dev/images/v1/8/v/medical17.jpg", "site": "Zacks Investment Research", "text": "Abbott's (ABT) latest hydration solution with specifically chosen nutrients along with optimal balance of electrolytes and glucose is expected to boost immunity.", "url": "https://www.zacks.com/stock/news/1168073/abbott-abt-launches-immunity-boosting-hydration-solution"}, {"symbol": "ABT", "publishedDate": "2020-12-15 06:08:00", "title": "This Dividend Aristocrat Just Gave Investors a Great Early Christmas Gift", "image": "https://cdn.snapi.dev/images/v1/f/c/200417-architect1-768x410.jpg", "site": "The Motley Fool", "text": "And the goodies should keep on coming.", "url": "https://www.fool.com/investing/2020/12/15/dividend-aristocrat-gave-investors-christmas-gift/"}, {"symbol": "ABT", "publishedDate": "2020-12-14 15:13:28", "title": "The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF", "image": "https://cdn.snapi.dev/images/v1/n/h/medical14.jpg", "site": "InvestorPlace", "text": "One aspect of the ANEW ETF is focused on the bleeding edge of medical advances. Here's what you need to know if you're considering investing.", "url": "https://investorplace.com/genomics-telehealth-and-the-future-of-healthcare-with-the-anew-etf/"}, {"symbol": "ABT", "publishedDate": "2020-12-14 14:38:46", "title": "3 Health Care Companies That Recently Raised Dividends", "image": "https://cdn.snapi.dev/images/v1/h/k/drugs14.jpg", "site": "GuruFocus", "text": "Dividend increase announcements continue to pile up as 2020 draws to a close. The health care sector remains one of my favorite places to find stocks offering solid yields and lengthy track records of dividend growth.", "url": "https://www.gurufocus.com/news/1310730/3-health-care-companies-that-recently-raised-dividends"}, {"symbol": "ABT", "publishedDate": "2020-12-14 09:00:00", "title": "Abbott Develops New Pedialyte\u00ae Hydration Solution to Help Support Immune Health", "image": "https://cdn.snapi.dev/images/v1/i/k/press12---fdrjkgc5oz.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., Dec. 14, 2020 /PRNewswire/ -- Because supporting the immune system is top of mind for many people, Abbott (NYSE: ABT) is launching a new Pedialyte formulation specifically designed with key nutrients to support immune health. Pedialyte with Immune Support was developed...", "url": "https://www.prnewswire.com/news-releases/abbott-develops-new-pedialyte-hydration-solution-to-help-support-immune-health-301191798.html"}, {"symbol": "ABT", "publishedDate": "2020-12-14 06:04:00", "title": "3 COVID Stocks That Are Screaming Buys", "image": "https://cdn.snapi.dev/images/v1/y/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038422fdollar-sign-in-the-midst-of-coronavirusjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These coronavirus leaders are great picks for different reasons.", "url": "https://www.fool.com/investing/2020/12/14/3-covid-stocks-that-are-screaming-buys/"}, {"symbol": "ABT", "publishedDate": "2020-12-11 17:16:00", "title": "Dividend Aristocrat Abbott Laboratories Hikes Dividend by 25%", "image": "https://cdn.snapi.dev/images/v1/x/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6046842fgloved-hand-holding-a-beaker-full-of-moneyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "That's a big bump, even for the habitual payout raiser.", "url": "https://www.fool.com/investing/2020/12/11/dividend-aristocrat-abbott-laboratories-hikes-divi/"}, {"symbol": "ABT", "publishedDate": "2020-12-11 11:07:40", "title": "Abbott raises quarterly dividend by 25% to 45 cents a share", "image": "https://cdn.snapi.dev/images/v1/1/8/medical4.jpg", "site": "Market Watch", "text": "Abbott said Friday its board has raised its quarterly dividend by 25% to 45 cents a share. The health care company has raised its dividend for 49 straight years, making it a member of the S&P 500 Dividend Aristocrats Index, which includes companies that have raised their dividends for at least 25 consecutive years.", "url": "https://www.marketwatch.com/story/abbott-raises-quarterly-dividend-by-25-to-45-cents-a-share-2020-12-11"}, {"symbol": "ABT", "publishedDate": "2020-12-11 11:00:00", "title": "Abbott Increases Quarterly Dividend by 25%", "image": "https://cdn.snapi.dev/images/v1/d/p/press19---bunepdmycu.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., Dec. 11, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its board of directors has increased the company's quarterly common dividend to 45 cents per share, reflecting a 25% increase. \"Paying a strong and growing dividend is foundational to Abbott,\" said...", "url": "https://www.prnewswire.com/news-releases/abbott-increases-quarterly-dividend-by-25-301191339.html"}, {"symbol": "ABT", "publishedDate": "2020-12-10 06:05:00", "title": "3 Warren Buffett Dividend Stocks You Can Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/t/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038332fsmiling-warren-buffett-tmfjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Solid dividends and solid businesses. Buffett likes these stocks -- and you might, too.", "url": "https://www.fool.com/investing/2020/12/10/3-warren-buffett-dividend-stocks-you-can-buy-right/"}, {"symbol": "ABT", "publishedDate": "2020-12-09 08:00:00", "title": "Quidel, Abbott, Quest: Why Covid-19 Testing Stocks Are Still Worth A Look", "image": "https://cdn.snapi.dev/images/v1/c/t/quidel-abbott-quest-why-covid-19-testing-stocks-are-still-worth-a-look.jpg", "site": "Forbes", "text": "Our indicative theme of Covid-19 Testing Stocks- which includes the stocks of companies that produce or carry out tests for the highly infectious virus - is up by about 51% year-to-date, on an equally weighted basis, compared to the broader S&P 500 which is up around 15%. While the conversation.", "url": "https://www.forbes.com/sites/greatspeculations/2020/12/09/quidel-abbott-quest-why-covid-19-testing-stocks-are-still-worth-a-look/"}, {"symbol": "ABT", "publishedDate": "2020-12-07 09:03:50", "title": "9 Stocks to Buy Despite the Rocky Transition", "image": "https://cdn.snapi.dev/images/v1/n/a/medical14.jpg", "site": "InvestorPlace", "text": "Under normal circumstances, an outgoing president would congratulate the incoming administration. But we're not living in normal circumstances, which bodes well for these stocks to buy during a rocky transition.", "url": "https://investorplace.com/2020/12/9-stocks-to-buy-during-rocky-transition/"}, {"symbol": "ABT", "publishedDate": "2020-12-05 06:17:00", "title": "New Coronavirus Tests Have These Diagnostics Companies Recalibrating", "image": "https://cdn.snapi.dev/images/v1/l/6/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6015502fgettyimages-1266805801jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The COVID-19 testing landscape is changing. Will that sap the growth of the incumbent leaders?", "url": "https://www.fool.com/investing/2020/12/05/new-coronavirus-tests-have-these-diagnostics-compa/"}, {"symbol": "ABT", "publishedDate": "2020-12-03 13:53:40", "title": "3 Dividend Stocks for Big Total Returns in 2021", "image": "https://cdn.snapi.dev/images/v1/r/s/drugs10.jpg", "site": "InvestorPlace", "text": "These dividend stocks continue to outperform thier competition in yielding higher and consistent returns despite the impact of the pandemic The post 3 Dividend Stocks for Big Total Returns in 2021 appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets", "url": "https://investorplace.com/2020/12/3-dividend-stocks-for-big-total-returns-in-2021-abbv-jnj-mdt/"}, {"symbol": "ABT", "publishedDate": "2020-11-30 15:48:00", "title": "December Will Bring A Significant Dividend Increases From Medical Companies Abbott, Stryker", "image": "https://cdn.snapi.dev/images/v1/s/9/cahs82-3.jpg", "site": "Seeking Alpha", "text": "I was optimistic with my dividend growth predictions for the last two weeks of November. Notably, Sysco held their dividend steady and Tyson Foods \u2013 from which I had expected a double digit boost \u2013 only increased their dividend by 6%.", "url": "https://seekingalpha.com/article/4392142-december-will-bring-significant-dividend-increases-from-medical-companies-abbott-stryker"}, {"symbol": "ABT", "publishedDate": "2020-11-28 06:50:00", "title": "3 Highest-Growth Stocks in the Market Today", "image": "https://cdn.snapi.dev/images/v1/d/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6023142fgettyimages-1226786198jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These stocks could make you a fortune over the next decade.", "url": "https://www.fool.com/investing/2020/11/28/3-highest-growth-stocks-in-the-market-today/"}, {"symbol": "ABT", "publishedDate": "2020-11-21 06:09:00", "title": "3 Top Coronavirus Stocks to Buy in November", "image": "https://cdn.snapi.dev/images/v1/6/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6009442fcoronavirus-globe-stock-chartjpgw700opresize.jpg", "site": "The Motley Fool", "text": "At least two of them could have significant catalysts on the way this month.", "url": "https://www.fool.com/investing/2020/11/21/3-top-coronavirus-stocks-to-buy-in-november/"}, {"symbol": "ABT", "publishedDate": "2020-11-20 11:30:41", "title": "Why Is Abbott (ABT) Up 1.4% Since Last Earnings Report?", "image": "https://cdn.snapi.dev/images/v1/n/w/medical30.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/1107219/why-is-abbott-abt-up-14-since-last-earnings-report"}, {"symbol": "ABT", "publishedDate": "2020-11-18 09:00:00", "title": "Abbott Becomes First Anchor Sponsor of American Diabetes Association's Health Equity Now Initiative to Advance Access to Care and Technology for People with Diabetes", "image": "https://cdn.snapi.dev/images/v1/u/3/press13.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill. and ARLINGTON, Va., Nov. 18, 2020 /PRNewswire/ -- Today, Abbott (NYSE: ABT) and the American Diabetes Association\u00ae (ADA) announced that Abbott has become the first anchor sponsor of the Health Equity Now (HEN) platform to address health disparities for people with...", "url": "https://www.prnewswire.com/news-releases/abbott-becomes-first-anchor-sponsor-of-american-diabetes-associations-health-equity-now-initiative-to-advance-access-to-care-and-technology-for-people-with-diabetes-301175816.html"}, {"symbol": "ABT", "publishedDate": "2020-11-18 06:36:00", "title": "These 3 Medical Device Stocks Leave Biotech in the Dust", "image": "https://cdn.snapi.dev/images/v1/u/u/uujm333.jpg", "site": "The Motley Fool", "text": "Biotech stocks simply can't match these reliable returns.", "url": "https://www.fool.com/investing/2020/11/18/these-3-medical-device-stocks-leave-biotech-in-the/"}, {"symbol": "ABT", "publishedDate": "2020-11-17 08:39:00", "title": "Better Buy: Abbott Laboratories vs. DexCom", "image": "https://cdn.snapi.dev/images/v1/x/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6008202fhealth-monitoring-diabetes-getty-1jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These two companies are battling for market share of continuous glucose monitoring devices for diabetes, with each coming out with new models soon.", "url": "https://www.fool.com/investing/2020/11/17/better-buy-abbott-laboratories-vs-dexcom/"}, {"symbol": "ABT", "publishedDate": "2020-11-16 10:20:00", "title": "Abbott Named Industry Sustainability Leader for the Eighth Year in a Row on the Dow Jones Sustainability Index (DJSI)", "image": "https://cdn.snapi.dev/images/v1/1/e/press8---kxlfuqieck.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., Nov. 16, 2020 /PRNewswire/ -- For the eighth consecutive year, Abbott (NYSE: ABT) has been named the industry leader in sustainability by the Dow Jones Sustainability Index (DJSI), one of the most prestigious global benchmarks for corporate sustainability. As the Global...", "url": "https://www.prnewswire.com/news-releases/abbott-named-industry-sustainability-leader-for-the-eighth-year-in-a-row-on-the-dow-jones-sustainability-index-djsi-301173727.html"}, {"symbol": "ABT", "publishedDate": "2020-11-14 07:12:00", "title": "3 Top Coronavirus Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/f/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6005092fgettyimages-987070228jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Potential for emergency use authorizations and presidential promises are reasons to pick up these leaders today.", "url": "https://www.fool.com/investing/2020/11/14/3-top-coronavirus-stocks-to-buy-right-now/"}, {"symbol": "ABT", "publishedDate": "2020-11-10 06:05:00", "title": "3 Stocks That Should Be Big Winners Under Joe Biden's Coronavirus Plan", "image": "https://cdn.snapi.dev/images/v1/j/f/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5997762fjoe-biden-whitehousegovjpgw700opresize.jpg", "site": "The Motley Fool", "text": "They check off the boxes for three of the President-elect's top COVID-19 priorities.", "url": "https://www.fool.com/investing/2020/11/10/3-stocks-that-should-be-big-winners-under-joe-bide/"}, {"symbol": "ABT", "publishedDate": "2020-11-07 06:50:00", "title": "3 Coronavirus Stocks With Long-Term Growth Potential", "image": "https://cdn.snapi.dev/images/v1/o/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5981932fgettyimages-1249249358jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These companies are working on drug catalysts that could fuel massive expansion.", "url": "https://www.fool.com/investing/2020/11/07/3-coronavirus-stocks-with-long-term-growth-potenti/"}, {"symbol": "ABT", "publishedDate": "2020-11-07 06:06:00", "title": "Better Coronavirus Stock: Gilead Sciences or Abbott Laboratories?", "image": "https://cdn.snapi.dev/images/v1/k/k/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5982142fwoman-wearing-surgical-maskjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These stocks have been going in opposite directions of late.", "url": "https://www.fool.com/investing/2020/11/07/better-coronavirus-stock-gilead-sciences-or-abbott/"}, {"symbol": "ABT", "publishedDate": "2020-11-06 07:15:09", "title": "Abbott Tacks On Massive Coronavirus Test Growth \u2014 But Is ABT Stock A Buy?", "image": "https://cdn.snapi.dev/images/v1/m/v/medical18.jpg", "site": "Investors Business Daily", "text": "Medical company Abbott has now launched a handful of coronavirus tests, and the U.S. is paying $750 million for 150 million of one of its recently approved tests. So, is ABT stock a buy now?", "url": "https://www.investors.com/news/technology/abt-stock-buy-now/"}, {"symbol": "ABT", "publishedDate": "2020-11-06 06:04:00", "title": "3 Stocks to Buy and Hold for Decades", "image": "https://cdn.snapi.dev/images/v1/p/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5981092fsleeping-man-on-pile-of-moneyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "You'll probably be glad you did.", "url": "https://www.fool.com/investing/2020/11/06/3-stocks-to-buy-and-hold-for-decades/"}, {"symbol": "ABT", "publishedDate": "2020-11-05 19:59:51", "title": "Cramer on four coronavirus testing stocks worth owning", "image": "https://cdn.snapi.dev/images/v1/m/q/cramer-on-four-coronavirus-testing-stocks-worth-owning.jpg", "site": "CNBC Television", "text": "\"I bet the testing stocks have a lot more room to run,\" the \"Mad Money\" host said.", "url": "https://www.youtube.com/watch?v=wbylTasuy0Q"}, {"symbol": "ABT", "publishedDate": "2020-11-04 08:20:00", "title": "Quidel, Abbott, Quest: Testing Stocks To Watch As Covid-19 Cases Surge", "image": "https://cdn.snapi.dev/images/v1/0/b/quidel-abbott-quest-testing-stocks-to-watch-as-covid-19-cases-surge.jpg", "site": "Forbes", "text": "Our indicative theme of Covid-19 Testing Stocks, which includes medical device and diagnostic companies that are involved in Covid-19 testing \u2013 is up by about 66% year-to-date, significantly outperforming the S&P 500 which has gained about 3% over the same period. Covid-19 testing stocks could be.", "url": "https://www.forbes.com/sites/greatspeculations/2020/11/04/quidel-abbott-quest-testing-stocks-to-watch-as-covid-19-cases-surge/"}, {"symbol": "ABT", "publishedDate": "2020-11-03 09:20:00", "title": "Continue To Ride Abbott Stock In The Current Pandemic", "image": "https://cdn.snapi.dev/images/v1/e/6/continue-to-ride-abbott-stock-in-the-current-pandemic.jpg", "site": "Forbes", "text": "Abbott's stock lost more than 27% \u2013 dropping from $87 at the beginning of the year to below $63 in late March \u2013 then spiked 66% to around $105 now. That means it is well above the levels where it started the year.", "url": "https://www.forbes.com/sites/greatspeculations/2020/11/03/continue-to-ride-abbott-stock-in-the-current-pandemic/"}, {"symbol": "ABT", "publishedDate": "2020-11-02 19:00:19", "title": "Jim Cramer names 9 stocks to watch amid election results, rising cases", "image": "https://cdn.snapi.dev/images/v1/1/0/106675186-1598244437202-gettyimages-1214247578-362162568-1-4.jpeg", "site": "CNBC", "text": "\"All of these names would work under both candidates,\" the \"Mad Money\" host said ahead of the presidential election.", "url": "https://www.cnbc.com/2020/11/02/jim-cramers-9-stocks-to-watch-amid-election-results-rising-cases.html"}, {"symbol": "ABT", "publishedDate": "2020-10-30 19:53:50", "title": "Abbott: Ballast Your Portfolio For Uncertain Times", "image": "https://cdn.snapi.dev/images/v1/j/w/medical8.jpg", "site": "Seeking Alpha", "text": "Abbott is one of the stock market's steadiest performers. COVID-19 opens the door for realizing the vision underlying the Alere acquisition.", "url": "https://seekingalpha.com/article/4383446-abbott-ballast-your-portfolio-for-uncertain-times"}, {"symbol": "ABT", "publishedDate": "2020-10-30 11:00:00", "title": "Global Coronavirus Test Kit Market in Europe- Featuring 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, and BGI Genomics Co. Ltd.", "image": "https://cdn.snapi.dev/images/v1/p/r/press18---rcuc3ppglx.jpg", "site": "Business Wire", "text": "LONDON--(BUSINESS WIRE)-- #CoronavirusTestKitsMarketinEurope--The Coronavirus Test Kits Market in Europe will grow by $ -139.05 mn during 2020-2024", "url": "https://www.businesswire.com/news/home/20201030005375/en/Global-Coronavirus-Test-Kit-Market-in-Europe--Featuring-3D-Biomedicine-Science-and-Technology-Co.-Ltd.-Abbott-Laboratories-and-BGI-Genomics-Co.-Ltd.-Among-Others/"}, {"symbol": "ABT", "publishedDate": "2020-10-30 07:55:00", "title": "2 No-Brainer Stocks to Buy In The Next Market Crash", "image": "https://cdn.snapi.dev/images/v1/p/o/top-dividend-stocks-for-august.jpg", "site": "The Motley Fool", "text": "Adding shares of these companies to your portfolio during a market crash would be a much better move than panic selling.", "url": "https://www.fool.com/investing/2020/10/30/2-no-brainer-stocks-to-buy-in-the-next-market-cras/"}, {"symbol": "ABT", "publishedDate": "2020-10-29 08:33:25", "title": "9 Companies to Invest In Before We Hit 2021", "image": "https://cdn.snapi.dev/images/v1/4/u/stocks101-12.jpg", "site": "InvestorPlace", "text": "No matter who wins the presidential election, the results will be jarring to millions of Americans. Prepare yourself early by getting into these companies to invest in before 2021.", "url": "https://investorplace.com/2020/10/9-companies-to-invest-in-before-2021/"}, {"symbol": "ABT", "publishedDate": "2020-10-29 06:50:00", "title": "2 Healthcare Dividend Stocks to Buy No Matter Who Wins the Election", "image": "https://cdn.snapi.dev/images/v1/g/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5964742fgettyimages-1133472008jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Too often, high-yield stocks are too good to be true. One metric in particular can help us find the most reliable dividend payers.", "url": "https://www.fool.com/investing/2020/10/29/2-healthcare-dividend-stocks-to-buy-no-matter-wh/"}, {"symbol": "ABT", "publishedDate": "2020-10-27 11:51:13", "title": "A Trio of Stocks Growing Revenue Per Share", "image": "https://cdn.snapi.dev/images/v1/p/q/3okjn333-4.jpg", "site": "GuruFocus", "text": "The S&P 500 Index stocks saw their aggregate trailing 12-month revenue per share grow by approximately 4% on average every year over the past five years. The share price of the benchmark for the U.S. stock market ($3,400.97 as of Monday) has gained nearly 65% over the past five years through Oct. 26.", "url": "https://www.gurufocus.com/news/1268020/a-trio-of-stocks-growing-revenue-per-share"}, {"symbol": "ABT", "publishedDate": "2020-10-25 06:10:00", "title": "3 No-Brainer Dividend Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/q/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5938172fgettyimages-1051617040jpgw700opresize.jpg", "site": "The Motley Fool", "text": "It's an easy decision with these stocks.", "url": "https://www.fool.com/investing/2020/10/25/3-no-brainer-dividend-stocks-to-buy-right-now/"}, {"symbol": "ABT", "publishedDate": "2020-10-23 00:00:00", "title": "Laboratory Information Management System (LIMS) Market | Growing Demand For Bio-banking to Boost the Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20201022006030/en/832785/23/IRTNTR41085.jpg", "site": "businesswire", "text": "The Global Laboratory Information Management System (LIMS) Market will grow by USD 705.85 mn during 2020-2024", "url": "https://www.businesswire.com/news/home/20201022006030/en/Laboratory-Information-Management-System-LIMS-Market-Growing-Demand-For-Bio-banking-to-Boost-the-Market-Growth-Technavio"}, {"symbol": "ABT", "publishedDate": "2020-10-22 08:04:54", "title": "Cwm LLC Purchases 7,076 Shares of Abbott Laboratories (NYSE:ABT)", "image": "https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg", "site": "https://www.thelincolnianonline.com", "text": "Cwm LLC increased its position in Abbott Laboratories (NYSE:ABT) by 52.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 20,579 shares of the healthcare product maker\u2019s stock after purchasing an additional 7,076 shares during the quarter. Cwm LLC\u2019s holdings in [\u2026]", "url": "https://www.thelincolnianonline.com/2020/10/22/cwm-llc-purchases-7076-shares-of-abbott-laboratories-nyseabt.html"}, {"symbol": "ABT", "publishedDate": "2020-10-22 00:00:00", "title": "Abbott Laboratories Has 'Solid Upside Potential,' BofA Says After Q3 Print", "image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cp_hd3d_proclaimdrg_front_shadow.jpg", "site": "https://www.benzinga.com", "text": "Abbott Laboratories (NYSE: ABT) reported strong third-quarter results Wednesday and looks able to generate\u00a0double-digit earnings growth going ahead, even without considering...", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/20/10/18017994/abbott-laboratories-has-solid-upside-potential-bofa-says-after-q3-print"}, {"symbol": "ABT", "publishedDate": "2020-10-21 23:13:20", "title": "Le vendite di Abbott Laboratories sono aumentate del 9,6% nel Q3 | Invezz", "image": "https://invezz.com/wp-content/uploads/2020/10/132249930-s.jpg", "site": "https://invezz.com", "text": "Abbott prevede almeno \u00a32,72 di EPS rettificato per l'intero anno. L'azienda sanitaria registra un utile netto di \u00a3940 milioni nel Q3.", "url": "https://invezz.com/it/notizie/2020/10/21/vendite-abbott-laboratories-aumentate-q3/"}, {"symbol": "ABT", "publishedDate": "2020-10-21 20:08:28", "title": "De omzet van Abbott Laboratories steeg met 9,6% in Q3 | Invezz", "image": "https://invezz.com/wp-content/uploads/2020/10/132249930-s.jpg", "site": "https://invezz.com", "text": "De omzet van Abbott Laboratories steeg met 9,6% in Q3. Het zorgbedrijf rapporteert \u00a3940 miljoen aan netto-inkomen in het derde kwartaal.", "url": "https://invezz.com/nl/nieuws/2020/10/21/omzet-abbott-laboratories/"}, {"symbol": "ABT", "publishedDate": "2020-10-21 17:50:35", "title": "Las ventas de Abbott Laboratories aumentan un 9,6% en el tercer trimestre fiscal | Invezz", "image": "https://invezz.com/wp-content/uploads/2020/10/132249930-s.jpg", "site": "https://invezz.com", "text": "Abbott Laboratories (NYSE: ABT) public\u00f3 su informe de ganancias para el tercer trimestre fiscal el mi\u00e9rcoles. La compa\u00f1\u00eda dijo que sus ganancias en el tercer trimestre fueron m\u00e1s favorables de lo que los analistas esperaban, y expres\u00f3 su confianza en que su desempe\u00f1o se mantendr\u00e1 fuerte durante el resto del a\u00f1o. Las acciones de la compa\u00f1\u00eda cayeron menos del 0,5% en las operaciones previas a la comercializaci\u00f3n el mi\u00e9rcoles y se hundieron otro 1,5% en la apertura del mercado. Abbott Laboratories cotiza ahora a 81,51 libras esterlinas por acci\u00f3n, lo que representa una recuperaci\u00f3n cercana al 55% desde marzo, cuando", "url": "https://invezz.com/es/noticias/2020/10/21/las-ventas-de-abbott-laboratories-aumentan-un-96-en-el-tercer-trimestre-fiscal/"}, {"symbol": "ABT", "publishedDate": "2020-10-21 15:33:23", "title": "Abbott Laboratories f\u00f6rs\u00e4ljning steg med 9,6% i tredje kvartalet | Invezz", "image": "https://invezz.com/wp-content/uploads/2020/10/132249930-s.jpg", "site": "https://invezz.com", "text": "Sjukv\u00e5rdsf\u00f6retaget rapporterar 940 miljoner pund i nettoresultat under tredje kvartalet. Abbott f\u00f6rutsp\u00e5r minst \u00a32,72 justerat EPS f\u00f6r hel\u00e5ret.", "url": "https://invezz.com/sv/nyheter/2020/10/21/abbott-laboratories-forsaljning-steg-96-i-tredje-kvartalet/"}, {"symbol": "ABT", "publishedDate": "2020-10-21 15:32:00", "title": "Coronavirus update: CDC says nearly 300,000 excess American deaths have occurred during pandemic", "image": "https://s.marketwatch.com/public/resources/images/MW-ID551_trump__ZG_20200401115900.jpg", "site": "marketwatch", "text": "The U.S. death toll from the coronavirus illness COVID-19 rose above 221,000 on Wednesday, according to data aggregated by Johns Hopkins University, and the...", "url": "https://www.marketwatch.com/story/coronavirus-update-cdc-says-virus-has-caused-deaths-of-nearly-300000-americans-2020-10-21"}, {"symbol": "ABT", "publishedDate": "2020-10-21 14:46:16", "title": "Abbott Laboratories\u2019 sales jump 9.6% in the fiscal third quarter.", "image": "https://invezz.com/wp-content/uploads/2020/10/132249930-s.jpg", "site": "https://invezz.com", "text": "Abbott Laboratories\u2019 sales jump 9.6% in the fiscal third quarter. The health care company reports \u00a3940 million of net income in Q3.", "url": "https://invezz.com/news/2020/10/21/abbott-laboratories-sales-jump-9-6-in-the-fiscal-third-quarter/"}, {"symbol": "ABT", "publishedDate": "2020-10-21 00:00:00", "title": "The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings", "image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_272.jpg", "site": "benzinga", "text": "Here's a roundup of top developments in the biotech space over the last 24 hours.\nScaling The Peaks\n(Biotech Stocks Hitting 52-week Highs Oct. 20)\n\nAileron Therapeutics Inc (...", "url": "https://www.benzinga.com/general/biotech/20/10/17992046/the-daily-biotech-pulse-prothena-progress-in-parkinsons-disease-pipeline-fast-track-for-xeris-bio"}, {"symbol": "ABT", "publishedDate": "2020-10-20 00:00:00", "title": "Global Bioabsorbable Stents Market Forecast 2020-2025 Featuring Key Players - Abbot Laboratories, Elixir Medical, Reva Medical, Kyoto Medical Planning - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20201020005550/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20201020005550/en/Global-Bioabsorbable-Stents-Market-Forecast-2020-2025-Featuring-Key-Players---Abbot-Laboratories-Elixir-Medical-Reva-Medical-Kyoto-Medical-Planning---ResearchAndMarkets.com"}, {"symbol": "ABT", "publishedDate": "2020-10-19 00:00:00", "title": "Global Wireless Health and Fitness Devices Market Report 2020: Products and Apps that Integrate Data from Varied Sources - The Future of Fitness and Health Tracking Devices - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20201019005517/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20201019005517/en/Global-Wireless-Health-and-Fitness-Devices-Market-Report-2020-Products-and-Apps-that-Integrate-Data-from-Varied-Sources---The-Future-of-Fitness-and-Health-Tracking-Devices---ResearchAndMarkets.com"}, {"symbol": "ABT", "publishedDate": "2020-10-18 15:45:05", "title": "Millions more virus rapid tests, but are results reported?", "image": "null", "site": "abcnews", "text": "The U.S. can now test several million people daily for coronavirus but the boom comes with a new challenge: keeping track of the results", "url": "https://abcnews.go.com/Business/wireStory/millions-virus-rapid-tests-results-reported-73680837"}, {"symbol": "ABT", "publishedDate": "2020-10-18 15:44:49", "title": "Millions more virus rapid tests, but are results reported?", "image": "null", "site": "abcnews", "text": "The U.S. can now test several million people daily for coronavirus but the boom comes with a new challenge: keeping track of the results", "url": "https://abcnews.go.com/Health/wireStory/millions-virus-rapid-tests-results-reported-73680836"}, {"symbol": "ABT", "publishedDate": "2020-10-18 00:00:00", "title": "The Week Ahead In Biotech: Spectrum Pharma FDA Decision, Biogen And Abbott Earnings, Cancer Conference", "image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medic-563423_1920_398_33.jpg", "site": "benzinga", "text": "Biopharma stocks, which started the week on a firm\u00a0footing, lost momentum mid-way through amid market-wide sell-off triggered by waning stimulus hopes.\nThe week was a quiet...", "url": "https://www.benzinga.com/general/biotech/20/10/17942727/the-week-ahead-in-biotech-spectrum-pharma-fda-decision-biogen-and-abbott-earnings-cancer-conferen"}, {"symbol": "ABT", "publishedDate": "2020-10-17 00:00:00", "title": "High Protein-Based Food Market will Showcase Positive Impact during 2020-2024 | Shift In Preference Toward Natural And Herbal Products to Boost the Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20201016005501/en/831045/23/IRTNTR45109.jpg", "site": "businesswire", "text": "The Global High Protein-Based Food Market will grow by $ 27.49 bn during 2020-2024", "url": "https://www.businesswire.com/news/home/20201016005501/en/High-Protein-Based-Food-Market-will-Showcase-Positive-Impact-during-2020-2024-Shift-In-Preference-Toward-Natural-And-Herbal-Products-to-Boost-the-Market-Growth-Technavio"}, {"symbol": "ABT", "publishedDate": "2020-10-16 18:03:30", "title": "Pounding The Table For Undervalued OPKO Health (NASDAQ:OPK)", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha", "text": "Rayaldee EU Approval is close and the clinical trial as a COVID therapeutic is underway. Pipeline star Somatrogon, the weekly human growth hormone drug, prepares for FDA BLA submission with partner Pfizer.", "url": "https://seekingalpha.com/article/4379451-pounding-table-for-undervalued-opko-health"}, {"symbol": "ABT", "publishedDate": "2020-10-16 00:00:00", "title": "Netherlands Diabetes Market Analysis & Forecast 2020-2025: Rising Diabetes Mellitus in an Aging Population Driving Growth - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20201016005349/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20201016005349/en/Netherlands-Diabetes-Market-Analysis-Forecast-2020-2025-Rising-Diabetes-Mellitus-in-an-Aging-Population-Driving-Growth---ResearchAndMarkets.com"}, {"symbol": "ABT", "publishedDate": "2020-10-15 00:00:00", "title": "Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market 2019-2020 & Forecast to 2028 - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20201015005665/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20201015005665/en/Europe-Extra-Corporeal-Membrane-Oxygenation-ECMO-System-Market-2019-2020-Forecast-to-2028---ResearchAndMarkets.com"}, {"symbol": "ABT", "publishedDate": "2020-10-13 14:33:48", "title": "Another Abbott antibody test is authorized", "image": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "site": "marketwatch", "text": "Shares of Abbott Laboratories undefined were down 1.6% in trading on Tuesday, the day after the company said it had received emergency authorization from the...", "url": "https://www.marketwatch.com/story/another-abbott-antibody-test-is-authorized-2020-10-13"}, {"symbol": "ABT", "publishedDate": "2020-10-13 08:38:41", "title": "Tiaa Fsb Has $31.95 Million Position in Abbott Laboratories (NYSE:ABT)", "image": "https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg", "site": "https://www.thelincolnianonline.com", "text": "Tiaa Fsb cut its holdings in Abbott Laboratories (NYSE:ABT) by 10.3% in the third quarter, Holdings Channel.com reports. The fund owned 293,536 shares of the healthcare product maker\u2019s stock after selling 33,650 shares during the quarter. Tiaa Fsb\u2019s holdings in Abbott Laboratories were worth $31,945,000 as of its most recent SEC filing. Several other institutional [\u2026]", "url": "https://www.thelincolnianonline.com/2020/10/13/tiaa-fsb-has-31-95-million-position-in-abbott-laboratories-nyseabt.html"}, {"symbol": "ABT", "publishedDate": "2020-10-12 10:38:45", "title": "Abbott Laboratories (NYSE:ABT) Upgraded to Buy by Zacks Investment Research", "image": "https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg", "site": "https://www.thelincolnianonline.com", "text": "Abbott Laboratories (NYSE:ABT) was upgraded by Zacks Investment Research from a \u201chold\u201d rating to a \u201cbuy\u201d rating in a research note issued on Monday, Zacks.com reports. The brokerage presently has a $116.00 target price on the healthcare product maker\u2019s stock. Zacks Investment Research\u2018s price objective would indicate a potential upside of 5.22% from the stock\u2019s [\u2026]", "url": "https://www.thelincolnianonline.com/2020/10/12/abbott-laboratories-nyseabt-upgraded-to-buy-by-zacks-investment-research.html"}, {"symbol": "ABT", "publishedDate": "2020-10-12 00:00:00", "title": "Global PCR Markets Report 2020-2024: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20201012005275/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20201012005275/en/Global-PCR-Markets-Report-2020-2024-Forecasts-for-qPCR-dPCR-Singleplex-Multiplex-Markets---ResearchAndMarkets.com"}, {"symbol": "ABT", "publishedDate": "2020-10-10 09:27:42", "title": "TRUE Private Wealth Advisors Has $533,000 Stake in Abbott Laboratories (NYSE:ABT)", "image": "https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg", "site": "https://www.thelincolnianonline.com", "text": "TRUE Private Wealth Advisors decreased its holdings in shares of Abbott Laboratories (NYSE:ABT) by 8.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,898 shares of the healthcare product maker\u2019s stock after selling 433 shares during the quarter. TRUE Private [\u2026]", "url": "https://www.thelincolnianonline.com/2020/10/10/true-private-wealth-advisors-has-533000-stake-in-abbott-laboratories-nyseabt.html"}, {"symbol": "ABT", "publishedDate": "2020-10-09 13:33:36", "title": "Smart Biosensor Market Size, Share , Growth , Trends, Company Analysis and Forecast 2020-2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 09, 2020 (Profound via COMTEX) --\nA recent report provides crucial insights along with application based and forecast information in the Global Smart...", "url": "https://www.marketwatch.com/press-release/smart-biosensor-market-size-share-growth-trends-company-analysis-and-forecast-2020-2026-2020-10-09"}, {"symbol": "ABT", "publishedDate": "2020-10-09 09:07:06", "title": "Oncology Apoptosis Modulators Market Share 2020 Global Trend, Industry News, Industry Demand, Business Growth, Top Key Players Update, Business Statistics and Research Methodology by Forecast to 2025", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 09, 2020 (The Expresswire) --\nGlobal Oncology Apoptosis Modulators Market Research Report offers an in-depth analysis of the market size (revenue),...", "url": "https://www.marketwatch.com/press-release/oncology-apoptosis-modulators-market-share-2020-global-trend-industry-news-industry-demand-business-growth-top-key-players-update-business-statistics-and-research-methodology-by-forecast-to-2025-2020-10-09"}, {"symbol": "ABT", "publishedDate": "2020-10-09 08:57:58", "title": "Geriatric Medicine Market Growth and Analysis, Top Manufacturers, Industry Trends, Size, Industry Share, Forecast to 2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 09, 2020 (The Expresswire) --\nGlobal \u201cGeriatric Medicine Market\u201d report includes overview of industry characteristics, manufacturing technology, industry...", "url": "https://www.marketwatch.com/press-release/geriatric-medicine-market-growth-and-analysis-top-manufacturers-industry-trends-size-industry-share-forecast-to-2026-2020-10-09"}, {"symbol": "ABT", "publishedDate": "2020-10-09 06:26:08", "title": "Trampoline Market Business Analysis, Production, CAGR and  Rising Trends | Fun Spot Manufacturing LLC, JumpSport Inc", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 09, 2020 (WiredRelease via Comtex) --\nMarketResearch.Biz has posted a newly modern statistical statistics, titled as Trampoline Market. It is a precious...", "url": "https://www.marketwatch.com/press-release/trampoline-market-business-analysis-production-cagr-and-rising-trends-fun-spot-manufacturing-llc-jumpsport-inc-2020-10-09"}, {"symbol": "ABT", "publishedDate": "2020-10-09 00:00:00", "title": "Ventricular Assist Devices Market will Showcase Positive Impact during 2020-2024 | Rising Incidence of Heart Failure to Boost the Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20201008005656/en/828757/23/IRTNTR40227.jpg", "site": "businesswire", "text": "The Global Ventricular Assist Devices Market will grow by USD 943.27 mn during 2020-2024", "url": "https://www.businesswire.com/news/home/20201008005656/en/Ventricular-Assist-Devices-Market-will-Showcase-Positive-Impact-during-2020-2024-Rising-Incidence-of-Heart-Failure-to-Boost-the-Market-Growth-Technavio"}, {"symbol": "ABT", "publishedDate": "2020-10-08 08:23:19", "title": "Diabetes Drug Market Research 2020 by Size, Business Opportunities, Major Manufacturing, Industry Growth, Industry Share Report, Covid-19 Impact Analysis on Regional Analysis, and Global Forecast to 2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (The Expresswire) --\nGlobal \u201cDiabetes Drug Market\u201d research report provides key statistics of the market status in terms of Diabetes Drug market...", "url": "https://www.marketwatch.com/press-release/diabetes-drug-market-research-2020-by-size-business-opportunities-major-manufacturing-industry-growth-industry-share-report-covid-19-impact-analysis-on-regional-analysis-and-global-forecast-to-2026-2020-10-08"}, {"symbol": "ABT", "publishedDate": "2020-10-08 06:05:23", "title": "Intelligent Apps Market Thoughtful data, Regional Trends, Demand and  Future Prospect | SAP SE, Hewlett Packard Enterprise Company", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (WiredRelease via Comtex) --\nMarketResearch.Biz has posted a newly modern statistical statistics, titled as Intelligent Apps Market. It is a...", "url": "https://www.marketwatch.com/press-release/intelligent-apps-market-thoughtful-data-regional-trends-demand-and-future-prospect-sap-se-hewlett-packard-enterprise-company-2020-10-08"}, {"symbol": "ABT", "publishedDate": "2020-10-08 06:05:20", "title": "Digital Audio Workstations Market Threat, Market Demand, Product Analysis, Growth and  Revenue | Apple Inc, Ableton AG", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (WiredRelease via Comtex) --\nMarketResearch.Biz has posted a newly modern statistical statistics, titled as Digital Audio Workstations Market....", "url": "https://www.marketwatch.com/press-release/digital-audio-workstations-market-threat-market-demand-product-analysis-growth-and-revenue-apple-inc-ableton-ag-2020-10-08"}, {"symbol": "ABT", "publishedDate": "2020-10-08 05:59:04", "title": "Cns Disorders Drug Market Size 2020 Industry Share, Trends Evaluation, Global Growth, Recent Developments, Latest Technology, and 2026 Future Forecast Research Report", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (The Expresswire) --\n\"Final Report will add the analysis of the impact of COVID-19 on this industry.\" Global \u201cCns Disorders Drug Market\u201d...", "url": "https://www.marketwatch.com/press-release/cns-disorders-drug-market-size-2020-industry-share-trends-evaluation-global-growth-recent-developments-latest-technology-and-2026-future-forecast-research-report-2020-10-08"}, {"symbol": "ABT", "publishedDate": "2020-10-08 04:23:45", "title": "Diabetes Therapeutics and Diagnostics Market Size 2020 Industry Size Analyzed by Business Opportunity, Development, Growth Factors, Applications Analysis and Future Prospects 2025", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 08, 2020 (The Expresswire) --\nGlobal \u201cDiabetes Therapeutics and Diagnostics Market\u201d Growth 2020 - 2025 report offers a complete breakdown of key drivers,...", "url": "https://www.marketwatch.com/press-release/diabetes-therapeutics-and-diagnostics-market-size-2020-industry-size-analyzed-by-business-opportunity-development-growth-factors-applications-analysis-and-future-prospects-2025-2020-10-08"}, {"symbol": "ABT", "publishedDate": "2020-10-08 01:53:31", "title": "Angina Market 2020 Global Industry Analysis, By Key Players, Segmentation, Trends and Forecast By 2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 07, 2020 (MarketersMedia) --\nWiseguyreports.Com Publish New Market Research Report On \"Angina Market 2020 Global Analysis, Size, Share, Trends,...", "url": "https://www.marketwatch.com/press-release/angina-market-2020-global-industry-analysis-by-key-players-segmentation-trends-and-forecast-by-2026-2020-10-07"}, {"symbol": "ABT", "publishedDate": "2020-10-08 00:00:00", "title": "Blood Glucose Monitoring Device Market to reach USD 15.60 billion by 2024, Abbott Laboratories and Agamatrix Inc. emerge as Key Contributors to growth | Technavio", "image": "https://mms.businesswire.com/media/20201008005104/en/828457/23/IRTNTR44338.jpg", "site": "businesswire", "text": "The Global Blood Glucose Monitoring Devices Market will grow by USD 15.60 bn during 2020-2024", "url": "https://www.businesswire.com/news/home/20201008005104/en/Blood-Glucose-Monitoring-Device-Market-to-reach-USD-15.60-billion-by-2024-Abbott-Laboratories-and-Agamatrix-Inc.-emerge-as-Key-Contributors-to-growth-Technavio"}, {"symbol": "ABT", "publishedDate": "2020-10-07 09:54:58", "title": "Companion Diagnostic Market Global Research Report 2020 to 2026 Abbott Laboratories(NYSE: ABT), Agilent Technologies(NYSE: A), Danaher(NYSE: DHR), Illumina", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 07, 2020 (Market Insight Reports) -- The Companion Diagnostic Market 2020 report is a comprehensive, professional, and in-depth research of the market...", "url": "https://www.marketwatch.com/press-release/companion-diagnostic-market-global-research-report-2020-to-2026-abbott-laboratoriesnyse-abt-agilent-technologiesnyse-a-danahernyse-dhr-illumina-2020-10-07"}, {"symbol": "ABT", "publishedDate": "2020-10-07 07:28:52", "title": "Gradient Investments LLC Buys 5,798 Shares of Abbott Laboratories (NYSE:ABT)", "image": "https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg", "site": "https://www.thelincolnianonline.com", "text": "Gradient Investments LLC increased its stake in shares of Abbott Laboratories (NYSE:ABT) by 17.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 38,300 shares of the healthcare product maker\u2019s stock after acquiring an additional 5,798 shares during the period. Gradient Investments LLC\u2019s holdings in Abbott Laboratories [\u2026]", "url": "https://www.thelincolnianonline.com/2020/10/07/gradient-investments-llc-buys-5798-shares-of-abbott-laboratories-nyseabt.html"}, {"symbol": "ABT", "publishedDate": "2020-10-07 00:00:00", "title": "Abbott Stock Is A Brilliant Buy", "image": "https://i-invdn-com.akamaized.net/redesign/images/seo/v2/investingcom_analysis_og.jpg", "site": "investing", "text": "Stocks Analysis by MarketBeat.com (Jea Yu) covering: S&P 500, Abbott Laboratories. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com", "url": "https://www.investing.com/analysis/abbott-nyse-abt-stock-is-a-brilliant-buy-the-news-play-200540225"}, {"symbol": "ABT", "publishedDate": "2020-10-06 05:37:38", "title": "Chemotherapy Market Size 2020 With Top Countries Data, Industry Analysis by Regions, Share, Revenue, Prominent Players, Development Strategy, Business Prospect and Forecast to 2025", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 06, 2020 (The Expresswire) --\nGlobal \u201cChemotherapy Market\u201d research report offers qualitative and quantitative insights in relation to industry growth...", "url": "https://www.marketwatch.com/press-release/chemotherapy-market-size-2020-with-top-countries-data-industry-analysis-by-regions-share-revenue-prominent-players-development-strategy-business-prospect-and-forecast-to-2025-2020-10-06"}, {"symbol": "ABT", "publishedDate": "2020-10-06 00:00:00", "title": "Vitamin C Supplements Market Will Showcase Neutral Impact During 2020-2024 | Increasing Prevalence of Vitamin C Deficiency to Boost the Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20201005005771/en/827405/23/IRTNTR43370.jpg", "site": "businesswire", "text": "The Global Vitamin C Supplements Market will grow by USD 2.52 bn during 2020-2024", "url": "https://www.businesswire.com/news/home/20201005005771/en/Vitamin-C-Supplements-Market-Will-Showcase-Neutral-Impact-During-2020-2024-Increasing-Prevalence-of-Vitamin-C-Deficiency-to-Boost-the-Market-Growth-Technavio"}, {"symbol": "ABT", "publishedDate": "2020-10-05 05:20:59", "title": "Global Solid Tumor Therapeutics Market 2020 Top countries data  - Industry Size, Growth Factors, Top Leaders, Development Strategy, Future Trends, Historical Analysis, Competitive Landscape and Regional Forecast By 360 Market Updates", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 05, 2020 (The Expresswire) --\nGlobal \u201cSolid Tumor Therapeutics Market\u201d Size report 2020 - 2024 gives complete analysis of industry position and viewpoint...", "url": "https://www.marketwatch.com/press-release/global-solid-tumor-therapeutics-market-2020-top-countries-data---industry-size-growth-factors-top-leaders-development-strategy-future-trends-historical-analysis-competitive-landscape-and-regional-forecast-by-360-market-updates-2020-10-05"}, {"symbol": "ABT", "publishedDate": "2020-10-05 00:46:50", "title": "Do Institutions Own Abbott India Limited (NSE:ABBOTINDIA) Shares?", "image": "https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299", "site": "https://simplywall.st", "text": "", "url": "https://simplywall.st/stocks/in/pharmaceuticals-biotech/nse-abbotindia/abbott-india-shares/news/do-institutions-own-abbott-india-limited-nseabbotindia-shares/"}, {"symbol": "ABT", "publishedDate": "2020-10-05 00:00:00", "title": "Global Biomarkers Market Forecasts for Immuno-Oncology Diagnostics 2020-2024 with Executive and Consultant Guides - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20201005005472/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20201005005472/en/Global-Biomarkers-Market-Forecasts-for-Immuno-Oncology-Diagnostics-2020-2024-with-Executive-and-Consultant-Guides---ResearchAndMarkets.com"}, {"symbol": "ABT", "publishedDate": "2020-10-03 13:35:57", "title": "The White House hoped testing would keep the coronavirus out \u2014 but it didn't", "image": "https://image.cnbcfm.com/api/v1/image/106467421-1585607444111gettyimages-1208678043.jpeg?v=1601664698", "site": "cnbc", "text": "\"I don't think any experts recommend that you use medical screening tests as a replacement for social distancing, or masks, or other kinds of mitigation efforts,\" Dr. Ben Mazer,\u00a0an anatomic and clinical pathologist at\u00a0Johns Hopkins Hospital, said.", "url": "https://www.cnbc.com/2020/10/03/white-house-hoped-testing-would-keep-coronavirus-out-but-it-didnt.html"}, {"symbol": "ABT", "publishedDate": "2020-10-02 12:00:14", "title": "Drug of Abuse Testing Services Market Analysis to 2025 \u2013 Revenue, Key Developments, SWOT Study and Assessment, and Future Prospects By Million Insights", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 02, 2020 (AB Digital via COMTEX) --\nGlobal Drug of Abuse Testing Services Market is anticipated to reach USD 2.9 billion by 2025. Drugs of abuse testing...", "url": "https://www.marketwatch.com/press-release/drug-of-abuse-testing-services-market-analysis-to-2025-revenue-key-developments-swot-study-and-assessment-and-future-prospects-by-million-insights-2020-10-02"}, {"symbol": "ABT", "publishedDate": "2020-10-02 08:36:44", "title": "Europe Autoimmune Disease Diagnostics Market 2020 Strategic Assessments - Abbott Laboratories, Biomrieux, Bio-rad Laboratories, F. Hoffmann-la Roche, and Thermo Fisher Scientific Inc", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 02, 2020 (Market Insight Reports) --\nThe Europe Autoimmune Disease Diagnostics Market report is a compilation of first-hand information, qualitative and...", "url": "https://www.marketwatch.com/press-release/europe-autoimmune-disease-diagnostics-market-2020-strategic-assessments---abbott-laboratories-biomrieux-bio-rad-laboratories-f-hoffmann-la-roche-and-thermo-fisher-scientific-inc-2020-10-02"}, {"symbol": "ABT", "publishedDate": "2020-10-02 08:19:42", "title": "In-Vitro Diagnostics Quality Control Market Analysis, Research and Study Report 2020-2025", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 02, 2020 (Market Insight Reports) --\nThe Global Report on In-Vitro Diagnostics Quality Control Market Size, Status, Growth and Forecast 2020-2025. The...", "url": "https://www.marketwatch.com/press-release/in-vitro-diagnostics-quality-control-market-analysis-research-and-study-report-2020-2025-2020-10-02"}, {"symbol": "ABT", "publishedDate": "2020-10-02 06:12:55", "title": "Advanced Parenteral Drug Delivery Devices Market | Size to Witness Huge Growth by 2027", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 02, 2020 (Heraldkeepers) --\nParenteral drug delivery devices are used for administration of medicine by routes apart from the oral mode of dosage....", "url": "https://www.marketwatch.com/press-release/advanced-parenteral-drug-delivery-devices-market-size-to-witness-huge-growth-by-2027-2020-10-02"}, {"symbol": "ABT", "publishedDate": "2020-10-02 04:25:20", "title": "Global CO2 Surgical Lasers Market 2020 Industry Size, Share, Revenue and Growth factor, Top Key Players and Forecast to 2024", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Oct 02, 2020 (The Expresswire) --\n\u201cFinal Report will add the analysis of the impact of COVID-19 on this industry\u201d Global \u201cCO2 Surgical Lasers Market\u201d...", "url": "https://www.marketwatch.com/press-release/global-co2-surgical-lasers-market-2020-industry-size-share-revenue-and-growth-factor-top-key-players-and-forecast-to-2024-2020-10-02"}, {"symbol": "ABT", "publishedDate": "2020-10-01 23:21:00", "title": "Opinion | Beat Covid Without a Vaccine", "image": "https://images.wsj.net/im-239083/social", "site": "wsj", "text": "Home testing and \u2018digital passports\u2019 could stop outbreaks.", "url": "https://www.wsj.com/articles/beat-covid-without-a-vaccine-11601594473"}, {"symbol": "ABT", "publishedDate": "2020-10-01 22:00:00", "title": "Abbott Tech, New Milford boys soccer teams thrilled to return to competition", "image": "https://s.hdnux.com/photos/01/14/36/50/20048408/7/rawImage.jpg", "site": "https://www.newstimes.com", "text": "Abbott Tech and New Milford opened the 2020 CIAC boys soccer season, playing the first varsity high school sports in Connecticut since March.", "url": "https://www.newstimes.com/sports/highschool/article/Abbott-Tech-New-Milford-boys-soccer-teams-15614194.php"}, {"symbol": "ABT", "publishedDate": "2020-09-30 18:16:24", "title": "The iShares U.S. Medical Devices ETF: Medical Devices Look A Little Risky During A Pandemic (NYSEARCA:IHI)", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha", "text": "The iShares U.S. Medical Devices ETF is a market-cap-weighted ETF that invests in medical device companies.", "url": "https://seekingalpha.com/article/4377036-ishares-u-s-medical-devices-etf-medical-devices-look-little-risky-during-pandemic"}, {"symbol": "ABT", "publishedDate": "2020-09-30 00:00:00", "title": "Nutraceuticals Market | Demand For Nutraceuticals with Medical Benefits to Boost the Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20200929005814/en/825973/23/IRTNTR41486.jpg", "site": "businesswire", "text": "The Global Nutraceuticals Market will grow by USD 180.38 bn during 2020-2024", "url": "https://www.businesswire.com/news/home/20200929005814/en/Nutraceuticals-Market-Demand-For-Nutraceuticals-with-Medical-Benefits-to-Boost-the-Market-Growth-Technavio"}, {"symbol": "ABT", "publishedDate": "2020-09-28 22:02:21", "title": "Feds to ship millions of tests in bid to reopen K-12 schools", "image": "https://s.abcnews.com/images/Business/WireAP_21068dea78a24dc6bb21c4bd8a35c75e_16x9_992.jpg", "site": "abcnews", "text": "President Donald Trump has announced the shipment of millions of rapid coronavirus tests to states this week", "url": "https://abcnews.go.com/Health/wireStory/us-ship-millions-tests-push-reopen-12-schools-73294713"}, {"symbol": "ABT", "publishedDate": "2020-09-28 13:01:12", "title": "Abbott :'s FreeStyle\u00ae Libre 3 System Receives CE Mark - Features World's Smallest, Thinnest Sensor with Best-in-Class Performance at the Same Low Cost for People with Diabetes | MarketScreener", "image": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png", "site": "https://www.marketscreener.com", "text": "", "url": "https://www.marketscreener.com/quote/stock/ABBOTT-LABORATORIES-11506/news/Abbott-s-FreeStyle-Libre-3-System-Receives-CE-Mark-Features-World-s-Smallest-Thinnest-Sensor-w-31370095/"}, {"symbol": "ABT", "publishedDate": "2020-09-28 00:00:00", "title": "Global COVID-19 Diagnostic Demand Outlook, 2020-2021 Q4 by Country, Assay Volume Quarterly - Updated to Include Q1 & Q2 2020 Actuals Data - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20200928005499/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20200928005499/en/Global-COVID-19-Diagnostic-Demand-Outlook-2020-2021-Q4-by-Country-Assay-Volume-Quarterly---Updated-to-Include-Q1-Q2-2020-Actuals-Data---ResearchAndMarkets.com"}, {"symbol": "ABT", "publishedDate": "2020-09-27 05:38:41", "title": "Andrea F. Wainer Sells 3,650 Shares of Abbott Laboratories (NYSE:ABT) Stock", "image": "https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg", "site": "https://www.thelincolnianonline.com", "text": "Abbott Laboratories (NYSE:ABT) EVP Andrea F. Wainer sold 3,650 shares of the firm\u2019s stock in a transaction dated Wednesday, September 23rd. The shares were sold at an average price of $102.47, for a total transaction of $374,015.50. Following the completion of the transaction, the executive vice president now directly owns 44,080 shares in the company, [\u2026]", "url": "https://www.thelincolnianonline.com/2020/09/27/andrea-f-wainer-sells-3650-shares-of-abbott-laboratories-nyseabt-stock.html"}, {"symbol": "ABT", "publishedDate": "2020-09-25 00:00:00", "title": "Insights on the Predictive and Presymptomatic Testing Global Market to 2027 - Featuring Mapmygenome, Myriad Genetics & Pathway Genomics Among Others - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20200925005146/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20200925005146/en/Insights-on-the-Predictive-and-Presymptomatic-Testing-Global-Market-to-2027---Featuring-Mapmygenome-Myriad-Genetics-Pathway-Genomics-Among-Others---ResearchAndMarkets.com"}, {"symbol": "ABT", "publishedDate": "2020-09-23 00:00:00", "title": "Anti-nuclear Antibody Testing Market- Roadmap for Recovery From COVID-19 | Increased Prevalence of Autoimmune Diseases to Boost the Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20200922005729/en/823676/23/IRTNTR44108.jpg", "site": "businesswire", "text": "The Global Anti-nuclear Antibody (ANA) Testing Market will grow by $ 128.70 mn during 2020-2024", "url": "https://www.businesswire.com/news/home/20200922005729/en/Anti-nuclear-Antibody-Testing-Market--Roadmap-for-Recovery-From-COVID-19-Increased-Prevalence-of-Autoimmune-Diseases-to-Boost-the-Market-Growth-Technavio"}, {"symbol": "ABT", "publishedDate": "2020-09-22 11:05:49", "title": "Angina Market 2020 Global Trends, Share, Growth, Analysis, Opportunities and Forecast To 2026", "image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "site": "marketwatch", "text": "Sep 22, 2020 (Heraldkeepers) --\nWiseguyreports.Com Publish New Market Research Report On \"Angina Market 2020 Global Analysis, Size, Share, Trends,...", "url": "https://www.marketwatch.com/press-release/angina-market-2020-global-trends-share-growth-analysis-opportunities-and-forecast-to-2026-2020-09-22"}, {"symbol": "ABT", "publishedDate": "2020-09-22 11:00:00", "title": "Covid-19 Testing Is Hampered by Shortages of Critical Ingredient", "image": "https://images.wsj.net/im-234722/social", "site": "wsj", "text": "Reagents, the chemicals used to process the tests, are hard to come by, and some hospitals are now reverting to restricting Covid-19 tests to the most essential patients.", "url": "https://www.wsj.com/articles/covid-19-testing-is-hampered-by-shortages-of-critical-ingredient-11600772400"}, {"symbol": "ABT", "publishedDate": "2020-09-22 03:30:43", "title": "Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of \u201cHold\u201d from Brokerages", "image": "https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg", "site": "https://www.thelincolnianonline.com", "text": "Abbott Laboratories (NYSE:ABT) has been given an average rating of \u201cHold\u201d by the twenty-one research firms that are covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a sell recommendation, five have given a hold recommendation and eleven have given a buy recommendation to the company. The average twelve-month price [\u2026]", "url": "https://www.thelincolnianonline.com/2020/09/22/abbott-laboratories-nyseabt-receives-consensus-rating-of-hold-from-brokerages.html"}, {"symbol": "ABT", "publishedDate": "2020-09-22 00:00:00", "title": "COVID-19 Recovery Analysis: Global Brain Health Supplements Market | Growing Urban Population to Boost Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20200922005119/en/823318/23/IRTNTR45020.jpg", "site": "businesswire", "text": "The Global Brain Health Supplements Market will grow by $ 1.63 bn during 2020-2024", "url": "https://www.businesswire.com/news/home/20200922005119/en/COVID-19-Recovery-Analysis-Global-Brain-Health-Supplements-Market-Growing-Urban-Population-to-Boost-Market-Growth-Technavio"}, {"symbol": "ABT", "publishedDate": "2020-09-21 00:00:00", "title": "Global Protein Therapeutics Market (2020 to 2025) - by Component, Therapy Area, Function & Region - ResearchAndMarkets.com", "image": "https://mms.businesswire.com/media/20200921005705/en/371054/23/ResearchAndMarkets_800px.jpg", "site": "businesswire", "text": "The", "url": "https://www.businesswire.com/news/home/20200921005705/en/Global-Protein-Therapeutics-Market-2020-to-2025---by-Component-Therapy-Area-Function-Region---ResearchAndMarkets.com"}, {"symbol": "ABT", "publishedDate": "2020-09-18 00:00:00", "title": "Biotechnology Reagents Market - Roadmap for Recovery from COVID-19 | Presence of High-throughput to Boost the Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20200918005291/en/822651/23/IRTNTR43101.jpg", "site": "businesswire", "text": "The Global Biotechnology Reagents Market will grow by USD 37.87 bn during 2020-2024", "url": "https://www.businesswire.com/news/home/20200918005291/en/Biotechnology-Reagents-Market---Roadmap-for-Recovery-from-COVID-19-Presence-of-High-throughput-to-Boost-the-Market-Growth-Technavio"}, {"symbol": "ABT", "publishedDate": "2020-09-16 12:14:07", "title": "Tracking Jeremy Grantham's GMO Capital Portfolio - Q2 2020 Update (MUTF:GBMFX)", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha", "text": "Jeremy Grantham\u2019s 13F portfolio value increased from $11.99B to $13.47B this quarter. GMO Capital increased Alibaba Group Holding while dropping Cognizant Technology during the quarter.", "url": "https://seekingalpha.com/article/4374630-tracking-jeremy-granthams-gmo-capital-portfolio-q2-2020-update"}, {"symbol": "ABT", "publishedDate": "2020-09-16 03:26:35", "title": "Market Mover: Li Auto Inc. (NASDAQ:LI), Abbott Laboratories (NYSE:ABT) - Stocks Equity", "image": "http://www.stocksequity.com/wp-content/uploads/2019/04/1-32.jpg", "site": "http://www.stocksequity.com", "text": "Li Auto Inc. (NASDAQ:LI) with the stream of 4.12% also noticed, India Abbott Laboratories (NYSE:ABT) encountered a rapid change of 0.84% in the last hour of Tuesday\u2019s trading session. Li \u2026", "url": "http://www.stocksequity.com/active-stocks/market-mover-li-auto-inc-nasdaqli-abbott-laboratories-nyseabt/"}, {"symbol": "ABT", "publishedDate": "2020-09-16 00:00:00", "title": "Respiratory Syncytial Virus Diagnostics Market- Roadmap for Recovery from COVID-19 | Increase in Product Launches to boost the Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20200915006102/en/821425/23/IRTNTR43463.jpg", "site": "businesswire", "text": "The Global Respiratory Syncytial Virus (RSV) Diagnostics Market will grow by USD 585.17 mn during 2020-2024", "url": "https://www.businesswire.com/news/home/20200915006102/en/Respiratory-Syncytial-Virus-Diagnostics-Market--Roadmap-for-Recovery-from-COVID-19-Increase-in-Product-Launches-to-boost-the-Market-Growth-Technavio"}, {"symbol": "ABT", "publishedDate": "2020-09-14 15:45:18", "title": "Becton Dickinson Trying To Leverage COVID-19 Opportunities While Fixing Some Longer-Term Issues", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "BD management has had to deal with new revenue headwinds from COVID-19 while also trying to resolve longer-standing issues like the Alaris pump recalls.", "url": "https://seekingalpha.com/article/4374223-becton-dickinson-trying-to-leverage-covidminus-19-opportunities-while-fixing-longer-term"}, {"symbol": "ABT", "publishedDate": "2020-09-14 14:33:39", "title": "Rapid and More Efficient CCP Virus Tests Help With Reopenings", "image": "https://img.theepochtimes.com/assets/uploads/2020/09/01/florida-school-reopen-2-1200x765.jpg", "site": "https://www.theepochtimes.com", "text": "Schools may soon be able to test their staff and students for COVID-19 and get results in a ...", "url": "https://www.theepochtimes.com/rapid-and-more-efficient-tests-and-may-be-key-to-lifting-ccp-virus-lockdowns_3497780.html"}, {"symbol": "ABT", "publishedDate": "2020-09-13 10:32:46", "title": "Dividend Income Update: August 2020", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "August was a little underwhelming for me as my income dropped a bit, but this was due to sales made last year.", "url": "https://seekingalpha.com/article/4373934-dividend-income-update-august-2020"}, {"symbol": "ABT", "publishedDate": "2020-09-13 06:41:32", "title": "Wall Street Breakfast: The Week Ahead", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.", "url": "https://seekingalpha.com/article/4373911-wall-street-breakfast-week-ahead"}, {"symbol": "ABT", "publishedDate": "2020-09-12 08:40:20", "title": "Stocks To Watch: Apple, Snowflake, Pfizer And Moderna In Focus", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.", "url": "https://seekingalpha.com/article/4373882-stocks-to-watch-apple-snowflake-pfizer-and-moderna-in-focus"}, {"symbol": "ABT", "publishedDate": "2020-09-12 00:00:00", "title": "Snack bars market in the US- Roadmap for Recovery from COVID-19 | New Product Launches to Boost the Market Growth | Technavio", "image": "https://mms.businesswire.com/media/20200911005374/en/820451/23/IRTNTR41135.jpg", "site": "businesswire", "text": "The Snack Bars Market in the US will grow by USD 806.08 mn during 2020-2024", "url": "https://www.businesswire.com/news/home/20200911005374/en/Snack-bars-market-in-the-US--Roadmap-for-Recovery-from-COVID-19-New-Product-Launches-to-Boost-the-Market-Growth-Technavio"}, {"symbol": "ABT", "publishedDate": "2020-09-09 10:37:06", "title": "Thermo Fisher Should Buy Quest To Fully Integrate Lab Testing", "image": "https://static2.seekingalpha.com/images/marketing_images/health_medical/biotech_lab4.jpeg", "site": "seekingalpha.com", "text": "A Thermo Fisher - Quest Diagnostics merger would have numerous cost synergy and sales growth possibilities.", "url": "https://seekingalpha.com/article/4373252-thermo-fisher-should-buy-quest-to-fully-integrate-lab-testing"}, {"symbol": "ABT", "publishedDate": "2020-09-06 23:16:07", "title": "Akebia Anemia Data, And Other News: The Good, Bad And Ugly Of Biopharma", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "Akebia reports data for its anemia drug candidate. Abbott moves ahead with Drug-Eluting resorbable scaffold.", "url": "https://seekingalpha.com/article/4372845-akebia-anemia-data-and-news-good-bad-and-ugly-of-biopharma"}, {"symbol": "ABT", "publishedDate": "2020-09-06 22:50:57", "title": "Calm Down: This Time Won't Be Different", "image": "https://static.seekingalpha.com/uploads/2020/9/5/29440305-1599295271741029.jpg", "site": "seekingalpha.com", "text": "The market closed down last week. Investors are getting jittery.", "url": "https://seekingalpha.com/article/4372844-calm-down-this-time-wont-be-different"}, {"symbol": "ABT", "publishedDate": "2020-09-04 15:50:06", "title": "Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update", "image": "https://static3.seekingalpha.com/uploads/2020/9/4/106657-15992214105202825.jpg", "site": "seekingalpha.com", "text": "Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.", "url": "https://seekingalpha.com/article/4372685-tracking-larry-robbins-glenview-capital-management-portfolio-q2-2020-update"}, {"symbol": "ABT", "publishedDate": "2020-09-04 02:45:56", "title": "My Dividend Growth Portfolio August Review: 38 Holdings, No Trades", "image": "https://static3.seekingalpha.com/images/marketing_images/stock_market/portfolio2_cc0.jpeg", "site": "seekingalpha.com", "text": "I received $768 in August, which was down from May and down from August 2019. I made no trades over the month as stocks continue their meteoric rise.", "url": "https://seekingalpha.com/article/4372553-dividend-growth-portfolio-august-review-38-holdings-no-trades"}, {"symbol": "ABT", "publishedDate": "2020-09-03 12:08:00", "title": "Covid-19 Tests: Answers on Cost, Accuracy and Turnaround Time", "image": "https://images.wsj.net/im-227392/social", "site": "https://www.wsj.com", "text": "A number of Covid-19 tests have received emergency regulatory approval from the FDA, and more employers, schools and destinations are asking people to show that they are virus-free, whether or not they have symptoms.", "url": "https://www.wsj.com/articles/covid-19-tests-answers-on-cost-accuracy-and-turnaround-time-11599134378"}, {"symbol": "ABT", "publishedDate": "2020-09-02 11:55:58", "title": "Abbott Laboratories: Bridging The Gap To A 6% Return", "image": "https://static3.seekingalpha.com/uploads/2020/9/1/3764491-15990082628697698.png", "site": "seekingalpha.com", "text": "P/E ratios and other share investment metrics are presently distorted by the impacts of COVID-19. Abbott currently has a high trailing twelve month P/E ratio of 36.37 - putting a question mark over the share price.", "url": "https://seekingalpha.com/article/4372124-abbott-laboratories-bridging-gap-to-6-return"}, {"symbol": "ABT", "publishedDate": "2020-08-31 15:59:18", "title": "Abbott Labs antigen test", "image": "https://multifiles.pressherald.com/uploads/sites/10/2020/08/Covid-19-Ag-Card-1024x683.jpg", "site": "https://www.pressherald.com", "text": "SCARBOROUGH \u2014 Chicago-based company Abbott Laboratories, which has a location in Scarborough, announced that the FDA has issued Emergency Use Authorization for a $5, 15-minute mobile Covid-19 test. On Aug. 26, the company said that the test kit, BinaxNOW COVID-19 Ag Card is about the size of a credit card, and comes with a complementary \u2026", "url": "https://www.pressherald.com/2020/08/31/abbott-labs-antigen-test/"}, {"symbol": "ABT", "publishedDate": "2020-08-29 14:01:25", "title": "Wall Street Breakfast: What Moved Markets", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.", "url": "https://seekingalpha.com/article/4371522-wall-street-breakfast-what-moved-markets"}, {"symbol": "ABT", "publishedDate": "2020-08-29 09:00:00", "title": "Lower Forever? Fed Shift Reinforces Rally", "image": "https://static1.seekingalpha.com/uploads/2019/11/1723581_15738608449996_rId4.jpg", "site": "seekingalpha.com", "text": "U.S. equity markets continued their relentless rally this week amid a bullish convergence of positive economic and housing data, encouraging coronavirus trends and a dovish tack from the Federal Reserve.", "url": "https://seekingalpha.com/article/4371495-lower-forever-fed-shift-reinforces-rally"}, {"symbol": "ABT", "publishedDate": "2020-08-29 00:32:00", "title": "Markets Rise on Covid Hopes. But Just Ahead Is a Treacherous Fall.", "image": "https://images.barrons.com/im-226517/social", "site": "barrons", "text": "September is a traditionally tough month for the markets, and then there\u2019s the anxieties of presidential elections, contested or not.", "url": "https://www.barrons.com/articles/markets-rise-on-covid-hopes-but-ahead-is-a-treacherous-fall-51598661167"}, {"symbol": "ABT", "publishedDate": "2020-08-28 21:22:01", "title": "Abbott is testing its rapid coronavirus test on asymptomatic people in hopes of expanding FDA authorization", "image": "https://image.cnbcfm.com/api/v1/image/106528620-1588951599370gettyimages-1044206610.jpeg?v=1588951663", "site": "cnbc", "text": "\"We are running our clinical trial and we'll eventually have data to be able to support that,\" Abbott Laboratories CEO Robert Ford told CNBC.", "url": "https://www.cnbc.com/2020/08/28/abbott-has-trial-of-its-rapid-coronavirus-test-for-asymptomatic-people.html"}, {"symbol": "ABT", "publishedDate": "2020-08-28 13:16:00", "title": "Abbott Shares Climb as U.S. Buys Out Supply of New Covid-19 Test", "image": "https://images.barrons.com/im-226157/social", "site": "barrons", "text": "Abbott appears to have sold the entire 2020 run of the test to the U.S. government.", "url": "https://www.barrons.com/articles/abbott-shares-climb-as-u-s-buys-out-supply-of-new-covid-19-test-51598620574"}, {"symbol": "ABT", "publishedDate": "2020-08-28 11:58:00", "title": "The Dow Is Ready to Erase Its 2020 Losses. It Still Can\u2019t Win.", "image": "https://images.barrons.com/im-226153/social", "site": "barrons", "text": "Trump accepts presidential nomination, Japanese Prime Minister Shinzo Abe resigns, Walmart jumps into TikTok sale, and other news to start your day.", "url": "https://www.barrons.com/articles/the-dow-is-ready-to-erase-its-2020-losses-it-still-cant-win-51598615915"}, {"symbol": "ABT", "publishedDate": "2020-08-28 10:54:42", "title": "Stifel Nicolaus Boosts Abbott Laboratories (NYSE:ABT) Price Target to $115.00", "image": "https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg", "site": "https://www.thelincolnianonline.com", "text": "Abbott Laboratories (NYSE:ABT) had its price objective lifted by Stifel Nicolaus from $108.00 to $115.00 in a research note issued to investors on Thursday, The Fly reports. They currently have a buy rating on the healthcare product maker\u2019s stock. ABT has been the topic of a number of other research reports. Citigroup boosted their target [\u2026]", "url": "https://www.thelincolnianonline.com/2020/08/28/stifel-nicolaus-boosts-abbott-laboratories-nyseabt-price-target-to-115-00.html"}, {"symbol": "ABT", "publishedDate": "2020-08-28 10:00:35", "title": "The FDA just gave emergency approval to a 15-minute COVID-19 test - Poynter", "image": "https://www.poynter.org/wp-content/uploads/2020/08/abbott.jpg", "site": "https://www.poynter.org", "text": "Plus, a government budget shutdown is looming, the injuries that happen after a hurricane, how storms affect animals, and more.", "url": "https://www.poynter.org/reporting-editing/2020/the-fda-just-gave-emergency-approval-to-a-15-minute-covid-19-test/"}, {"symbol": "ABT", "publishedDate": "2020-08-28 09:46:13", "title": "Trump gets biggest convention boost in Betfair market history, as Biden lead in betting markets narrows", "image": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "site": "marketwatch", "text": "Betting odds have shifted dramatically toward President Donald Trump, though former Vice President Joe Biden remains narrowly ahead. The U.K. site Betfair...", "url": "https://www.marketwatch.com/story/trump-gets-biggest-convention-boost-in-betfair-market-history-as-biden-lead-in-betting-markets-narrows-2020-08-28"}, {"symbol": "ABT", "publishedDate": "2020-08-28 07:29:08", "title": "Abbott Laboratories (NYSE:ABT) Given a $94.00 Price Target by Goldman Sachs Group Analysts", "image": "https://www.marketbeat.com/logos/abbott-laboratories-logo.jpg", "site": "https://www.thelincolnianonline.com", "text": "Goldman Sachs Group set a $94.00 target price on Abbott Laboratories (NYSE:ABT) in a research note issued to investors on Thursday morning, Borsen Zeitung reports. The brokerage currently has a sell rating on the healthcare product maker\u2019s stock. Several other equities research analysts have also recently commented on ABT. Citigroup increased their price objective on [\u2026]", "url": "https://www.thelincolnianonline.com/2020/08/28/abbott-laboratories-nyseabt-given-a-94-00-price-target-by-goldman-sachs-group-analysts.html"}, {"symbol": "ABT", "publishedDate": "2020-08-28 07:08:37", "title": "Wall Street Breakfast: Unlikely Suitor For TikTok", "image": "", "site": "seekingalpha.com", "text": "", "url": "https://seekingalpha.com/article/4371319-wall-street-breakfast-unlikely-suitor-for-tiktok"}, {"symbol": "ABT", "publishedDate": "2020-08-28 06:11:33", "title": "Japanese stocks fall while the yen rises on reports Abe to resign", "image": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "site": "marketwatch", "text": "Japanese stocks fell while the yen rose in the wake of reports that long-serving Prime Minister Shinzo Abe will step down due to his declining health. The...", "url": "https://www.marketwatch.com/story/japanese-stocks-fall-while-the-yen-rises-on-reports-abe-to-resign-2020-08-28"}, {"symbol": "ABT", "publishedDate": "2020-08-27 23:26:55", "title": "Abbott Labs gave the recovery plays a 'huge boost,' Jim Cramer says", "image": "https://image.cnbcfm.com/api/v1/image/106485189-1586697697536gettyimages-1209702640.jpeg?v=1594416647", "site": "cnbc", "text": "\"If you know your fellow passengers don't have the virus, you'd be a lot more willing to fly or book a cruise,\" the \"Mad Money\" host said.", "url": "https://www.cnbc.com/2020/08/27/abbott-labs-gave-the-recovery-plays-a-huge-boost-jim-cramer-says.html"}, {"symbol": "ABT", "publishedDate": "2020-08-27 20:07:00", "title": "S&P 500 closes at record as investors parse Fed's historic policy shift", "image": "https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg", "site": "marketwatch", "text": "U.S. stocks closed mostly higher on Thursday after the Federal Reserve said it would aim for an average inflation target of 2%, a move that affirmed its easy...", "url": "https://www.marketwatch.com/story/sp-500-closes-at-record-as-investors-parse-feds-historic-policy-shift-2020-08-27"}, {"symbol": "ABT", "publishedDate": "2020-08-27 18:34:15", "title": "Boeing Wins And Glides", "image": "https://static1.seekingalpha.com/uploads/2020/8/27/9932311-15985576717960353.jpg", "site": "seekingalpha.com", "text": "Shares of Boeing gained on news of a fast and cheap COVID-19 test. Tests are a big positive, but a small step in the multi-stage process required for recovery of demand for air travel, recovery for networks and improving balance sheet health.", "url": "https://seekingalpha.com/article/4371246-boeing-wins-and-glides"}, {"symbol": "ABT", "publishedDate": "2020-08-27 17:45:00", "title": "\"Great Reopening\" Gets 2 Big Boosts: Fed & Abbott", "image": "https://cdn.snapi.dev/images/v1/m/n/medical21.jpg", "site": "Zacks Investment Research", "text": "The reason for this good news comes from two specific areas, both of which hit the news cycle ahead of today's open.", "url": "https://www.zacks.com/stock/news/1048730/great-reopening-gets-2-big-boosts-fed-abbott"}, {"symbol": "ABT", "publishedDate": "2020-08-27 17:29:00", "title": "Stocks Slide After Fed Says Economy Can \u2018Run Hot\u2019", "image": "https://images.barrons.com/im-197210/social", "site": "barrons", "text": "Stocks gave up some earlier gains on the heels of Federal Reserve Chief Jerome Powell\u2019s remarks about inflation and employment levels. \u201cBasically, the Fed is now definitively stating that official policy can let the economy \u2018run hot\u2019 to achieve their average inflation goal over time,\u201d one observer noted.", "url": "https://www.barrons.com/articles/stocks-slide-after-fed-says-economy-can-run-hot-dow-sp500-51598549293"}, {"symbol": "ABT", "publishedDate": "2020-08-27 17:14:30", "title": "Trump to announce $750 million deal with Abbott for at least 150 million rapid coronavirus tests", "image": "https://image.cnbcfm.com/api/v1/image/106681038-1598548598714-gettyimages-1269132617-0k7a1403_20200827112905527.jpeg?v=1598548682", "site": "cnbc", "text": "\"Under President Trump's leadership, the U.S. is leading the world in testing,\" White House communications director Alyssa Farah said in a statement to CNBC.", "url": "https://www.cnbc.com/2020/08/27/trump-to-announce-750-million-deal-with-abbott-for-at-least-150-million-rapid-coronavirus-tests.html"}, {"symbol": "ABT", "publishedDate": "2020-08-27 17:10:26", "title": "Rapid, inexpensive COVID-19 test to be produced in Maine, creating 1,200 jobs", "image": "https://multifiles.pressherald.com/uploads/sites/10/2020/08/20181011_flutest07-1589489328-1024x707.jpg", "site": "https://www.pressherald.com", "text": "President Trump is expected to announce a $750 million deal with Abbott to have the company produce 150 million of its rapid-results COVID-19 tests for the federal government.", "url": "https://www.pressherald.com/2020/08/27/rapid-inexpensive-covid-19-test-to-be-produced-in-maine-create-1200-jobs/"}, {"symbol": "ABT", "publishedDate": "2020-08-27 17:07:26", "title": "4 Top Stock Trades for Friday: WMT, ULTA, ABT, QDEL", "image": "https://cdn.snapi.dev/images/v1/5/h/stocks131-60.jpg", "site": "InvestorPlace", "text": "Walmart, Abbott Labs, Ulta Beauty and Quidel were our top stock trades for Friday. So, here's what the charts are trying to tell us now.", "url": "https://investorplace.com/2020/08/4-top-stock-trades-for-friday-wmt-ulta-abt-qdel/"}, {"symbol": "ABT", "publishedDate": "2020-08-27 16:58:00", "title": "Coronavirus update: Global case tally tops 24 million, U.S. tally above 5.8 million and CDC head walks back testing change after outcry", "image": "https://s.marketwatch.com/public/resources/images/MW-IN366_Corona_ZG_20200827112159.jpg", "site": "marketwatch", "text": "The number of confirmed cases of the coronavirus illness COVID-19 worldwide climbed above 24 million on Thursday, and the U.S. tally topped 5.8 million, as...", "url": "https://www.marketwatch.com/story/coronavirus-update-global-case-tally-tops-24-million-us-tally-above-58-million-and-experts-say-testing-and-tracing-is-crucial-2020-08-27"}, {"symbol": "ABT", "publishedDate": "2020-08-27 16:49:35", "title": "Stocks making the biggest moves midday: Walmart, Microsoft, Abbott Labs, Peloton, JPMorgan & more", "image": "https://image.cnbcfm.com/api/v1/image/106623947-1595264435763-GettyImages-1132529709.jpg?v=1598546032", "site": "cnbc", "text": "Take a look at the stocks making headlines in midday trading.", "url": "https://www.cnbc.com/2020/08/27/abbott-laboratories---shares-of-abbott-laboratories-jumped-more-than-6percent-after-the-company-received-us-marketing-authorization-for-a-covid-19-antigen-test-that-can-deliver-results-within-15-minut.html"}, {"symbol": "ABT", "publishedDate": "2020-08-27 16:49:27", "title": "Government to pay $750 million to Abbott Labs for new Covid-19 test", "image": "https://cdn.snapi.dev/images/v1/v/o/government-to-pay-750-million-to-abbott-labs-for-new-covid-19-test.jpg", "site": "CNBC Television", "text": "CNBC's Ylan Mui reports on President Donald Trump's forthcoming announcement to the purchase of 150 million rapid Covid-19 tests as part of a $750 million agreement with Abbott Laboratories.", "url": "https://www.youtube.com/watch?v=ZMsTn1mlXgs"}, {"symbol": "ABT", "publishedDate": "2020-08-27 16:44:49", "title": "Walmart Leads Dow Jones Rally; Intuitive Surgical Surges", "image": "https://cdn.snapi.dev/images/v1/4/c/etf27-17.jpg", "site": "Investors Business Daily", "text": "The Nasdaq recovered nicely Thursday after a 1% intraday drop.", "url": "https://www.youtube.com/watch?v=rPI3tR67lpY"}, {"symbol": "ABT", "publishedDate": "2020-08-27 16:40:35", "title": "New Abbott Labs Rapid Coronavirus Test Receives FDA Authorization", "image": "https://patch.com/img/cdn20/users/22915293/20200827/124034/styles/patch_image/public/abbott-photos___27123316164.jpg", "site": "https://patch.com", "text": "The FDA says it's the first COVID-19 antigen test where results can be read directly from a testing card \u2014 much like a pregnancy test.", "url": "https://patch.com/us/across-america/s/h81yq/new-abbott-labs-rapid-coronavirus-test-receives-fda-authorization"}, {"symbol": "ABT", "publishedDate": "2020-08-27 15:58:39", "title": "Coronavirus 5 minute test: FDA approves $5 rapid COVID-19 antigen test from Abbott", "image": "https://cdn.snapi.dev/images/v1/q/5/coronavirus-5-minute-test-fda-approves-5-rapid-covid-19-antigen-test-from-abbott.jpg", "site": "Yahoo Finance", "text": "Dr. Darria Long, ER Physician and Clinical Assistant Professor at University of Tennessee School of Medicine, joins Yahoo Finance\u2019s Zack Guzman to discuss the latest developments in rapid COVID-19 testing.", "url": "https://www.youtube.com/watch?v=R175XjoUO-0"}, {"symbol": "ABT", "publishedDate": "2020-08-27 15:56:36", "title": "Abbott\u2019s rapid COVID-19 test: Here\u2019s how it\u2019s different from the rest", "image": "https://cdn.snapi.dev/images/v1/t/y/abbottoffice-1.jpg", "site": "Fast Company", "text": "Abott\u2019s pocket-sized, $5, 15-minute COVID-19 test was just granted emergency use authorization.\r\nAbbott Laboratories has just been granted emergency use authorization by the Food and Drug Administration for its pocket-sized, $5, 15-minute COVID-19 antigen test.", "url": "https://www.fastcompany.com/90544507/abbotts-rapid-covid-19-test-heres-how-its-different-from-the-rest"}, {"symbol": "ABT", "publishedDate": "2020-08-27 14:43:17", "title": "Abbott Labs jumps as Wall Street says new rapid test may be 'game changer'", "image": "https://image.cnbcfm.com/api/v1/image/106660230-1597236588445-gettyimages-1227927203-363806381_1-5.jpeg?v=1598530743", "site": "cnbc", "text": "Analysts from Morgan Stanley and Bank of America were bullish on Abbott's new 15-minute test, which was granted an emergency use authorization by the FDA.", "url": "https://www.cnbc.com/2020/08/27/abbott-labs-jumps-as-wall-street-says-new-rapid-test-may-be-game-changer.html"}, {"symbol": "ABT", "publishedDate": "2020-08-27 14:42:48", "title": "Maine reports 28 new cases of COVID-19, no additional deaths", "image": "https://multifiles.pressherald.com/uploads/sites/10/2020/03/Abbott_02_-e1598563647105-1024x666.jpg", "site": "https://www.pressherald.com", "text": "Abbott Laboratories to hire 1,200 at Westbrook plant to produce $5 COVID-19 antigen test authorized by the Food and Drug Administration.", "url": "https://www.pressherald.com/2020/08/27/maine-reports-28-new-cases-of-covid-19-no-additional-deaths/"}, {"symbol": "ABT", "publishedDate": "2020-08-27 14:07:34", "title": "Trump administration makes $750 million deal to buy 150 million of Abbott's new coronavirus tests", "image": "https://cdn.snapi.dev/images/v1/n/0/medical19.jpg", "site": "Market Watch", "text": "The Trump administration has struck a $750 million deal with Abbott Laboratories ABT, +8.26% to buy 150 million of the company's new rapid-response COVID-19 antigen tests.", "url": "https://www.marketwatch.com/story/trump-administration-makes-750-million-deal-to-buy-150-million-of-abbotts-new-coronavirus-tests-2020-08-27"}, {"symbol": "ABT", "publishedDate": "2020-08-27 14:06:00", "title": "Abbott to Receive Order for 150 Million Rapid COVID-19 Tests", "image": "https://cdn.snapi.dev/images/v1/9/8/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5895542fgettyimages-1205778418jpgw700opresize.jpg", "site": "The Motley Fool", "text": "A recently authorized point-of-care COVID-19 test could be the most popular one yet.", "url": "https://www.fool.com/investing/2020/08/27/abbott-to-receive-order-for-150-million-rapid-covi/"}, {"symbol": "ABT", "publishedDate": "2020-08-27 14:04:43", "title": "Coronavirus testing: President Trump to unveil $750 million dollar deal with Abbott for rapid tests", "image": "https://cdn.snapi.dev/images/v1/u/k/coronavirus-testing-president-trump-to-unveil-750-million-dollar-deal-with-abbott-for-rapid-tests.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Julie Hyman reports on the announcement that President Trump will be unveiling a $750 million dollar deal with Aboott Labs for a rapid test that will be affordable with results that are available in minutes.", "url": "https://www.youtube.com/watch?v=efLCFOu6F7A"}, {"symbol": "ABT", "publishedDate": "2020-08-27 14:00:07", "title": "Op-Ed: Abbott CEO says coronavirus testing needs to be done on a massive scale to fight pandemic", "image": "https://image.cnbcfm.com/api/v1/image/106680727-1598535895724-Abbott_BinaxNow_kit_002.png?v=1598536232", "site": "cnbc", "text": "Abbott Laboratories said on Wednesday it won U.S. marketing authorization for a Covid-19 portable antigen test that can deliver results within 15 minutes and will sell for $5. CEO Robert B. Ford explains how it is a gamechanger.", "url": "https://www.cnbc.com/2020/08/27/abbott-labs-ceo-testing-covid-19-at-massive-scale-is-best-strategy.html"}, {"symbol": "ABT", "publishedDate": "2020-08-27 13:18:00", "title": "Dow Jones Jumps on Rapid COVID-19 Test; Microsoft and Walmart Team Up for TikTok Bid", "image": "https://cdn.snapi.dev/images/v1/a/x/stocks101-12.jpg", "site": "The Motley Fool", "text": "A fast and cheap test could hasten the economic recovery, and Microsoft is now working with Walmart to acquire the popular social media app.", "url": "https://www.fool.com/investing/2020/08/27/dow-jones-jumps-on-rapid-covid-19-test-microsoft-a/"}, {"symbol": "ABT", "publishedDate": "2020-08-27 13:14:30", "title": "Trump to announce $750 million deal with Abbott for at least 150 million rapid coronavirus tests", "image": "https://cdn.snapi.dev/images/v1/3/0/106676037-15982878952020-08-24t165029z-2022534660-rc2gki9doi4n-rtrmadp-0-usa-election-convention.jpeg", "site": "CNBC", "text": "President Donald Trump plans to announce Thursday the purchase of 150 million rapid Covid-19 tests as part of a $750 million agreement with Abbott Laboratories, a White House official confirmed to NBC News.", "url": "https://www.cnbc.com/2020/08/27/trump-to-announce-750-million-deal-with-abbott-for-at-least-150-million-rapid-coronavirus-tests.html"}, {"symbol": "ABT", "publishedDate": "2020-08-27 12:19:23", "title": "Quidel: Covering Short With Risk/Reward More Balanced", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "Quidel has traded down materially on the launch of Abbott's BinaxNOW COVID-19 test. Abbott's test has several advantages over Quidel's test, including price and the lack of an instrument.", "url": "https://seekingalpha.com/article/4371128-quidel-covering-short-risk-reward-balanced"}, {"symbol": "ABT", "publishedDate": "2020-08-27 11:35:00", "title": "Fed Lifts Stock Markets; Abbott's $5 Quick Test Gives Travel Stocks Big Gains", "image": "https://cdn.snapi.dev/images/v1/j/j/stock-market-ticker-lights-768x432.jpg", "site": "The Motley Fool", "text": "Hope for an end to coronavirus worries is continuing the bull market run.", "url": "https://www.fool.com/investing/2020/08/27/fed-lifts-stock-market-abbott-5-quick-test-travel/"}, {"symbol": "ABT", "publishedDate": "2020-08-27 11:31:32", "title": "Stock market live updates: Dow gains more than 100, new S&P record, VIX jumps to 6-week high", "image": "https://image.cnbcfm.com/api/v1/image/106052751-1564623137916rtx71q0z.jpg?v=1564623197", "site": "cnbc", "text": "This is CNBC's markets live blog that will be updated throughout the day.", "url": "https://www.cnbc.com/2020/08/27/stock-market-today-live.html"}, {"symbol": "ABT", "publishedDate": "2020-08-27 11:28:16", "title": "5 things to know before the stock market opens Thursday", "image": "https://image.cnbcfm.com/api/v1/image/106638050-1596032927278-gettyimages-1223642774-hillfed003.jpeg?v=1596033026", "site": "cnbc", "text": "U.S. stock futures fell Thursday after the S&P 500 and Nasdaq hit records and ahead of Fed Chairman Jerome Powell's morning speech.", "url": "https://www.cnbc.com/2020/08/27/5-things-to-know-before-the-stock-market-opens-august-27-2020.html"}, {"symbol": "ABT", "publishedDate": "2020-08-27 11:13:00", "title": "Stock-index futures edge lower as investors await speech by Fed\u2019s Powell", "image": "https://s.marketwatch.com/public/resources/images/MW-IN315_powell_ZG_20200826201229.jpg", "site": "marketwatch", "text": "Stock-index futures drifted lower early Thursday as investors await what\u2019s being billed as a landmark speech by Federal Reserve Chairman Jerome Powell.", "url": "https://www.marketwatch.com/story/stock-index-futures-edge-lower-as-investors-await-speech-by-feds-powell-2020-08-27"}, {"symbol": "ABT", "publishedDate": "2020-08-27 10:23:23", "title": "This $5 rapid test is a potential game-changer in Covid testing", "image": "https://cdn.snapi.dev/images/v1/1/w/1wef.jpg", "site": "CNN Business", "text": "Abbott Labs got emergency approval from the US Food and Drug Administration for its rapid antigen test, which can detect a Covid-19 infection in 15 minutes.", "url": "https://www.cnn.com/2020/08/27/investing/abbott-labs-rapid-covid-test/index.html"}, {"symbol": "ABT", "publishedDate": "2020-08-27 10:18:25", "title": "Abbott Labs shares surge after FDA approves new $5 rapid Covid-19 test", "image": "https://cdn.snapi.dev/images/v1/q/i/abbott-labs-shares-surge-after-fda-approves-new-5-rapid-covid-19-test.jpg", "site": "CNBC Television", "text": "Abbott Laboratories said on Wednesday it won U.S.", "url": "https://www.youtube.com/watch?v=6r77dWVqgzo"}, {"symbol": "ABT", "publishedDate": "2020-08-27 10:00:07", "title": "Op-Ed: Abbott CEO says coronavirus testing needs to be done on a massive scale to fight pandemic", "image": "https://cdn.snapi.dev/images/v1/4/l/106680727-1598535895724-abbott-binaxnow-kit-002.png", "site": "CNBC", "text": "Abbott Laboratories said on Wednesday it won U.S. marketing authorization for a Covid-19 portable antigen test that can deliver results within 15 minutes and will sell for $5.", "url": "https://www.cnbc.com/2020/08/27/abbott-labs-ceo-testing-covid-19-at-massive-scale-is-best-strategy.html"}, {"symbol": "ABT", "publishedDate": "2020-08-27 08:55:16", "title": "Abbott Labs Stock Jumps After FDA Approves Its 15-Minute, $5 Coronavirus Test", "image": "https://cdn.snapi.dev/images/v1/q/o/medical8.jpg", "site": "Investors Business Daily", "text": "Abbott Laboratories' winning Food and Drug Administration emergency use authorization for an easy-to-perform, 15-minute, $5 coronavirus test sent ABT stock soaring in Thursday trading. \nThe post Abbott Labs Stock Jumps After FDA Approves Its 15-Minute, $5 Coronavirus Test appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/abt-stock-jumps-fda-ok-quick-cheap-coronavirus-test/"}, {"symbol": "ABT", "publishedDate": "2020-08-27 08:52:33", "title": "A $5 Covid-19 test from Abbott Labs just got emergency FDA authorization", "image": "https://cdn.snapi.dev/images/v1/2/c/200821015325-miami-covid-testing-0805-super-169.jpg", "site": "CNN Business", "text": "Abbott Labs' got emergency approval from the US Food and Drug Administration for its rapid antigen test, which can detect a Covid-19 infection in 15 minutes.", "url": "https://www.cnn.com/2020/08/27/investing/abbot-labs-rapid-covid-test/index.html"}, {"symbol": "ABT", "publishedDate": "2020-08-27 08:38:53", "title": "Abbott's stock jumps 9% following authorization of its rapid $5 COVID-19 test", "image": "https://cdn.snapi.dev/images/v1/p/i/medical7-2.jpg", "site": "Market Watch", "text": "Shares of Abbott Laboratories ABT, +0.70% gained 9.1% in premarket trading on Thursday, the day after the company had announced regulatory authorization for a new COVID-19 test that costs $5, does not require instrumentation, and can produce a result in 15 minutes.", "url": "https://www.marketwatch.com/story/abbotts-stock-jumps-9-following-authorization-of-its-rapid-5-covid-19-test-2020-08-27"}, {"symbol": "ABT", "publishedDate": "2020-08-27 07:01:05", "title": "Wall Street Breakfast: Fed's New Monetary Policy Approach", "image": "https://static3.seekingalpha.com/assets/og_image_192-59bfd51c9fe6af025b2f9f96c807e46f8e2f06c5ae787b15bf1423e6c676d4db.png", "site": "seekingalpha.com", "text": "Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.", "url": "https://seekingalpha.com/article/4371043-wall-street-breakfast-feds-new-monetary-policy-approach"}, {"symbol": "ABT", "publishedDate": "2020-08-27 00:40:58", "title": "Abbott wins U.S. authorization for $5 rapid Covid-19 antigen", "image": "https://image.cnbcfm.com/api/v1/image/106533216-1589281528131ws_gmea_ap6_3.jpg?v=1589281615", "site": "cnbc", "text": "Abbott Laboratories said on Wednesday it won U.S. marketing authorization for a Covid-19 portable antigen test that can deliver results within 15 minutes and will sell for $5.", "url": "https://www.cnbc.com/2020/08/26/abbott-wins-us-authorization-for-5-rapid-covid-19-antigen.html"}, {"symbol": "ABT", "publishedDate": "2020-08-27 00:23:00", "title": "FDA grants emergency-use status to Abbott\u2019s $5 COVID-19 rapid antigen test", "image": "https://s.marketwatch.com/public/resources/images/MW-IN316_abbott_ZG_20200826202245.jpg", "site": "marketwatch", "text": "The U.S. Food and Drug Administration has granted emergency-use authorization to Abbott Laboratories for a $5 rapid-response COVID-19 antigen test that is...", "url": "https://www.marketwatch.com/story/fda-grants-emergency-use-status-to-abbotts-5-covid-19-rapid-antigen-test-2020-08-26"}, {"symbol": "ABT", "publishedDate": "2020-08-27 00:00:00", "title": "Wall Street futures down ahead of Powell's speech on monetary policy", "image": "https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEG7Q0T7_M.jpg", "site": "investing", "text": "Wall Street futures down ahead of Powell's speech on monetary policy", "url": "https://www.investing.com/news/stock-market-news/wall-street-futures-down-ahead-of-powells-speech-on-monetary-policy-2278307"}, {"symbol": "ABT", "publishedDate": "2020-08-26 21:52:14", "title": "Abbott Gets FDA Emergency Use Approval For $5 Rapid COVID-19 Test", "image": "https://cdn.snapi.dev/images/v1/9/k/abott.jpg", "site": "Benzinga", "text": "The United States Food and Drug Administration granted\u00a0emergency use authorization to a\u00a015-minute COVID-19 test produced by Abbott Laboratories (NYSE: ABT) on Wednesday.", "url": "https://www.benzinga.com/general/biotech/20/08/17261781/abbott-gets-fda-emergency-use-approval-for-5-rapid-covid-19-test"}, {"symbol": "ABT", "publishedDate": "2020-08-26 21:35:34", "title": "Abbott Receives FDA Authorization for a $5 App-Enabled 15-Minute COVID-19 Test", "image": "https://cdn.snapi.dev/images/v1/a/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5894782fcovid-19-testjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The cheap, rapid test could help get people back to work.", "url": "https://www.fool.com/investing/2020/08/26/abbott-receives-fda-authorization-for-its-5-app-en/"}, {"symbol": "ABT", "publishedDate": "2020-08-26 21:22:56", "title": "$5 Rapid Covid-19 Test From Abbott Labs Gets Emergency FDA Approval", "image": "https://cdn.snapi.dev/images/v1/d/p/dppw22.jpg", "site": "Forbes", "text": "The rapid antigen test produces results in 15 minutes.", "url": "https://www.forbes.com/sites/danielcassady/2020/08/26/5-rapid-covid-19-test-from-abbott-labs-gets-emergency-fda-approval/"}, {"symbol": "ABT", "publishedDate": "2020-08-26 20:40:58", "title": "Abbott wins U.S. authorization for $5 rapid Covid-19 antigen", "image": "https://cdn.snapi.dev/images/v1/v/l/106492040-1587057527800covid.jpg", "site": "CNBC", "text": "Abbott Laboratories said on Wednesday it won U.S. marketing authorization for a Covid-19 portable antigen test that can deliver results within 15 minutes and will sell for $5.", "url": "https://www.cnbc.com/2020/08/26/abbott-wins-us-authorization-for-5-rapid-covid-19-antigen.html"}, {"symbol": "ABT", "publishedDate": "2020-08-26 18:30:00", "title": "Abbott's Fast, $5, 15-Minute, Easy-to-Use COVID-19 Antigen Test Receives FDA Emergency Use Authorization; Mobile App Displays Test Results to Help Our Return to Daily Life; Ramping Production to 50 Million Tests a Month", "image": "https://cdn.snapi.dev/images/v1/r/n/press20-3.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., Aug. 26, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S.", "url": "https://www.prnewswire.com/news-releases/abbotts-fast-5-15-minute-easy-to-use-covid-19-antigen-test-receives-fda-emergency-use-authorization-mobile-app-displays-test-results-to-help-our-return-to-daily-life-ramping-production-to-50-million-tests-a-month-301119289.html"}, {"symbol": "ABT", "publishedDate": "2020-08-26 00:00:00", "title": "Abbott Gets FDA Emergency Use Approval For $5 Rapid COVID-19 Test", "image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/abott.jpg", "site": "benzinga", "text": "The United States Food and Drug Administration granted\u00a0emergency use authorization to a\u00a015-minute COVID-19 test produced by Abbott Laboratories (NYSE: ABT) on Wednesday...", "url": "https://www.benzinga.com/general/biotech/20/08/17261781/abbott-gets-fda-emergency-use-approval-for-5-rapid-covid-19-test"}, {"symbol": "ABT", "publishedDate": "2020-08-24 14:47:14", "title": "The 4 Best Dividend Aristocrats to Buy Now", "image": "https://cdn.snapi.dev/images/v1/6/5/653-3.jpg", "site": "InvestorPlace", "text": "Dividend aristocrats have increased dividends for at least 25 consecutive years. Here are four of the best dividend aristocrats you can buy.", "url": "https://investorplace.com/2020/08/4-best-dividend-aristocrats-to-buy-now-abt-rost-pep-vfc/"}, {"symbol": "ABT", "publishedDate": "2020-08-19 16:40:31", "title": "Top Dividend Stocks For August", "image": "https://cdn.snapi.dev/images/v1/3/z/top-dividend-stocks-for-august.jpg", "site": "Forbes", "text": "If you're looking to protect your income, dividend stocks are the way to go. Our deep learning algorithms and Artificial Intelligence (\"AI\") technology has gone through some data to provide you with the Top Dividend Stocks to invest in with your portfolio.", "url": "https://www.forbes.com/sites/qai/2020/08/19/top-dividend-stocks-for-august/"}, {"symbol": "ABT", "publishedDate": "2020-08-18 12:46:58", "title": "Abbott Laboratories Is a Surefire Covid-19 Diagnostics Investment", "image": "https://cdn.snapi.dev/images/v1/w/o/106528620-1588951599370gettyimages-1044206610.jpeg", "site": "InvestorPlace", "text": "Don't hesitate to buy ABT stock as vast quantities of Covid-19 test shipments indicate robust business for Abbott Laboratories.\r\nThe post Abbott Laboratories Is a Surefire Covid-19 Diagnostics Investment appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/08/abt-stock-is-a-surefire-covid-19-diagnostics-investment/"}, {"symbol": "ABT", "publishedDate": "2020-08-15 11:30:30", "title": "Why Is Abbott (ABT) Up 3.7% Since Last Earnings Report?", "image": "https://cdn.snapi.dev/images/v1/s/b/medical24.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/1042424/why-is-abbott-abt-up-37-since-last-earnings-report"}, {"symbol": "ABT", "publishedDate": "2020-08-09 09:38:00", "title": "3 Large-Cap Stocks That Should Soar If Coronavirus Vaccines Flop", "image": "https://cdn.snapi.dev/images/v1/2/7/etf29.jpg", "site": "The Motley Fool", "text": "No one wants COVID-19 vaccines to fail. But if you want to hedge for the possibility, check out these solid stocks.", "url": "https://www.fool.com/investing/2020/08/09/3-large-cap-stocks-that-should-soar-if-coronavirus.aspx"}, {"symbol": "ABT", "publishedDate": "2020-08-04 12:44:22", "title": "3 Charts That Suggest Sin Stocks Are Headed Higher", "image": "https://cdn.snapi.dev/images/v1/m/a/awq1qwsed.jpg", "site": "Investopedia", "text": "Spending on leisure and vice has remained high in recent months, making this sector one to watch during this period of uncertainty.", "url": "https://www.investopedia.com/3-charts-that-suggest-sin-stocks-are-headed-higher-5073563"}, {"symbol": "ABT", "publishedDate": "2020-08-01 06:44:00", "title": "3 Safe Stocks to Hold Through the Next Market Crash", "image": "https://cdn.snapi.dev/images/v1/6/0/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5848412fpile-of-coinsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These are investments you can buy and forget about.", "url": "https://www.fool.com/investing/2020/08/01/3-safe-stocks-to-hold-through-the-next-market-cras.aspx"}, {"symbol": "ABT", "publishedDate": "2020-07-31 08:00:00", "title": "Despite 60% Rally Abbott Stock Still Has Room To Grow", "image": "https://cdn.snapi.dev/images/v1/r/h/despite-60-rally-abbott-stock-still-has-room-to-grow.jpg", "site": "Forbes", "text": "Abbott\u2019s stock (NYSE: ABT) lost more than 27% \u2013 dropping from $87 at the beginning of the year to below $63 in late March \u2013 then spiked 58% to around $100 now. That means it is well above the levels where it started the year.", "url": "https://www.forbes.com/sites/greatspeculations/2020/07/31/despite-60-rally-abbott-stock-still-has-room-to-grow/"}, {"symbol": "ABT", "publishedDate": "2020-07-29 07:47:58", "title": "Deep Dive: Here are five value-stock picks that set up your portfolio for a pandemic recovery", "image": "https://cdn.snapi.dev/images/v1/v/r/1blis-4.jpg", "site": "Market Watch", "text": "If you really want to call yourself a contrarian investor, it\u2019s time for a hard look at what hasn\u2019t worked so far this year \u2014 value stocks and dividend stocks.", "url": "https://www.marketwatch.com/story/here-are-five-value-stock-picks-that-set-up-your-portfolio-for-a-pandemic-recovery-2020-07-29"}, {"symbol": "ABT", "publishedDate": "2020-07-28 13:42:57", "title": "Beyond COVID-19, Credit Suisse Shows Its Top Health Care Recovery Stock Picks", "image": "https://cdn.snapi.dev/images/v1/a/y/etf35.jpg", "site": "24/7 Wall Street", "text": "Health care is supposed to be a very defensive sector in investing. After all, diseases and conditions such as cancer, diabetes, heart disease, kidney failure, dementia, joint damage and spinal issues are just a small percentage of the ailments that have to be routinely treated.", "url": "https://247wallst.com/healthcare-business/2020/07/28/beyond-covid-19-credit-suisse-shows-its-top-health-care-recovery-stock-picks/"}, {"symbol": "ABT", "publishedDate": "2020-07-28 09:48:00", "title": "3 Rock-Solid Healthcare Stocks to Buy in a Market Crash", "image": "https://cdn.snapi.dev/images/v1/w/2/medical6.jpg", "site": "The Motley Fool", "text": "These companies have proven they can rebound from the worst.", "url": "https://www.fool.com/investing/2020/07/28/3-rock-solid-healthcare-stocks-to-buy-in-a-market.aspx"}, {"symbol": "ABT", "publishedDate": "2020-07-28 08:11:00", "title": "If You Had Invested $1,000 in Abbott Labs During the Last Recession, This Is How Much You Would Have Today", "image": "https://cdn.snapi.dev/images/v1/c/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5838562fmoney-in-three-jars-growing-investmentjpgw700opresize.jpg", "site": "The Motley Fool", "text": "You can still actively invest even during a global downturn.", "url": "https://www.fool.com/investing/2020/07/28/if-you-had-invested-1000-in-abbott-labs-during-the.aspx"}, {"symbol": "ABT", "publishedDate": "2020-07-26 09:14:00", "title": "How Smartwatches Could Transform the Healthcare Industry", "image": "https://cdn.snapi.dev/images/v1/j/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5834582fheart-rate-showing-on-a-watchjpgw700opresize.jpg", "site": "The Motley Fool", "text": "More healthcare-related metrics will make it easier for doctors to track patients remotely.", "url": "https://www.fool.com/investing/2020/07/26/how-smartwatches-could-transform-the-healthcare-in.aspx"}, {"symbol": "ABT", "publishedDate": "2020-07-26 07:32:00", "title": "Here's the Least Risky Solid-Growth Coronavirus Stock to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/u/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5714282fgettyimages-1204866804jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Why trade off solid growth prospects for high risk levels if you don't have to?", "url": "https://www.fool.com/investing/2020/07/26/heres-the-least-risky-solid-growth-coronavirus-sto.aspx"}, {"symbol": "ABT", "publishedDate": "2020-07-24 19:06:00", "title": "Stocks Showing Improved Relative Strength: Abbott Laboratories", "image": "https://cdn.snapi.dev/images/v1/t/n/medical18.jpg", "site": "Investors Business Daily", "text": "Abbott Laboratories shows rising price performance, earning an upgrade to its IBD Relative Strength Rating\nThe post Stocks Showing Improved Relative Strength: Abbott Laboratories appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/stocks-showing-improved-relative-strength-abbott-laboratories/"}, {"symbol": "ABT", "publishedDate": "2020-07-23 04:44:45", "title": "Abbott: Pandemic Houdini Puts On A Show For The Ages", "image": "https://cdn.snapi.dev/images/v1/a/q/medical1-2.jpg", "site": "Seeking Alpha", "text": "Abbott: Pandemic Houdini Puts On A Show For The Ages", "url": "https://seekingalpha.com/article/4360115-abbott-pandemic-houdini-puts-on-show-for-ages"}, {"symbol": "ABT", "publishedDate": "2020-07-21 19:29:00", "title": "Stock Upgrades: Abbott Laboratories Shows Rising Relative Strength", "image": "https://cdn.snapi.dev/images/v1/i/u/pt-25-193726-o.jpg", "site": "Investors Business Daily", "text": "Abbott Laboratories shows improving price performance, earning an upgrade to its IBD Relative Strength Rating\r\nThe post Stock Upgrades: Abbott Laboratories Shows Rising Relative Strength appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/stock-upgrades-abbott-laboratories-shows-rising-relative-strength/"}, {"symbol": "ABT", "publishedDate": "2020-07-21 09:07:00", "title": "Have $2,000? Consider Buying These 2 Top Coronavirus Stocks", "image": "https://cdn.snapi.dev/images/v1/l/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5657122fgettyimages-1206969058jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Here's why Abbott Laboratories and Pfizer are great picks for long-term investors.", "url": "https://www.fool.com/investing/2020/07/21/have-2000-consider-buying-these-2-top-coronavirus.aspx"}, {"symbol": "ABT", "publishedDate": "2020-07-20 13:19:03", "title": "The \"Halftime Report\" traders answer viewer questions in #AskHalftime", "image": "https://cdn.snapi.dev/images/v1/s/y/syqtf2.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions in #AskHalftime", "url": "https://www.youtube.com/watch?v=U4HV2d13Tdk"}, {"symbol": "ABT", "publishedDate": "2020-07-19 21:17:13", "title": "Defense Wins Championships: Abbott Labs", "image": "https://cdn.snapi.dev/images/v1/y/w/medical23.jpg", "site": "Seeking Alpha", "text": "Abbott's stock quote is beginning to discount a bright earnings future, as Wall Street estimates skip higher.", "url": "https://seekingalpha.com/article/4359268-defense-wins-championships-abbott-labs"}, {"symbol": "ABT", "publishedDate": "2020-07-17 19:12:51", "title": "Jim Cramer: A better way to invest in the Covid-19 vaccine gold rush", "image": "https://cdn.snapi.dev/images/v1/p/f/jim-cramer-a-better-way-to-invest-in-the-covid-19-vaccine-gold-rush.jpg", "site": "CNBC Television", "text": "Instead of making a risky bet on vaccine developers, \"Mad Money\" host Jim Cramer makes recommendations of companies supplying research equipment.", "url": "https://www.youtube.com/watch?v=s0L3_hVjLqg"}, {"symbol": "ABT", "publishedDate": "2020-07-16 18:24:21", "title": "Abbott Laboratories Beats on Q2 Estimates, But Stock Slides", "image": "https://cdn.snapi.dev/images/v1/y/3/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5826172fhospital-lobbyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The company's COVID-19 diagnostics solutions sold briskly during the quarter.", "url": "https://www.fool.com/investing/2020/07/16/abbott-laboratories-beats-on-q2-estimates-but-stoc.aspx"}, {"symbol": "ABT", "publishedDate": "2020-07-16 13:53:06", "title": "Abbott Laboratories (ABT) CEO, Robert Ford on Q2 2020 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/o/1/transcript7.jpg", "site": "Seeking Alpha", "text": "Abbott Laboratories (ABT) CEO, Robert Ford on Q2 2020 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4358872-abbott-laboratories-abt-ceo-robert-ford-on-q2-2020-results-earnings-call-transcript"}, {"symbol": "ABT", "publishedDate": "2020-07-16 11:43:00", "title": "Abbott Labs' Earnings Sink in Q2 but Still Trounce Wall Street Estimates", "image": "https://cdn.snapi.dev/images/v1/d/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5825252fabbott-sign-at-hqjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The COVID-19 pandemic both helped and hurt Abbott in the second quarter.", "url": "https://www.fool.com/investing/2020/07/16/abbott-labs-earnings-sink-in-q2-but-still-trounce.aspx"}, {"symbol": "ABT", "publishedDate": "2020-07-16 10:35:00", "title": "Abbott (ABT) Q2 Earnings Top, Coronavirus Test Sales Solid", "image": "https://cdn.snapi.dev/images/v1/e/4/medical3.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) Q2 earnings reflect healthy growth within its Diabetes Care business and encouraging coronavirus test sales.", "url": "https://www.zacks.com/stock/news/1006594/abbott-abt-q2-earnings-top-coronavirus-test-sales-solid"}, {"symbol": "ABT", "publishedDate": "2020-07-16 07:53:05", "title": "Recap: Abbott Laboratories Q2 Earnings", "image": "https://cdn.snapi.dev/images/v1/i/a/medical25.jpg", "site": "Benzinga", "text": "Shares of Abbott Laboratories (NYSE:ABT) rise 1.7% in pre-market trading after the company reported Q2 results.", "url": "https://www.benzinga.com/news/earnings/20/07/16648623/recap-abbott-laboratories-q2-earnings"}, {"symbol": "ABT", "publishedDate": "2020-07-16 07:48:15", "title": "Abbott Labs' stock gains after profit, revenue and full-year outlook top expectations", "image": "https://cdn.snapi.dev/images/v1/g/r/medical24.jpg", "site": "Market Watch", "text": "Shares of Abbott Laboratories ABT, +2.01% rose 0.7% in premarket trading Thursday, after the health care company reported second-quarter profit and revenue that beat expectations and provided an upbeat full-year outlook.", "url": "https://www.marketwatch.com/story/abbott-labs-stock-gains-after-profit-revenue-and-full-year-outlook-top-expectations-2020-07-16"}, {"symbol": "ABT", "publishedDate": "2020-07-16 07:43:00", "title": "Abbott Earnings Beat Views; Medical Giant Guides Higher", "image": "https://cdn.snapi.dev/images/v1/x/z/medical22.jpg", "site": "Investors Business Daily", "text": "Abbott earnings beat views, while the medical giant also guided higher for full-year EPS. ABT stock rose early Thursday, nearing a buy point.", "url": "https://www.investors.com/news/technology/abbott-earnings-abt-stock-q2-2020/"}, {"symbol": "ABT", "publishedDate": "2020-07-16 07:30:00", "title": "Abbott Reports Second-Quarter 2020 Results, Exceeds Analysts' Expectations", "image": "https://cdn.snapi.dev/images/v1/f/2/press2.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., July 16, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2020.", "url": "https://www.prnewswire.com/news-releases/abbott-reports-second-quarter-2020-results-exceeds-analysts-expectations-301094737.html"}, {"symbol": "ABT", "publishedDate": "2020-07-15 17:53:00", "title": "5 Earnings Charts for the Coronavirus Recovery", "image": "https://cdn.snapi.dev/images/v1/e/t/etf8-42.jpg", "site": "Zacks Investment Research", "text": "Drug makers, restaurants, industrials and transports will tell you what is really going on in the US economy.", "url": "https://www.zacks.com/stock/news/1006019/5-earnings-charts-for-the-coronavirus-recovery"}, {"symbol": "ABT", "publishedDate": "2020-07-14 10:10:00", "title": "Why Earnings Season Could Be Great for Abbott (ABT)", "image": "https://cdn.snapi.dev/images/v1/n/c/medical27.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.", "url": "https://www.zacks.com/stock/news/1003821/why-earnings-season-could-be-great-for-abbott-abt"}, {"symbol": "ABT", "publishedDate": "2020-07-14 07:01:00", "title": "Why Big Pharma's $1 Billion Bet to Prevent a Bacterial Pandemic Matters for You", "image": "https://cdn.snapi.dev/images/v1/f/5/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5820542fscientists-looking-through-microscopesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Large drugmakers are hoping to stop a looming global crisis that could be much worse than COVID-19.", "url": "https://www.fool.com/investing/2020/07/14/why-big-pharmas-1-billion-bet-to-prevent-a-bacteri.aspx"}, {"symbol": "ABT", "publishedDate": "2020-07-13 23:58:02", "title": "Abbott Laboratories and Edwards Lifesciences Settle Patent Fight", "image": "https://cdn.snapi.dev/images/v1/p/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5822002fjudge-signing-order-behind-stethescope-and-gavel-on-a-tablejpgw700opresize.jpg", "site": "The Motley Fool", "text": "The two companies' agreement puts to rest an escalating dispute over heart valve repair products.", "url": "https://www.fool.com/investing/2020/07/13/abbott-laboratories-and-edwards-lifesciences-settl.aspx"}, {"symbol": "ABT", "publishedDate": "2020-07-13 16:51:13", "title": "Abbott Labs, Edwards Lifesciences settle patent dispute over heart valve products", "image": "https://cdn.snapi.dev/images/v1/f/8/medical19.jpg", "site": "Market Watch", "text": "Abbott Laboratories ABT, +0.05% and Edwards Lifesciences Corp. EW, -0.92% said late Monday they settled a patent dispute with each other over certain heart valve repair products.", "url": "https://www.marketwatch.com/story/abbott-labs-edwards-lifesciences-settle-patent-dispute-over-heart-valve-products-2020-07-13"}, {"symbol": "ABT", "publishedDate": "2020-07-13 16:15:00", "title": "Abbott Agrees to Global Transcatheter Litigation Settlement with Edwards Lifesciences", "image": "https://cdn.snapi.dev/images/v1/y/u/press4-4.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., July 13, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has reached an agreement with Edwards Lifesciences Corporation to settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products. The...", "url": "https://www.prnewswire.com/news-releases/abbott-agrees-to-global-transcatheter-litigation-settlement-with-edwards-lifesciences-301092459.html"}, {"symbol": "ABT", "publishedDate": "2020-07-13 09:54:00", "title": "Coronavirus Tests Rollout to Drive Abbott (ABT) Q2 Earnings?", "image": "https://cdn.snapi.dev/images/v1/m/o/medical10.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) is entangled in issues like procedural delays for its non-coronavirus products, which may have impacted its Q2 earnings.", "url": "https://www.zacks.com/stock/news/1002879/coronavirus-tests-rollout-to-drive-abbott-abt-q2-earnings"}, {"symbol": "ABT", "publishedDate": "2020-07-12 06:35:00", "title": "Have $5,000? 3 Coronavirus Stocks You Can Buy in July Without Losing Any Sleep", "image": "https://cdn.snapi.dev/images/v1/e/a/cahs82-3.jpg", "site": "The Motley Fool", "text": "These healthcare leaders give you a relatively low-risk way to invest in the fight against COVID-19.", "url": "https://www.fool.com/investing/2020/07/12/have-5000-3-coronavirus-stocks-you-can-buy-in-july.aspx"}, {"symbol": "ABT", "publishedDate": "2020-07-09 12:30:24", "title": "Analysts Estimate Abbott (ABT) to Report a Decline in Earnings: What to Look Out for", "image": "https://cdn.snapi.dev/images/v1/c/y/medical23.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/1001139/analysts-estimate-abbott-abt-to-report-a-decline-in-earnings-what-to-look-out-for"}, {"symbol": "ABT", "publishedDate": "2020-07-08 17:50:00", "title": "Abbott Laboratories Shows Improved Relative Strength; Still Shy Of Benchmark", "image": "https://cdn.snapi.dev/images/v1/c/4/medical16.jpg", "site": "Investors Business Daily", "text": "Abbott Laboratories shows improving price performance, earning an upgrade to its IBD Relative Strength Rating\nThe post Abbott Laboratories Shows Improved Relative Strength; Still Shy Of Benchmark appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/abbott-laboratories-shows-improved-relative-strength-still-shy-of-benchmark/"}, {"symbol": "ABT", "publishedDate": "2020-07-06 15:03:43", "title": "Abbott Deal, UnitedHealth Coverage Push Up Tandem Shares", "image": "https://cdn.snapi.dev/images/v1/v/s/medical23.jpg", "site": "GuruFocus", "text": "Two leaders in the diabetes market are teaming up to provide a better way to administer insulin to patients.", "url": "https://www.gurufocus.com/news/1179132/abbott-deal-unitedhealth-coverage-push-up-tandem-shares"}, {"symbol": "ABT", "publishedDate": "2020-07-06 07:30:00", "title": "Abbott Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote Monitoring", "image": "https://cdn.snapi.dev/images/v1/x/e/press4-7.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., July 6, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation Gallant\u2122 implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D)...", "url": "https://www.prnewswire.com/news-releases/abbott-receives-fda-approval-for-new-heart-rhythm-devices-featuring-bluetooth-connectivity-and-continuous-remote-monitoring-301087824.html"}, {"symbol": "ABT", "publishedDate": "2020-07-06 06:31:00", "title": "4 Stocks to Play the Alarming Spike in Cases of COVID-19", "image": "https://cdn.snapi.dev/images/v1/q/a/stock-market-ticker-lights-768x432.jpg", "site": "Zacks Investment Research", "text": "From an investment perspective, the spurt in new coronavirus cases over the July fourth weekend bodes well for certain stocks.", "url": "https://www.zacks.com/stock/news/998016/4-stocks-to-play-the-alarming-spike-in-cases-of-covid-19"}, {"symbol": "ABT", "publishedDate": "2020-07-04 07:32:00", "title": "3 Top Medical-Device Stocks to Buy in the Second Half of 2020", "image": "https://cdn.snapi.dev/images/v1/n/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5803492fmedical-devices-technologyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Catalysts are potentially on the way for these leading medical device stocks.", "url": "https://www.fool.com/investing/2020/07/04/3-top-medical-device-stocks-to-buy-for-the-second.aspx"}, {"symbol": "ABT", "publishedDate": "2020-07-03 08:11:00", "title": "Medical Products Industry's Near-Term Outlook Lacks Spark", "image": "https://cdn.snapi.dev/images/v1/a/w/medical9.jpg", "site": "Zacks Investment Research", "text": "Medical Products Industry's Near-Term Outlook Lacks Spark", "url": "https://www.zacks.com/commentary/997478/medical-products-industrys-near-term-outlook-lacks-spark"}, {"symbol": "ABT", "publishedDate": "2020-07-02 09:14:00", "title": "3 MedTech Stocks to Buy Amid Intensifying Coronavirus Fears", "image": "https://cdn.snapi.dev/images/v1/2/4/medical1.jpg", "site": "Zacks Investment Research", "text": "Let's keep a watch on three stocks that have shown tremendous promise amid the pandemic.", "url": "https://www.zacks.com/stock/news/996888/3-medtech-stocks-to-buy-amid-intensifying-coronavirus-fears"}, {"symbol": "ABT", "publishedDate": "2020-06-30 14:31:00", "title": "Abbott, Tandem Diabetes Seal Deal on Diabetes Management", "image": "https://cdn.snapi.dev/images/v1/i/q/medical14.jpg", "site": "Zacks Investment Research", "text": "Abbott's (ABT) FreeStyle Libre CGM technology to be integrated with Tandem Diabetes' insulin pumps to enhance diabetes care.", "url": "https://www.zacks.com/stock/news/995623/abbott-tandem-diabetes-seal-deal-on-diabetes-management"}, {"symbol": "ABT", "publishedDate": "2020-06-26 17:45:15", "title": "Abbott (ABT) Stock Moves -1.02%: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/q/6/medical12.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) closed the most recent trading day at $88.71, moving -1.02% from the previous trading session.", "url": "https://www.zacks.com/stock/news/993520/abbott-abt-stock-moves-102-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2020-06-26 09:00:00", "title": "New Research Finds Abbott's Optical Coherence Tomography Imaging Changed Treatment Decisions in 88% of Artery Blockages", "image": "https://cdn.snapi.dev/images/v1/h/w/press8-3.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., June 26, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new data from the company's LightLab Initiative that showed optical coherence tomography (OCT) imaging significantly changes how physicians decide to treat a vessel compared to traditional angiography by...", "url": "https://www.prnewswire.com/news-releases/new-research-finds-abbotts-optical-coherence-tomography-imaging-changed-treatment-decisions-in-88-of-artery-blockages-301084234.html"}, {"symbol": "ABT", "publishedDate": "2020-06-25 10:00:00", "title": "New Late-Breaking Data Highlight Impact of Abbott's Minimally Invasive Structural Heart Therapies", "image": "https://cdn.snapi.dev/images/v1/4/p/press3-2.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., June 25, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced late-breaking data on a number of its life-changing products to treat people with structural heart diseases. The data included findings on the MitraClip\u2122 system for transcatheter mitral valve repair and...", "url": "https://www.prnewswire.com/news-releases/new-late-breaking-data-highlight-impact-of-abbotts-minimally-invasive-structural-heart-therapies-301083357.html"}, {"symbol": "ABT", "publishedDate": "2020-06-24 11:23:32", "title": "A Trio of Strong Performers to Consider (June 24)", "image": "https://cdn.snapi.dev/images/v1/w/h/what-will-the-stock-market-return-in-2020.jpg", "site": "GuruFocus", "text": "Shareholders of Abbott Laboratories (NYSE:ABT), Mastercard Inc (NYSE:MA) and Lowe's Companies Inc (NYSE:LOW) have seen their stocks return more than the S&P 500 index in recent years.", "url": "https://www.gurufocus.com/news/1170348/a-trio-of-strong-performers-to-consider"}, {"symbol": "ABT", "publishedDate": "2020-06-23 07:19:00", "title": "Coronavirus Diagnostic Tests in High Demand: 4 Stocks in Focus", "image": "https://cdn.snapi.dev/images/v1/5/a/medical27.jpg", "site": "Zacks Investment Research", "text": "Amid the pandemic, these four companies with strong diagnostics testing developments might show better resilience.", "url": "https://www.zacks.com/stock/news/990828/coronavirus-diagnostic-tests-in-high-demand-4-stocks-in-focus"}, {"symbol": "ABT", "publishedDate": "2020-06-22 12:09:00", "title": "Abbott Laboratories Stock May Be Setting Up For New Run After Hitting All-Time High", "image": "https://cdn.snapi.dev/images/v1/j/o/medical21.jpg", "site": "Investors Business Daily", "text": "A Relative Strength Rating upgrade for Abbott Laboratories shows improving technical performance. Will it continue?", "url": "https://www.investors.com/news/technology/stocks-with-rising-relative-strength-abbott-laboratories-2/"}, {"symbol": "ABT", "publishedDate": "2020-06-20 07:02:00", "title": "The 3 Best Coronavirus Stocks to Buy for Long-Term Investors", "image": "https://cdn.snapi.dev/images/v1/7/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5748202fcoronavirus-model-on-100-billsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Strong COVID-19 programs, great growth prospects, attractive dividends. These stocks check off all the boxes.", "url": "https://www.fool.com/investing/2020/06/20/the-3-best-coronavirus-stocks-to-buy-for-long-term.aspx"}, {"symbol": "ABT", "publishedDate": "2020-06-18 10:14:52", "title": "Better Coronavirus Stock: Abbott Labs or Hologic?", "image": "https://cdn.snapi.dev/images/v1/q/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5787942fgettyimages-1215518076jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Which one of these COVID-19 test-kit manufacturers is a better investment?", "url": "https://www.fool.com/investing/2020/06/18/better-coronavirus-stock-abbott-labs-or-hologic.aspx"}, {"symbol": "ABT", "publishedDate": "2020-06-17 07:11:00", "title": "3 MedTech Stocks to Watch Amid Coronavirus Catastrophe", "image": "https://cdn.snapi.dev/images/v1/t/v/medical20.jpg", "site": "Zacks Investment Research", "text": "Let's keep a watch on three stocks that have displayed strong performance amid market turmoil led by the ongoing pandemic.", "url": "https://www.zacks.com/stock/news/986957/3-medtech-stocks-to-watch-amid-coronavirus-catastrophe"}, {"symbol": "ABT", "publishedDate": "2020-06-16 12:34:00", "title": "Abbott's Libre 2 iCGM Gets FDA Nod to Better Manage Diabetes", "image": "https://cdn.snapi.dev/images/v1/w/g/medical14-2.jpg", "site": "Zacks Investment Research", "text": "Abbott's (ABT) FDA-cleared FreeStyle Libre 2 iCGM is the only available system to continuously transmit glucose data with real-time alarms.", "url": "https://www.zacks.com/stock/news/986522/abbotts-libre-2-icgm-gets-fda-nod-to-better-manage-diabetes"}, {"symbol": "ABT", "publishedDate": "2020-06-15 10:53:54", "title": "Abbott Gains New Clearance As Devices Rivalry With Dexcom Builds", "image": "https://cdn.snapi.dev/images/v1/e/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5683052fabbott-coronavirus-test1jpgw700opresize.jpg", "site": "Investors Business Daily", "text": "Abbott Laboratories hopes to close the competitive gap with Dexcom after gaining U.S. clearance for a next-generation diabetes treatment device on Monday.", "url": "https://www.investors.com/news/technology/diabetes-treatment-abbott-new-device-rival-dexcom/"}, {"symbol": "ABT", "publishedDate": "2020-06-15 10:49:00", "title": "Abbott's (ABT) FreeStyle Libre Study Outcome Favorable", "image": "https://cdn.snapi.dev/images/v1/2/g/medical4.jpg", "site": "Zacks Investment Research", "text": "The latest study outcome aligns with the American Diabetes Association's recommended A1c level of 7% for adults with diabetes.", "url": "https://www.zacks.com/stock/news/984479/abbotts-abt-freestyle-libre-study-outcome-favorable"}, {"symbol": "ABT", "publishedDate": "2020-06-15 10:25:00", "title": "Abbott's Bluetooth-Enabled Glucose Monitor Finally Clears FDA Hurdle", "image": "https://cdn.snapi.dev/images/v1/v/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5787082ffda-approved-stamp-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The company's second-generation integrated continuous glucose monitoring system, the Freestyle Libre 2, earned regulatory in Europe over two years ago.", "url": "https://www.fool.com/investing/2020/06/15/abbotts-bluetooth-enabled-glucose-monitor-finally.aspx"}, {"symbol": "ABT", "publishedDate": "2020-06-15 10:00:09", "title": "Is Abbott Stock A Buy As Worries Of A Second Coronavirus Wave Spread?", "image": "https://cdn.snapi.dev/images/v1/t/i/medical6.jpg", "site": "Investors Business Daily", "text": "Medical company Abbott has now launched five coronavirus tests. It's expected to own a big share of the market.", "url": "https://www.investors.com/news/technology/abt-stock-buy-now/"}, {"symbol": "ABT", "publishedDate": "2020-06-15 09:39:02", "title": "2 Million Patients And Beyond: Abbott\u2019s FreeStyle Libre 2 Cleared In The U.S. For Adults And Children With Diabetes", "image": "https://cdn.snapi.dev/images/v1/6/w/2-million-patients-and-beyond-abbotts-freestyle-libre-2-cleared-in-the-us-for-adults-and-children-with-diabetes.jpg", "site": "Forbes", "text": "Abbott (NYSE: ABT), a publicly-traded multinational medical devices and health care company with $31.9 billion in revenue, announced today the FDA cleared its next-generation FreeStyle\u00ae Libre 2 integrated continuous glucose monitoring (iCGM) system for adults and children.", "url": "https://www.forbes.com/sites/chasefeiger/2020/06/15/2-million-patients-and-beyond-abbotts-freestyle-libre-2-cleared-in-the-us-for-adults-and-children-with-diabetes/"}, {"symbol": "ABT", "publishedDate": "2020-06-15 07:01:00", "title": "Abbott's FreeStyle\u00ae Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards", "image": "https://cdn.snapi.dev/images/v1/m/y/press17-3.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., June 15, 2020 /PRNewswire/ -- Abbott (NYSE: ABT), the worldwide leader in continuous glucose monitoring (CGM), announced today the U.S. Food and Drug Administration (FDA) cleared its next-generation FreeStyle\u00ae Libre 2 integrated continuous glucose monitoring (iCGM)...", "url": "https://www.prnewswire.com/news-releases/abbotts-freestyle-libre-2-icgm-cleared-in-us-for-adults-and-children-with-diabetes-achieving-highest-level-of-accuracy-and-performance-standards-301076725.html"}, {"symbol": "ABT", "publishedDate": "2020-06-14 06:55:00", "title": "3 Top Dividend Stocks to  Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/k/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5783292fbills-and-coinsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These aristocrats are among the safest dividend stocks you can hold in your portfolio today.", "url": "https://www.fool.com/investing/2020/06/14/3-top-dividend-stocks-to-buy-right-now.aspx"}, {"symbol": "ABT", "publishedDate": "2020-06-13 11:00:00", "title": "New Late-Breaking Data Show Use of Abbott's FreeStyle\u00ae Libre System Significantly Reduces HbA1C Levels in People with Type 2 Diabetes Using Insulin or Not", "image": "https://cdn.snapi.dev/images/v1/u/y/press19.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., June 13, 2020 /PRNewswire/ -- Today, Abbott (NYSE: ABT) announced new late-breaking data demonstrating use of its FreeStyle Libre system, the world's leading3 continuous glucose monitoring (CGM) technology, is associated with significant reduction in hemoglobin A1c...", "url": "https://www.prnewswire.com/news-releases/new-late-breaking-data-show-use-of-abbotts-freestyle-libre-system-significantly-reduces-hba1c-levels-in-people-with-type-2-diabetes-using-insulin-or-not-301075390.html"}, {"symbol": "ABT", "publishedDate": "2020-06-12 10:28:00", "title": "Abbott Declares 386th Consecutive Quarterly Dividend", "image": "https://cdn.snapi.dev/images/v1/a/4/press8.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., June 12, 2020 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share. This marks the 386th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 17, 2020,...", "url": "https://www.prnewswire.com/news-releases/abbott-declares-386th-consecutive-quarterly-dividend-301075124.html"}, {"symbol": "ABT", "publishedDate": "2020-06-12 08:58:00", "title": "3 Diabetes Management Stocks in the Spotlight Amid Coronavirus", "image": "https://cdn.snapi.dev/images/v1/c/s/medical27.jpg", "site": "Zacks Investment Research", "text": "Amid the widespread pandemic crisis, the diabetes management sector continues to thrive on account of multiple positive developments", "url": "https://www.zacks.com/stock/news/979595/3-diabetes-management-stocks-in-the-spotlight-amid-coronavirus"}, {"symbol": "ABT", "publishedDate": "2020-06-11 07:30:00", "title": "After A 40% Rally Should You Pick Boston Scientific Over Abbott?", "image": "https://cdn.snapi.dev/images/v1/v/q/after-a-40-rally-should-you-pick-boston-scientific-over-abbott.jpg", "site": "Forbes", "text": "Medical Devices companies \u2013 Abbott and Boston Scientific\u2013 have seen their stock price grow over 40% since the March 23 lows. This can partly be attributed to the overall recovery seen in the market over the recent weeks, as well as the opening up of economies.", "url": "https://www.forbes.com/sites/greatspeculations/2020/06/11/after-a-40-rally-should-you-pick-boston-scientific-over-abbott/"}, {"symbol": "ABT", "publishedDate": "2020-06-11 07:09:00", "title": "Diagnostic Testing Remains Crucial in Combatting Coronavirus", "image": "https://cdn.snapi.dev/images/v1/z/j/medical20.jpg", "site": "Zacks Investment Research", "text": "Let's keep a watch on three stocks that are focused on offering advanced diagnostic testing to fight against coronavirus.", "url": "https://www.zacks.com/stock/news/977414/diagnostic-testing-remains-crucial-in-combatting-coronavirus"}, {"symbol": "ABT", "publishedDate": "2020-06-06 07:41:00", "title": "$3,000 Invested in These Coronavirus Stocks Could Pay Off Big Time", "image": "https://cdn.snapi.dev/images/v1/k/5/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5766172fcoronavirus-and-100-billsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "And they should do so even if their COVID-19 programs aren't as successful as hoped.", "url": "https://www.fool.com/investing/2020/06/06/3000-invested-in-these-coronavirus-stocks-could-pa.aspx"}, {"symbol": "ABT", "publishedDate": "2020-06-06 05:52:00", "title": "3 Top Coronavirus Stocks to Buy in  June", "image": "https://cdn.snapi.dev/images/v1/y/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5769272fgettyimages-1205966780jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These companies should benefit from vaccines, tests and beyond.", "url": "https://www.fool.com/investing/2020/06/06/3-top-coronavirus-stocks-to-buy-in-june.aspx"}, {"symbol": "ABT", "publishedDate": "2020-06-05 20:03:21", "title": "FDA Evaluates 5 More COVID-19 Antibody Tests", "image": "https://cdn.snapi.dev/images/v1/t/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5775862fcoronavirus-positive-testjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Independent analysis shows some of the post-exposure tests work fairly well.", "url": "https://www.fool.com/investing/2020/06/05/fda-evaluates-5-more-covid-19-antibody-tests.aspx"}, {"symbol": "ABT", "publishedDate": "2020-06-05 09:21:00", "title": "Abbott Stock Down on Urgent Field Safety Notice for TactiCath", "image": "https://cdn.snapi.dev/images/v1/p/u/medical26.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) also mentions certain guidelines related to product return, reporting, and customer assistance.", "url": "https://www.zacks.com/stock/news/965535/abbott-stock-down-on-urgent-field-safety-notice-for-tacticath"}, {"symbol": "ABT", "publishedDate": "2020-06-02 14:05:00", "title": "Should You Sell Abbott Laboratories Stock?", "image": "https://cdn.snapi.dev/images/v1/i/7/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5768772fgettyimages-1201549319jpgw700opresize.jpg", "site": "The Motley Fool", "text": "A Goldman Sachs analyst just downgraded the medical device and healthcare company's stock.", "url": "https://www.fool.com/investing/2020/06/02/should-you-sell-abbott-laboratories-stock.aspx"}, {"symbol": "ABT", "publishedDate": "2020-05-30 07:44:00", "title": "Better Coronavirus Stock: Abbott Labs or Roche?", "image": "https://cdn.snapi.dev/images/v1/h/s/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5757622fcoronavirus-testjpgw700opresize.jpg", "site": "The Motley Fool", "text": "They're both leaders in COVID-19 diagnostics testing and a whole lot more. But one stock appears to be the better pick right now.", "url": "https://www.fool.com/investing/2020/05/30/better-coronavirus-stock-abbott-labs-or-roche.aspx"}, {"symbol": "ABT", "publishedDate": "2020-05-24 07:33:00", "title": "3 Large-Cap Coronavirus Stocks Still Worth Buying", "image": "https://cdn.snapi.dev/images/v1/f/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5748202fcoronavirus-model-on-100-billsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These big healthcare companies have strong COVID-19 programs plus a lot more.", "url": "https://www.fool.com/investing/2020/05/24/3-large-cap-coronavirus-stocks-still-worth-buying.aspx"}, {"symbol": "ABT", "publishedDate": "2020-05-24 06:32:00", "title": "Is Abbott Labs Stock in Trouble?", "image": "https://cdn.snapi.dev/images/v1/b/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5754092fpeople-working-in-a-labjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Questions surrounding the accuracy of its COVID-19 tests could cause problems for the company.", "url": "https://www.fool.com/investing/2020/05/24/is-abbott-labs-stock-in-trouble.aspx"}, {"symbol": "ABT", "publishedDate": "2020-05-21 16:11:00", "title": "Abbott Releases Interim Clinical Study Data on ID NOW COVID-19 Rapid Test Showing Strong Agreement to Lab-Based Molecular PCR Tests", "image": "https://cdn.snapi.dev/images/v1/2/9/press4.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., May 21, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) announced today an interim analysis of an ongoing multi-site clinical study in urgent care clinics that indicates its ID NOW COVID-19 rapid test is showing strong agreement to lab-based molecular polymerase chain reaction...", "url": "https://www.prnewswire.com/news-releases/abbott-releases-interim-clinical-study-data-on-id-now-covid-19-rapid-test-showing-strong-agreement-to-lab-based-molecular-pcr-tests-301063953.html"}, {"symbol": "ABT", "publishedDate": "2020-05-19 07:12:00", "title": "Is Abbott Labs Stock a Buy After Its COVID-19 Test Controversy?", "image": "https://cdn.snapi.dev/images/v1/y/b/83452593-s-740x416.jpg", "site": "The Motley Fool", "text": "The fastest COVID-19 test on the market just encountered some turbulence. But does this create a buying opportunity for long-term investors?", "url": "https://www.fool.com/investing/2020/05/19/is-abbott-labs-stock-a-buy-after-its-covid-19-test.aspx"}, {"symbol": "ABT", "publishedDate": "2020-05-18 20:08:30", "title": "Abbott Labs: NYU study on ID Now Covid-19 test an outlier", "image": "https://cdn.snapi.dev/images/v1/h/y/abbott-labs-nyu-study-on-id-now-covid-19-test-an-outlier.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell talks to Dr. John Hackett, vp of infectious disease diagnostics at Abbott Labs. With Dr. Scott Gottlieb.", "url": "https://www.youtube.com/watch?v=UFKHYGV2_WU"}, {"symbol": "ABT", "publishedDate": "2020-05-16 11:30:07", "title": "Why Is Abbott (ABT) Down 6.4% Since Last Earnings Report?", "image": "https://cdn.snapi.dev/images/v1/6/o/medical4.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/928530/why-is-abbott-abt-down-64-since-last-earnings-report"}, {"symbol": "ABT", "publishedDate": "2020-05-15 13:24:34", "title": "Trump says he isn't concerned about Abbott's coronavirus test as FDA probes accuracy", "image": "https://cdn.snapi.dev/images/v1/a/f/medical1.jpg", "site": "Market Watch", "text": "President Donald Trump on Friday said he's not concerned about Abbott Laboratories' ABT, -2.18% rapid test for COVID-19, calling it \"a great test.", "url": "https://www.marketwatch.com/story/trump-says-he-isnt-concerned-about-abbotts-coronavirus-test-as-fda-probes-accuracy-2020-05-15"}, {"symbol": "ABT", "publishedDate": "2020-05-15 11:12:00", "title": "FDA Warns Public About Inaccuracy Issues With Abbott's Coronavirus Test", "image": "https://cdn.snapi.dev/images/v1/q/2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5746252fclinical-trial-theme-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Adverse event reports suggest the Abbott ID NOW test has been delivering a troubling number of false negative results.", "url": "https://www.fool.com/investing/2020/05/15/fda-warns-public-about-inaccuracy-issues-with-abbo.aspx"}, {"symbol": "ABT", "publishedDate": "2020-05-15 10:45:02", "title": "CDC releases reopening guidelines plus, Abbott labs changes testing instructions after FDA warning", "image": "https://cdn.snapi.dev/images/v1/b/w/cdc-releases-reopening-guidelines-plus-abbott-labs-changes-testing-instructions-after-fda-warning.jpg", "site": "Yahoo Finance", "text": "Anjalee Khemlani reports on the latest developments in the FDA warning concerning Abbott labs accuracy in testing, plus coronavirus cases continue to rise as more states reopen and the CDC releases guidelines on reopening.", "url": "https://www.youtube.com/watch?v=ZhTnLf9Udl8"}, {"symbol": "ABT", "publishedDate": "2020-05-15 10:38:38", "title": "Abbott's inaccurate coronavirus test results may be due to 'user error,' US health secretary Azar says", "image": "https://cdn.snapi.dev/images/v1/e/h/106539243-1589552127504gettyimages-1212974200.jpeg", "site": "CNBC", "text": "The White House still has \"confidence in the test,\" Health and Human Services Secretary Alex Azar says.", "url": "https://www.cnbc.com/2020/05/15/abbotts-inaccurate-coronavirus-test-results-may-be-due-to-user-error-us-health-secretary-azar-says.html"}, {"symbol": "ABT", "publishedDate": "2020-05-15 08:00:09", "title": "Is Abbott Stock A Buy As Coronavirus Test Accuracy Called Into Question?", "image": "https://cdn.snapi.dev/images/v1/a/b/medical25.jpg", "site": "Investors Business Daily", "text": "Medical company Abbott has now launched five coronavirus tests. It's expected to take a sizable share of the market.", "url": "https://www.investors.com/news/technology/abt-stock-buy-now/"}, {"symbol": "ABT", "publishedDate": "2020-05-15 06:06:24", "title": "FDA Warns Abbott's Coronavirus Rapid Test Kits Used By White House Possibly Shows False Negative", "image": "https://cdn.snapi.dev/images/v1/r/f/abbott.png", "site": "Benzinga", "text": "The Food and Drug Administration (FDA) on Thursday warned that rapid novel coronavirus (COVID-19) testing kits developed by Abbott Laboratories (NYSE: ABT)\u00a0are frequently returning false negatives, according to preliminary data.", "url": "https://www.benzinga.com/government/20/05/16040250/fda-warns-abbotts-coronavirus-rapid-test-kits-used-by-white-house-possibly-shows-false-negative"}, {"symbol": "ABT", "publishedDate": "2020-05-14 22:59:41", "title": "FDA Warns Abbott Coronavirus Tests Could Be Inaccurate", "image": "https://cdn.snapi.dev/images/v1/s/c/fda-warns-abbott-coronavirus-tests-could-be-inaccurate.jpg", "site": "Forbes", "text": "The alert comes after an NYU study showed the company\u2019s tests missed diagnosing up to half of known positive cases.", "url": "https://www.forbes.com/sites/rachelsandler/2020/05/14/fda-warns-abbott-coronavirus-tests-could-be-inaccurate/"}, {"symbol": "ABT", "publishedDate": "2020-05-14 21:48:39", "title": "U.S. regulator is reviewing Abbott's fast COVID test after studies raise accuracy concerns", "image": "https://cdn.snapi.dev/images/v1/r/z/m02d20200515t2i1518699825rlynxmpeg4e04gw640.jpg", "site": "Reuters", "text": "The U.S. Food and Drug Administration said on Thursday that Abbott Laboratories\u2019  speedy coronavirus test, which can deliver results within minutes and is used at the White House, could potentially be inaccurate but can still be used to test patients.", "url": "https://www.reuters.com/article/us-health-coronavirus-testing-abbott/u-s-regulator-is-reviewing-abbotts-fast-covid-test-after-studies-raise-accuracy-concerns-idUSKBN22R07G"}, {"symbol": "ABT", "publishedDate": "2020-05-14 20:38:00", "title": "FDA: Data suggests Abbott's rapid coronavirus diagnostic test is delivering inaccurate results", "image": "https://cdn.snapi.dev/images/v1/c/y/106467437-1585607847896gettyimages-1208678012.jpeg", "site": "CNBC", "text": "The U.S. Food and Drug Administration issued an alert on Thursday saying there is early data that suggests Abbott Labs' rapid coronavirus diagnostic test for Covid-19 may be delivering inaccurate results.", "url": "https://www.cnbc.com/2020/05/14/fda-data-suggests-abbotts-rapid-coronavirus-diagnostic-test-is-delivering-inaccurate-results.html"}, {"symbol": "ABT", "publishedDate": "2020-05-14 18:40:00", "title": "Abbott Provides Update on ID NOW\u2122", "image": "https://cdn.snapi.dev/images/v1/6/l/press17.jpg", "site": "PRNewsWire", "text": "ABBOTT PARK, Ill., May 14, 2020 /PRNewswire/ -- (NYSE: ABT) -- Abbott's ID NOW\u2122 is the fastest molecular point-of-care rapid test available today and has been delivering reliable results when and where they're needed. The availability and ease-of-access of ID NOW, which delivers results...", "url": "https://www.prnewswire.com/news-releases/abbott-provides-update-on-id-now-301059851.html"}, {"symbol": "ABT", "publishedDate": "2020-05-14 12:07:39", "title": "Abbott Strikes Back Against Claims Its Coronavirus Test Is Inaccurate", "image": "https://cdn.snapi.dev/images/v1/9/n/medical11.jpg", "site": "Investors Business Daily", "text": "Abbott Laboratories refuted claims Thursday that its coronavirus test is about half as accurate as a rival diagnostic. But ABT stock continued to tumble for the third straight day.", "url": "https://www.investors.com/news/technology/coronavirus-test-accuracy-questioned-abt-stock-dives/"}, {"symbol": "ABT", "publishedDate": "2020-05-13 15:42:34", "title": "Abbott's rapid coronavirus test misses positive cases, raising questions, NYU study finds", "image": "https://cdn.snapi.dev/images/v1/t/q/106492040-1587057527800covid.jpg", "site": "CNBC", "text": "The urgency to ramp up coronavirus testing in the U.S. \"has eased the usual scrutiny\" applied by the Food and Drug Administration before the release of a new test, according to the authors of the study.", "url": "https://www.cnbc.com/2020/05/13/abbotts-rapid-coronavirus-test-misses-positive-cases-raising-questions-nyu-study-finds.html"}, {"symbol": "ABT", "publishedDate": "2020-05-11 14:10:00", "title": "Coronavirus Antibody Test From Abbott Receives Emergency Use Authorization", "image": "https://cdn.snapi.dev/images/v1/o/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5736842fsample-tubes-olympus-rack-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The company plans to ship 90 million of the laboratory-run blood tests for SARS-CoV-2 antibodies by the end of June.", "url": "https://www.fool.com/investing/2020/05/11/coronavirus-antibody-test-from-abbott-receives-eme.aspx"}, {"symbol": "ABT", "publishedDate": "2020-05-11 10:02:10", "title": "Abbott gets second EUA for COVID-19 antibody test", "image": "https://cdn.snapi.dev/images/v1/v/w/medical21.jpg", "site": "Market Watch", "text": "Shares of Abbott Laboratories ABT, +0.47% were up 0.1% in trading on Monday after the company announced that it received its second authorization from the Food and Drug Administration to market a COVID-19 antibody test.", "url": "https://www.marketwatch.com/story/abbott-gets-second-eua-for-covid-19-antibody-test-2020-05-11"}, {"symbol": "ABT", "publishedDate": "2020-05-11 09:28:33", "title": "FDA grants emergency use authorization to Abbott Labs' coronavirus antibody test", "image": "https://cdn.snapi.dev/images/v1/z/9/106528620-1588951599370gettyimages-1044206610.jpeg", "site": "CNBC", "text": "Abbott plans to ship nearly 30 million tests this month and will have the capacity to ship 60 million tests in June.", "url": "https://www.cnbc.com/2020/05/11/coronavirus-fda-grants-emergency-use-authorization-abbott-labs-antibody-test.html"}, {"symbol": "ABT", "publishedDate": "2020-05-08 14:07:00", "title": "Abbott's Coronavirus Antibody Test Proves Highly Accurate", "image": "https://cdn.snapi.dev/images/v1/l/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5730292fgettyimages-1210053287jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Researchers found the test correctly returned negative results 99.9% of the time and positive results 100% of the time.", "url": "https://www.fool.com/investing/2020/05/08/abbotts-coronavirus-antibody-test-proves-highly-ac.aspx"}, {"symbol": "ABT", "publishedDate": "2020-05-08 11:53:00", "title": "Study suggests Abbott Covid-19 antibody test highly likely to give correct results", "image": "https://cdn.snapi.dev/images/v1/t/1/106528620-1588951599370gettyimages-1044206610.jpeg", "site": "CNBC", "text": "Abbott Laboratories' antibody test for the new coronavirus is highly likely to correctly determine whether people have ever been infected with the fast-spreading virus, the company said, citing a U.S. study.", "url": "https://www.cnbc.com/2020/05/08/study-suggests-abbott-covid-19-antibody-test-highly-likely-to-give-correct-results.html"}, {"symbol": "ABT", "publishedDate": "2020-05-08 07:00:50", "title": "Coronavirus Roundtable - Opportunities Around The World", "image": "https://cdn.snapi.dev/images/v1/j/a/medical25.jpg", "site": "Seeking Alpha", "text": "Coronavirus Roundtable - Opportunities Around The World", "url": "https://seekingalpha.com/article/4344533-coronavirus-roundtable-opportunities-around-world"}, {"symbol": "ABT", "publishedDate": "2020-05-06 18:03:27", "title": "Trader says 'no guidance, no problem' for this medical device company\u2014Here's why", "image": "https://cdn.snapi.dev/images/v1/o/a/oaksdj1234.jpg", "site": "CNBC Television", "text": "Is Abbott Labs a buy? With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Pete Najarian and Steve Grasso.", "url": "https://www.youtube.com/watch?v=ZxFBPdTQYTY"}, {"symbol": "ABT", "publishedDate": "2020-05-06 11:40:07", "title": "HRC vs. ABT: Which Stock Should Value Investors Buy Now?", "image": "https://cdn.snapi.dev/images/v1/c/g/stock-market-3.jpg", "site": "Zacks Investment Research", "text": "HRC vs. ABT: Which Stock Is the Better Value Option?", "url": "https://www.zacks.com/stock/news/915398/hrc-vs-abt-which-stock-should-value-investors-buy-now"}, {"symbol": "ABT", "publishedDate": "2020-05-06 09:42:00", "title": "3 Stocks Set to Pop Once the Economy Gets Back to Business", "image": "https://cdn.snapi.dev/images/v1/o/x/techstock1600-768x432-2.jpg", "site": "Zacks Investment Research", "text": "We have highlighted three stocks will flourish when the economy reopens. Notably, an increasing number of states are expected to reopen their economies in the first two weeks of May.", "url": "https://www.zacks.com/stock/news/915144/3-stocks-set-to-pop-once-the-economy-gets-back-to-business"}, {"symbol": "ABT", "publishedDate": "2020-05-06 07:01:00", "title": "3 Best-Performing Dividend Aristocrats of 2020 So Far", "image": "https://cdn.snapi.dev/images/v1/t/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5717612fcrown-on-top-of-pile-of-cashjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Can their momentum continue?", "url": "https://www.fool.com/investing/2020/05/06/3-best-performing-dividend-aristocrats-of-2020-so.aspx"}, {"symbol": "ABT", "publishedDate": "2020-05-05 17:50:25", "title": "5 Top Stock Trades for Wednesday:\u00a0ATVI, SHOP, CHGG, ABT, ABBV", "image": "https://cdn.snapi.dev/images/v1/2/y/3okjn333-4.jpg", "site": "InvestorPlace", "text": "Activision Blizzard, Shopify, Chegg, Abbott Labs and AbbVie were our top stock trades for Wednesday. That said, here's a look at the charts.", "url": "https://investorplace.com/2020/05/5-top-stock-trades-for-wednesday-atvi-shop-chgg-abt-abbv/"}, {"symbol": "ABT", "publishedDate": "2020-05-05 14:18:48", "title": "3 Healthcare Stocks Popping Off Support", "image": "https://cdn.snapi.dev/images/v1/o/d/healthcare1600d-768x432.jpg", "site": "InvestorPlace", "text": "Healthcare stocks are pulling the market higher today. Here are three of the best stocks to buy in the sector right now.", "url": "https://investorplace.com/2020/05/3-healthcare-stocks-popping-off-support/"}, {"symbol": "ABT", "publishedDate": "2020-05-05 08:00:00", "title": "Abbott Labs Eclipses 1.4 Million Rapid Coronavirus Tests Shipped Across U.S.", "image": "https://cdn.snapi.dev/images/v1/7/k/abbott-labs-eclipses-14-million-rapid-coronavirus-tests-shipped-across-us.jpg", "site": "Forbes", "text": "Abbott Laboratories has shipped 1.4 million of its highly touted \u201crapid\u201d molecular tests for the Coronavirus strain COVID-19 to all 50 U. S. states.", "url": "https://www.forbes.com/sites/brucejapsen/2020/05/05/abbott-labs-eclipses-14-million-rapid-coronavirus-tests-shipped-across-us/"}, {"symbol": "ABT", "publishedDate": "2020-05-04 09:59:00", "title": "Why Abbott Shares Rose 16.7% in April", "image": "https://cdn.snapi.dev/images/v1/e/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5714282fgettyimages-1204866804jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The launch of a third coronavirus test and optimism about a fourth boosted the stock.", "url": "https://www.fool.com/investing/2020/05/04/why-abbott-shares-rose-167-in-april.aspx"}, {"symbol": "ABT", "publishedDate": "2020-05-01 08:30:00", "title": "Best Medical Devices Stock: DexCom Or Abbott?", "image": "https://cdn.snapi.dev/images/v1/z/a/best-medical-devices-stock-dexcom-or-abbott.jpg", "site": "Forbes", "text": "Based on year-to-date returns, DexCom stands out with 43% gains vis-a-vis -9% decline for broader S&P 500. DexCom\u2019s glucose monitoring devices, which can be used at-home, are seeing a surge in demand, amid movement restrictions and lockdown in various cities.", "url": "https://www.forbes.com/sites/greatspeculations/2020/05/01/best-medical-devices-stock-dexcom-or-abbott/"}, {"symbol": "ABT", "publishedDate": "2020-04-30 13:34:25", "title": "Final Trades: Fireye, Starbucks & more", "image": "https://cdn.snapi.dev/images/v1/c/u/final-trades-fireye-starbucks-more.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders give their top stocks to watch for the second half.", "url": "https://www.youtube.com/watch?v=tfxryetKGfo"}, {"symbol": "ABT", "publishedDate": "2020-04-30 07:01:00", "title": "Have $3,000 to Invest? Here Are 3 Top Coronavirus Stocks to Buy Right Now.", "image": "https://cdn.snapi.dev/images/v1/2/i/what-will-the-stock-market-return-in-2020.jpg", "site": "The Motley Fool", "text": "They're battling COVID-19 in different ways. And they each have a lot more going for them than just their coronavirus programs.", "url": "https://www.fool.com/investing/2020/04/30/have-3000-to-invest-here-are-3-top-coronavirus-sto.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-29 08:00:00", "title": "Best Coronavirus Testing Stocks: Abbott, Quest Or Chembio Diagnostics?", "image": "https://cdn.snapi.dev/images/v1/7/y/best-coronavirus-testing-stocks-abbott-quest-or-chembio-diagnostics.jpg", "site": "Forbes", "text": "Testing is viewed as key to containing the spread of the Coronavirus pandemic and re-opening the economy until a safe vaccine is developed. For instance, the U.S.", "url": "https://www.forbes.com/sites/greatspeculations/2020/04/29/best-coronavirus-testing-stocks-abbott-quest-or-chembio-diagnostics/"}, {"symbol": "ABT", "publishedDate": "2020-04-26 09:55:00", "title": "3 Coronavirus Stocks to Buy Now", "image": "https://cdn.snapi.dev/images/v1/o/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5695782fgettyimages-1210053287jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These companies are trying for coronavirus success -- but their commercialized products offer revenue no matter what.", "url": "https://www.fool.com/investing/2020/04/26/3-coronavirus-stocks-to-buy-now.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-25 12:31:26", "title": "Abbott Labs Has Shipped One Million Rapid Coronavirus Tests To All 50 U.S. States", "image": "https://cdn.snapi.dev/images/v1/r/t/rtht66-2.jpg", "site": "Forbes", "text": "In less than a month, Abbott Laboratories has shipped more than one million of its highly touted \u201crapid\u201d molecular tests for the Coronavirus strain COVID-19 to all 50 U.S. states.", "url": "https://www.forbes.com/sites/brucejapsen/2020/04/25/abbott-labs-has-shipped-one-million-rapid-coronavirus-tests-to-all-50-us-states/"}, {"symbol": "ABT", "publishedDate": "2020-04-24 16:25:02", "title": "Abbott's COVID-19 Test Is Fast, but Lab Personnel Are Worried About Their Safety", "image": "https://cdn.snapi.dev/images/v1/e/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5696032fid-now-covid-19-testjpgw700opresize.jpg", "site": "The Motley Fool", "text": "A report from Kaiser Health News highlights the issue.", "url": "https://www.fool.com/investing/2020/04/24/abbotts-covid-19-test-is-fast-but-lab-personnel-ar.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-23 14:23:29", "title": "Is This Company the Best Coronavirus Stock Yet?", "image": "https://cdn.snapi.dev/images/v1/d/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5690432fnurse-holds-blood-for-coronavirus-testingjpgw700opresize.jpg", "site": "The Motley Fool", "text": "This business already has three coronavirus-related products on the market -- and possibly a fourth on the way.", "url": "https://www.fool.com/investing/2020/04/23/is-this-company-the-best-coronavirus-stock-yet.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-22 06:00:00", "title": "3 Stocks Hitting All-Time Highs", "image": "https://cdn.snapi.dev/images/v1/x/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5686612fdollar-signs-growing-on-chalk-boardjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These three businesses are handling the COVID-19 pandemic with ease.", "url": "https://www.fool.com/investing/2020/04/22/3-stocks-hitting-all-time-highs.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-21 07:01:00", "title": "Better Coronavirus Stock: Abbott Labs vs. Moderna", "image": "https://cdn.snapi.dev/images/v1/x/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5686132fcovid-19-coronavirus-wood-blocksjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Both companies stand to win from their coronavirus programs. But one of them is the better choice.", "url": "https://www.fool.com/investing/2020/04/21/better-coronavirus-stock-abbott-labs-vs-moderna.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-20 09:10:00", "title": "Abbott Launches Antibody Test to Detect Coronavirus Infection", "image": "https://cdn.snapi.dev/images/v1/e/u/medical13.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) launches a lab-based serology blood test to detect the presence of antibodies post the coronavirus infection.", "url": "https://www.zacks.com/stock/news/880217/abbott-launches-antibody-test-to-detect-coronavirus-infection"}, {"symbol": "ABT", "publishedDate": "2020-04-19 09:01:00", "title": "Will the Stock Market Crash Again or Keep Rising? Here's What to Do Either Way.", "image": "https://cdn.snapi.dev/images/v1/w/3/cahs82-3.jpg", "site": "The Motley Fool", "text": "There's no need to try to predict what the market might do.", "url": "https://www.fool.com/investing/2020/04/19/will-the-stock-market-crash-again-or-keep-rising-h.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-18 17:31:52", "title": "Abbott Laboratories' 1st-Quarter Results Show Why It's Best of Breed", "image": "https://cdn.snapi.dev/images/v1/l/e/medical7.jpg", "site": "GuruFocus", "text": "Abbott Laboratories (NYSE:ABT) reported first-quarter earnings results on April 16.", "url": "https://www.gurufocus.com/news/1108447/abbott-laboratories-1stquarter-results-show-why-its-best-of-breed"}, {"symbol": "ABT", "publishedDate": "2020-04-17 16:40:31", "title": "Univ. of Washington ramps up Abbott Labs\u2019 \u2018really fantastic\u2019 test for COVID-19 antibodies", "image": "https://cdn.snapi.dev/images/v1/2/0/200417-architect1-768x410.jpg", "site": "GeekWire", "text": "The University of Washington\u2019s Virology Lab is reporting encouraging results from trial runs of a new test from Abbott Laboratories that detects the antibodies created by people who have had COVID-19, whether they knew they had it or not.", "url": "https://www.geekwire.com/2020/univ-washington-ramps-abbott-labs-really-fantastic-test-covid-19-antibodies/"}, {"symbol": "ABT", "publishedDate": "2020-04-16 17:02:19", "title": "Tech Stocks Lift Nasdaq To Another Bullish Gain", "image": "https://cdn.snapi.dev/images/v1/v/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5513122fturnaround-stockjpgw700opresize.jpg", "site": "Investors Business Daily", "text": "More breakouts emerged even as New York extended its coronavirus shutdown to May 15.", "url": "https://www.youtube.com/watch?v=uatW8N2shG4"}, {"symbol": "ABT", "publishedDate": "2020-04-16 17:00:16", "title": "By June, Abbott Labs Rapid Coronavirus Test To Reach \u2018General Population\u2019", "image": "https://cdn.snapi.dev/images/v1/9/x/by-june-abbott-labs-rapid-coronavirus-test-to-reach-general-population.jpg", "site": "Forbes", "text": "Abbott Laboratories hopes to begin rolling out its rapid diagnostic test for the Coronavirus strain COVID-19 to the general population beyond \u201cfrontline healthcare workers\u201d in May and into June.", "url": "https://www.forbes.com/sites/brucejapsen/2020/04/16/by-june-abbott-labs-rapid-coronavirus-test-to-reach-general-population/"}, {"symbol": "ABT", "publishedDate": "2020-04-16 16:12:00", "title": "Good News for COVID-19 Testing Companies: Medicare Nearly Doubles Reimbursement", "image": "https://cdn.snapi.dev/images/v1/o/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5683052fabbott-coronavirus-test1jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Diagnostic laboratories, rather than the test manufacturers, may be the biggest beneficiaries.", "url": "https://www.fool.com/investing/2020/04/16/good-news-for-covid-19-testing-companies-medicare.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-16 15:30:58", "title": "Abbott Labs Soars After Pandemic Buying Boosts Results", "image": "https://cdn.snapi.dev/images/v1/q/2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5682762fgettyimages-1206790646jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Consumers stock up as Abbott launches three COVID-19 tests.", "url": "https://www.fool.com/investing/2020/04/16/abbott-labs-soars-after-pandemic-buying-boosts-res.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-16 14:34:21", "title": "Coronavirus Limelight Sends These Bullish Medical Stocks Into Breakouts", "image": "https://cdn.snapi.dev/images/v1/b/u/106007058-1562599908150bull.jpg", "site": "Investors Business Daily", "text": "Medical stocks cruised higher Thursday led by breakouts from high-ranking players Abbott Laboratories and Bio-Rad Laboratories. The pandemic gives medical stock a chance to shine.", "url": "https://www.investors.com/news/technology/medical-stocks-break-out-broad-strength-despite-coronavirus-pandemic/"}, {"symbol": "ABT", "publishedDate": "2020-04-16 13:39:18", "title": "Abbott Labs Earnings: ABT Stock Jumps on Q1 Beats", "image": "https://cdn.snapi.dev/images/v1/f/g/medical21.jpg", "site": "InvestorPlace", "text": "Abbott Labs earnings for Q1 2020 have ABT stock rising on Thursday after the company beat EPS and revenue estimates from Wall Street.\nThe post Abbott Labs Earnings: ABT Stock Jumps on Q1 Beats appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/04/abbott-labs-earnings-abt-stock-jumps-on-q1-beats/"}, {"symbol": "ABT", "publishedDate": "2020-04-16 13:18:05", "title": "Abbott Laboratories (ABT) CEO, Robert Ford on Q1 2020 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/h/f/transcript18.jpg", "site": "Seeking Alpha", "text": "Abbott Laboratories (ABT) CEO, Robert Ford on Q1 2020 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4338017-abbott-laboratories-abt-ceo-robert-ford-on-q1-2020-results-earnings-call-transcript"}, {"symbol": "ABT", "publishedDate": "2020-04-16 13:00:00", "title": "Here's Why Investors Liked Abbott Labs' Q1 Earnings Results", "image": "https://cdn.snapi.dev/images/v1/t/9/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5682472fhealthcare-professionals-looking-at-a-slidejpgw700opresize.jpg", "site": "The Motley Fool", "text": "The healthcare giant beat Wall Street expectations and continues to be a key player in the fight against COVID-19.", "url": "https://www.fool.com/investing/2020/04/16/heres-why-investors-liked-abbott-labs-q1-earnings.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-16 12:08:54", "title": "Writing Covered Calls To Capture Volatility Enhanced Premiums", "image": "https://cdn.snapi.dev/images/v1/9/3/etf45.jpg", "site": "Seeking Alpha", "text": "Writing Covered Calls To Capture Volatility Enhanced Premiums", "url": "https://seekingalpha.com/article/4337990-writing-covered-calls-to-capture-volatility-enhanced-premiums"}, {"symbol": "ABT", "publishedDate": "2020-04-16 11:49:15", "title": "Coronavirus test ramp-up to help Abbott weather 'toughest quarter'", "image": "https://cdn.snapi.dev/images/v1/8/v/abbott-id-now-platform.jpg", "site": "Reuters", "text": "Abbott Laboratories Inc  said on Thursday a recent ramp up in coronavirus tests production would help it ride out a tough current quarter as the outbreak chokes demand for its other diagnostic kits.", "url": "https://www.reuters.com/article/us-abbott-results/coronavirus-test-ramp-up-to-help-abbott-weather-toughest-quarter-idUSKCN21Y1MP"}, {"symbol": "ABT", "publishedDate": "2020-04-16 11:20:44", "title": "Triage Your Portfolio With Abbott Laboratories", "image": "https://cdn.snapi.dev/images/v1/b/r/medical10.jpg", "site": "InvestorPlace", "text": "ABT stock is trading at pre-pandemic levels thanks to strong earnings and a new test for coronavirus antibodies that's garnering attention.\nThe post Triage Your Portfolio With Abbott Laboratories appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/04/triage-portfolio-abbott-abt-stock-coronavirus/"}, {"symbol": "ABT", "publishedDate": "2020-04-16 10:48:14", "title": "Abbott Laboratories records a 16% lower profit in the first quarter", "image": "https://cdn.snapi.dev/images/v1/d/n/83452593-s-740x416.jpg", "site": "Invezz", "text": "Abbott Laboratories (NYSE:ABT) said on Thursday that its profit in the first quarter declined by 16%. The American medical devices and healthcare company attributed the decline primarily to a tax expense.", "url": "https://invezz.com/news/2020/04/16/abbott-laboratories-records-a-16-lower-profit-in-the-first-quarter/"}, {"symbol": "ABT", "publishedDate": "2020-04-16 10:04:00", "title": "Abbott (ABT) Beats on Q1 Earnings, Suspends '20 Guidance", "image": "https://cdn.snapi.dev/images/v1/w/t/medical9.jpg", "site": "Zacks Investment Research", "text": "Uncertainties about the duration and impact of the coronavirus pandemic on its overall business compel Abbott (ABT) to suspend its full-year guidance.", "url": "https://www.zacks.com/stock/news/874202/abbott-abt-beats-on-q1-earnings-suspends-20-guidance"}, {"symbol": "ABT", "publishedDate": "2020-04-16 09:30:19", "title": "Abbott Labs Stock at Cusp of Major Breakout", "image": "https://cdn.snapi.dev/images/v1/q/e/medical7-2.jpg", "site": "Investopedia", "text": "Abbott Labs stock has completed a round trip into January's all-time high in response to the roll-out of the 13-minute COVID test.", "url": "https://www.investopedia.com/abbott-labs-stock-at-cusp-of-major-breakout-4842310"}, {"symbol": "ABT", "publishedDate": "2020-04-16 08:55:03", "title": "Abbott (ABT) Beats Q1 Earnings and Revenue Estimates", "image": "https://cdn.snapi.dev/images/v1/w/q/medical4.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) delivered earnings and revenue surprises of 18.18% and 8.38%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/873967/abbott-abt-beats-q1-earnings-and-revenue-estimates"}, {"symbol": "ABT", "publishedDate": "2020-04-16 08:18:35", "title": "Abbott Labs reports earnings beats, withdraws full year guidance", "image": "https://cdn.snapi.dev/images/v1/y/l/abbott-labs-reports-earnings-beats-withdraws-full-year-guidance.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell breaks down what Abbott Labs is saying about its new antibody tests.", "url": "https://www.youtube.com/watch?v=l9hzxuVZ2z0"}, {"symbol": "ABT", "publishedDate": "2020-04-16 08:14:33", "title": "Abbott beats quarterly profit, but pulls forecast on coronavirus concerns", "image": "https://cdn.snapi.dev/images/v1/d/2/m02d20200416t2i1515327504rlynxnpeg3f152w640.jpg", "site": "Reuters", "text": "Abbott Laboratories  beat quarterly profit estimates on Thursday as stay-at-home orders prompted customers to stockpile its nutrition products but the company suspended its full-year forecast due to the coronavirus-fueled uncertainty.", "url": "https://www.reuters.com/article/us-abbott-results/abbott-beats-quarterly-profit-but-pulls-forecast-on-coronavirus-concerns-idUSKCN21Y1MP"}, {"symbol": "ABT", "publishedDate": "2020-04-16 08:00:42", "title": "Abbott's stock rises on revenue jump despite COVID-19 hit to business", "image": "https://cdn.snapi.dev/images/v1/n/8/medical3.jpg", "site": "Market Watch", "text": "Shares of Abbott Laboratories ABT, +2.01% gained 1.0% in premarket trading on Thursday after the company beat revenue expectations for the quarter.", "url": "https://www.marketwatch.com/story/abbotts-stock-rises-on-revenue-jump-despite-covid-19-hit-to-business-2020-04-16"}, {"symbol": "ABT", "publishedDate": "2020-04-16 07:59:25", "title": "Abbott posts a 16% drop in profit and suspends its 2020 forecast on coronavirus concerns", "image": "https://cdn.snapi.dev/images/v1/o/g/106467437-1585607847896gettyimages-1208678012.jpeg", "site": "CNBC", "text": "Abbott Laboratories posted a 16% drop in quarterly profit on Thursday partly due to a tax expense and suspended its full-year forecast citing the uncertainty caused by the coronavirus outbreak.", "url": "https://www.cnbc.com/2020/04/16/abbott-abt-earnings-q1-2020.html"}, {"symbol": "ABT", "publishedDate": "2020-04-16 07:52:52", "title": "Abbott posts 16% fall in profit, suspends 2020 forecast on coronavirus concerns", "image": "https://cdn.snapi.dev/images/v1/7/5/m02d20200416t2i1515326651rlynxnpeg3f14dw640.jpg", "site": "Reuters", "text": "Abbott Laboratories Inc  posted a 16% drop in quarterly profit on Thursday partly due to a tax expense and suspended its full-year forecast citing the uncertainty caused by the coronavirus outbreak.", "url": "https://www.reuters.com/article/us-abbott-results/abbott-posts-16-fall-in-profit-suspends-2020-forecast-on-coronavirus-concerns-idUSKCN21Y1MP"}, {"symbol": "ABT", "publishedDate": "2020-04-16 07:51:00", "title": "3 Great Stocks That Are Still Ridiculously Cheap Right Now", "image": "https://cdn.snapi.dev/images/v1/d/w/what-will-the-stock-market-return-in-2020.jpg", "site": "The Motley Fool", "text": "And two of the three offer nice dividends, too.", "url": "https://www.fool.com/investing/2020/04/16/3-great-stocks-that-are-still-ridiculously-cheap-r.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-16 00:53:50", "title": "My Dividend Achievers Quarterly Review. More Than Up To The Investment Challenge Of COVID-19", "image": "https://cdn.snapi.dev/images/v1/j/j/etf29.jpg", "site": "Seeking Alpha", "text": "I hold 15 Dividend Achievers. That index is available in ETF form by way of Vanguard's Dividend Appreciation Fund - ticker VIG.", "url": "https://seekingalpha.com/article/4337864-dividend-achievers-quarterly-review-up-to-investment-challenge-of-covidminus-19"}, {"symbol": "ABT", "publishedDate": "2020-04-15 16:18:25", "title": "Stock Market Today: Apple\u2019s New iPhone; Abbott\u2019s New Coronavirus Test", "image": "https://cdn.snapi.dev/images/v1/s/t/stocks22-24.jpg", "site": "InvestorPlace", "text": "Apple launched a new iPhone, while the earnings reports continue to trickle in. Here's what happened in the stock market today.", "url": "https://investorplace.com/2020/04/stock-market-today-apples-new-iphone-abbotts-new-coronavirus-test/"}, {"symbol": "ABT", "publishedDate": "2020-04-15 13:58:00", "title": "Abbott Rolling Out a Coronavirus Antibody Test", "image": "https://cdn.snapi.dev/images/v1/0/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5681072fa-coronavirus-colonyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "It is the company's third test for SARS-CoV-2, but its first that can tell if a person has recovered from it.", "url": "https://www.fool.com/investing/2020/04/15/abbott-rolling-out-a-coronavirus-antibody-test.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-15 13:39:53", "title": "#AskHalftime lightning round", "image": "https://cdn.snapi.dev/images/v1/o/s/oslk2e4433.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer 2 rounds of viewer questions in #AskHalftime", "url": "https://www.youtube.com/watch?v=o8upN9BHvlI"}, {"symbol": "ABT", "publishedDate": "2020-04-15 10:12:49", "title": "Abbott Labs will begin shipping new Covid-19 antibody test on Thursday", "image": "https://cdn.snapi.dev/images/v1/s/s/abbott-labs-will-begin-shipping-new-covid-19-antibody-test-on-thursday.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on the latest about Abbott Labs' new antibody test for Covid-19.", "url": "https://www.youtube.com/watch?v=KDtzC7DJgrI"}, {"symbol": "ABT", "publishedDate": "2020-04-15 09:47:09", "title": "Abbott's shares rise as it launches antibody test", "image": "https://cdn.snapi.dev/images/v1/k/g/medical18-2.jpg", "site": "Market Watch", "text": "Shares of Abbott ABT, +0.18% were up 1.0% in trading on Wednesday morning after the company announced the launch of a serological test that can be used to detect if an individual has COVID-19 antibodies even if they never have had symptoms of the virus.", "url": "https://www.marketwatch.com/story/abbotts-shares-rise-as-it-launches-antibody-test-2020-04-15"}, {"symbol": "ABT", "publishedDate": "2020-04-15 09:24:43", "title": "Abbott announces new coronavirus antibody test that could do up to 20 million screenings in June", "image": "https://cdn.snapi.dev/images/v1/s/h/106489469-1586952702293gettyimages-1209950060.jpeg", "site": "CNBC", "text": "Abbott said it plans to distribute 4 million of the new tests by the end of this month, after an initial shipment of 1 million tests this week to U.S. customers.", "url": "https://www.cnbc.com/2020/04/15/new-coronavirus-antibody-test-announced-by-abbott.html"}, {"symbol": "ABT", "publishedDate": "2020-04-14 16:57:15", "title": "Buy Abbott (ABT) Stock Ahead of Earnings on Coronavirus Testing Push?", "image": "https://cdn.snapi.dev/images/v1/d/k/m02d20191016t2i1441465394rlynxmpef9f10cw640.jpg", "site": "Zacks Investment Research", "text": "zacks.com\r\nzacks.com/ultimate", "url": "https://www.youtube.com/watch?v=Z0K_M5voaB8"}, {"symbol": "ABT", "publishedDate": "2020-04-14 11:17:28", "title": "Look To Buy Further Dips On Abbott Laboratories", "image": "https://cdn.snapi.dev/images/v1/y/9/medical8.jpg", "site": "Seeking Alpha", "text": "Look To Buy Further Dips On Abbott Laboratories", "url": "https://seekingalpha.com/article/4337505-look-to-buy-dips-on-abbott-laboratories"}, {"symbol": "ABT", "publishedDate": "2020-04-14 09:47:00", "title": "Solid Diagnostics to Aid Abbott (ABT) Q1 Earnings Amid Crisis?", "image": "https://cdn.snapi.dev/images/v1/i/o/medical3.jpg", "site": "Zacks Investment Research", "text": "Though the magnitude of loss due to the virus outbreak in Abbott's (ABT) Core Laboratory business is still unclear, the company's point-of-care business is anticipated to generate profit.", "url": "https://www.zacks.com/stock/news/870373/solid-diagnostics-to-aid-abbott-abt-q1-earnings-amid-crisis"}, {"symbol": "ABT", "publishedDate": "2020-04-13 09:07:00", "title": "Will Low Product Revenues Impact Abbott (ABT) Q1 Earnings?", "image": "https://cdn.snapi.dev/images/v1/a/8/medical14.jpg", "site": "Zacks Investment Research", "text": "Revenues of Abbott's (ABT) Diabetes Care business, which has been, otherwise on a strong growth trajectory, are likely to have declined in Q1 due to the coronavirus-related market turbulence.", "url": "https://www.zacks.com/stock/news/868417/will-low-product-revenues-impact-abbott-abt-q1-earnings"}, {"symbol": "ABT", "publishedDate": "2020-04-13 08:07:30", "title": "Entire pharmaceutical industry is focused on the coronavirus pandemic: Ken Langone", "image": "https://cdn.snapi.dev/images/v1/m/q/entire-pharmaceutical-industry-is-focused-on-the-coronavirus-pandemic-ken-langone.jpg", "site": "CNBC Television", "text": "Ken Langone, Invemed Associates chairman, joins 'Squawk Box' to discuss the stories of the those on the frontlines fighting the coronavirus including pharmaceuticals and hospitals.", "url": "https://www.youtube.com/watch?v=RBySOOoCYDY"}, {"symbol": "ABT", "publishedDate": "2020-04-12 15:20:36", "title": "Abbott Laboratories: Good Pick In Uncertain Times", "image": "https://cdn.snapi.dev/images/v1/s/u/medical12.jpg", "site": "Seeking Alpha", "text": "Abbott Laboratories: Good Pick In Uncertain Times", "url": "https://seekingalpha.com/article/4337133-abbott-laboratories-good-pick-in-uncertain-times"}, {"symbol": "ABT", "publishedDate": "2020-04-09 17:35:00", "title": "What to Expect from Big Bank Earnings Amid the Coronavirus?", "image": "https://cdn.snapi.dev/images/v1/3/7/371-8.jpg", "site": "Zacks Investment Research", "text": "The large money-center banks that will kick-off the 2020 Q1 earnings season for the sector this week have been hit hard in the ongoing downturn.", "url": "https://www.zacks.com/commentary/863579/what-to-expect-from-big-bank-earnings-amid-the-coronavirus"}, {"symbol": "ABT", "publishedDate": "2020-04-09 15:48:00", "title": "Coronavirus Testing, Vaccines & Treatments: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/e/c/podc8.jpg", "site": "Zacks Investment Research", "text": "In this episode of ETF Spotlight, I speak with biotech expert Brad Loncar, about latest developments in coronavirus testing, vaccines and treatments.", "url": "https://www.zacks.com/stock/news/863503/coronavirus-testing-vaccines-treatments-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2020-04-09 12:30:26", "title": "Earnings Preview: Abbott (ABT) Q1 Earnings Expected to Decline", "image": "https://cdn.snapi.dev/images/v1/n/g/medical6.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/863204/earnings-preview-abbott-abt-q1-earnings-expected-to-decline"}, {"symbol": "ABT", "publishedDate": "2020-04-06 14:59:00", "title": "Healthcare Stocks & ETFs to Gain on Coronavirus Test Progress", "image": "https://cdn.snapi.dev/images/v1/x/a/medical3-2.jpg", "site": "Zacks Investment Research", "text": "It seems that testing for COVID-19 is the major key in controlling the outbreak and helps in making decisions like treatment protocols,  resource allocation and drafting the right healthcare policies.", "url": "https://www.zacks.com/stock/news/857565/healthcare-stocks-etfs-to-gain-on-coronavirus-test-progress"}, {"symbol": "ABT", "publishedDate": "2020-04-03 12:07:00", "title": "Why Abbott Labs Shares Rose 2.44% in March", "image": "https://cdn.snapi.dev/images/v1/f/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5666072fgettyimages-covid-testjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The approval of Abbott\u2019s five-minute coronavirus test buoyed the shares.", "url": "https://www.fool.com/investing/2020/04/03/why-abbott-labs-shares-rose-244-in-march.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-02 12:09:41", "title": "Rapid Tests Hope to Contain Coronavirus Spread", "image": "https://cdn.snapi.dev/images/v1/m/q/rapid-tests-hope-to-contain-coronavirus-spread.jpg", "site": "Bloomberg Markets and Finance", "text": "Countries desperate to curb the spread of the coronavirus are now betting on rapid diagnostics that can be as simple as a home-pregnancy test and deliver results in minutes.", "url": "https://www.youtube.com/watch?v=yUdwHEC93jE"}, {"symbol": "ABT", "publishedDate": "2020-04-02 12:00:06", "title": "Abbott Labs just sent out its first batch of five-minute coronavirus tests", "image": "https://cdn.snapi.dev/images/v1/x/d/abbott-labs-just-sent-out-its-first-batch-of-five-minute-coronavirus-tests.jpg", "site": "CNBC Television", "text": "Abbott Laboratories just sent out its first batch of new coronavirus tests that can produce positive results in as little as five minutes and negative results in 13 minutes.", "url": "https://www.youtube.com/watch?v=Z9CJj6zXRts"}, {"symbol": "ABT", "publishedDate": "2020-04-02 08:35:05", "title": "Detroit To Be The First City To Roll Out Abbott's 5-Minute Coronavirus Tests", "image": "https://cdn.snapi.dev/images/v1/w/q/abbott-laboratories.jpg", "site": "Benzinga", "text": "Detroit will make available Abbott Laboratories (NYSE: ABT) five-minute COVID-19 tests\u00a0to first responders beginning Friday.", "url": "https://www.benzinga.com/government/20/04/15724419/detroit-to-be-the-first-city-to-roll-out-abbotts-5-minute-coronavirus-tests"}, {"symbol": "ABT", "publishedDate": "2020-04-02 07:05:00", "title": "Better Coronavirus Stock: Abbott Labs vs. Gilead Sciences", "image": "https://cdn.snapi.dev/images/v1/i/w/medical14.jpg", "site": "The Motley Fool", "text": "Their coronavirus programs are only part of the attraction for these two healthcare giants.", "url": "https://www.fool.com/investing/2020/04/02/better-coronavirus-stock-abbott-labs-vs-gilead-sci.aspx"}, {"symbol": "ABT", "publishedDate": "2020-04-01 20:26:26", "title": "Detroit to be first to deploy Abbott Lab\u2019s 5 minute Covid-19 test, mayor says", "image": "https://cdn.snapi.dev/images/v1/4/y/106464618-1585353328997idnow-inaction3-macro-300dpi-1200x628.jpg", "site": "TechCrunch", "text": "Detroit Mayor Mike Duggan said today on Wolf Blitzer\u2019s CNN show that the city of Detroit is on track to be the first city to deploy Abbott Lab\u2019s 5 minute Covid-19 test. The mayor said that the test would be available for first responders.", "url": "https://techcrunch.com/2020/04/01/detroit-to-be-first-to-deploy-abbott-labs-5-minute-covid-19-test-mayor-says/"}, {"symbol": "ABT", "publishedDate": "2020-04-01 07:23:31", "title": "Abbott Labs rolls out rapid COVID-19 testing at GoHealth Urgent Care centers", "image": "https://cdn.snapi.dev/images/v1/3/n/abbott-labs-rolls-out-rapid-covid-19-testing-at-gohealth-urgent-care-centers.jpg", "site": "CNBC Television", "text": "Todd Latz, CEO of GoHealth Urgent Care, joins \"Squawk Box\" to discuss the new coronavirus test that Abbott labs is rolling out.", "url": "https://www.youtube.com/watch?v=o4TIgw05AMg"}, {"symbol": "ABT", "publishedDate": "2020-04-01 07:02:00", "title": "Got $5,000 to Invest? 3 Great Medical Device Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/a/e/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5659422fmedical-devices-technologyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "There's no better time than the present to scoop up shares of these high-growth medical device makers.", "url": "https://www.fool.com/investing/2020/04/01/got-5000-to-invest-3-great-medical-device-stocks-t.aspx"}, {"symbol": "ABT", "publishedDate": "2020-03-31 14:43:00", "title": "Healthcare ETFs Gain on Rising Demand for COVID-19 Tests", "image": "https://cdn.snapi.dev/images/v1/y/t/medical18.jpg", "site": "Zacks Investment Research", "text": "A growing demand for COVID-19 tests has indulged major healthcare place in the race to develop competent testing kits.", "url": "https://www.zacks.com/stock/news/847514/healthcare-etfs-gain-on-rising-demand-for-covid-19-tests"}, {"symbol": "ABT", "publishedDate": "2020-03-31 11:09:03", "title": "Cramer sees new, five-minute test as possible turning point in coronavirus-driven market decline", "image": "https://cdn.snapi.dev/images/v1/k/n/106467437-1585607847896gettyimages-1208678012.jpeg", "site": "CNBC", "text": "CNBC's Jim Cramer said Tuesday that a faster coronavirus test could turn the tide in fighting the outbreak \u2014 and by extension, the battered economy and the stock market.", "url": "https://www.cnbc.com/2020/03/31/cramer-new-rapid-test-a-possible-coronavirus-turning-point-for-market.html"}, {"symbol": "ABT", "publishedDate": "2020-03-31 10:22:19", "title": "Cramer: The battle against COVID-19 will be won by science", "image": "https://cdn.snapi.dev/images/v1/m/q/cramer-the-battle-against-covid-19-will-be-won-by-science.jpg", "site": "CNBC Television", "text": "CNBC's Jim Cramer says that the battle against COVID-19 will only be won by science, which will allow the U.S. to begin repairing the economy.", "url": "https://www.youtube.com/watch?v=x68N9KbTHj0"}, {"symbol": "ABT", "publishedDate": "2020-03-31 10:20:00", "title": "Abbott (ABT) in Focus: Stock Moves 6.4% Higher", "image": "https://cdn.snapi.dev/images/v1/l/w/medical11.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.", "url": "https://www.zacks.com/stock/news/847109/abbott-abt-in-focus-stock-moves-64-higher"}, {"symbol": "ABT", "publishedDate": "2020-03-31 10:07:00", "title": "Abbott (ABT) Rides on Point-of-Care Coronavirus Test Launch", "image": "https://cdn.snapi.dev/images/v1/k/e/medical12.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) launches a portable molecular point-of-care test to speed up coronavirus detection, especially in areas with severe outbreaks.", "url": "https://www.zacks.com/stock/news/847081/abbott-abt-rides-on-point-of-care-coronavirus-test-launch"}, {"symbol": "ABT", "publishedDate": "2020-03-31 10:03:00", "title": "Here's Why You Should Hold on to Abbott (ABT) Stock for Now", "image": "https://cdn.snapi.dev/images/v1/o/p/medical13.jpg", "site": "Zacks Investment Research", "text": "Investors continue to be optimistic about Abbott (ABT) on its strong segmental results in the fourth quarter of 2019.", "url": "https://www.zacks.com/stock/news/847063/heres-why-you-should-hold-on-to-abbott-abt-stock-for-now"}, {"symbol": "ABT", "publishedDate": "2020-03-31 08:30:00", "title": "Ride Abbott To $100 With Its New COVID-19 Test?", "image": "https://cdn.snapi.dev/images/v1/z/c/ride-abbott-to-100-with-its-new-covid-19-test.jpg", "site": "Forbes", "text": "Based on historical performance, Abbott Labs (NYSE: ABT) appears to be a better bet compared to Medtronic in the current crisis. The current coronavirus crisis will likely impact medical devices company on two fronts, 1.", "url": "https://www.forbes.com/sites/greatspeculations/2020/03/31/ride-abbott-to-100-with-its-new-covid-19-test/"}, {"symbol": "ABT", "publishedDate": "2020-03-31 07:32:18", "title": "3 Big Stock Charts for Tuesday: Abbott Laboratories, Johnson & Johnson, and Regeneron Pharmaceuticals", "image": "https://cdn.snapi.dev/images/v1/a/j/653.jpg", "site": "InvestorPlace", "text": "Tuesday's big stock charts feature three companies that are contributing, in their own ways, to the fight against the coronavirus.\r\nThe post 3 Big Stock Charts for Tuesday: Abbott Laboratories, Johnson & Johnson, and Regeneron Pharmaceuticals appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/03/3-big-stock-charts-for-tuesday-abbott-laboratories-johnson-johnson-and-regeneron-pharmaceuticals/"}, {"symbol": "ABT", "publishedDate": "2020-03-31 07:05:06", "title": "Why Big Pharmaceutical Stocks May Be the Best Place for Worried Investors Now", "image": "https://cdn.snapi.dev/images/v1/3/x/medical8.jpg", "site": "24/7 Wall Street", "text": "One thing has become increasingly obvious as the weeks have passed since the coronavirus threat entered the daily lexicon.", "url": "https://247wallst.com/healthcare-business/2020/03/31/why-big-pharmaceutical-stocks-may-be-the-best-place-for-worried-investors-now/"}, {"symbol": "ABT", "publishedDate": "2020-03-31 07:03:00", "title": "Is Abbott Labs Stock a Screaming Buy Because of Its Game-Changing COVID-19 Test?", "image": "https://cdn.snapi.dev/images/v1/a/6/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5657582fabbott-sign-at-hqjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Hint: The answer is both yes and no.", "url": "https://www.fool.com/investing/2020/03/31/is-abbott-labs-stock-a-screaming-buy-because-of-it.aspx"}, {"symbol": "ABT", "publishedDate": "2020-03-30 20:31:54", "title": "Abbott Labs CEO on new coronavirus test launches: 'There's a need for more'", "image": "https://cdn.snapi.dev/images/v1/r/n/106467418-1585607337789gettyimages-1208678039.jpeg", "site": "CNBC", "text": "Abbott Labs teams are working around the clock to ramp up COVID-19 tests and to develop more diagnosis products, outgoing CEO Miles White said.", "url": "https://www.cnbc.com/2020/03/30/abbott-labs-ceo-on-new-coronavirus-tests-there-is-a-need-for-more.html"}, {"symbol": "ABT", "publishedDate": "2020-03-30 19:11:50", "title": "Abbott Labs CEO says rapid coronavirus tests prioritized for frontline workers", "image": "https://cdn.snapi.dev/images/v1/d/9/abbott-labs-ceo-says-rapid-coronavirus-tests-prioritized-for-frontline-workers.jpg", "site": "CNBC Television", "text": "After launching two tests in the last couple of weeks, \"there's still more and there's a need for more,\" Abbott Labs CEO Miles White says.", "url": "https://www.youtube.com/watch?v=fFtt6oN4Erc"}, {"symbol": "ABT", "publishedDate": "2020-03-30 16:47:44", "title": "5 Top Stock Trades for Tuesday: ZM, WORK, TWTR, ABT, DDD", "image": "https://cdn.snapi.dev/images/v1/n/m/data-internet25.jpg", "site": "InvestorPlace", "text": "Zoom Video, Abbott Labs, Slack, Twitter and 3D Systems are our top stock trades from Monday. That said, here's what the charts look like now.", "url": "https://investorplace.com/2020/03/5-top-stock-trades-for-tuesday-zm-work-twtr-abt-ddd/"}, {"symbol": "ABT", "publishedDate": "2020-03-30 14:16:03", "title": "Abbott Labs News: ABT Stock Surges 7% on 5-Minute Coronavirus Test", "image": "https://cdn.snapi.dev/images/v1/z/e/abbottoffice-1.jpg", "site": "InvestorPlace", "text": "Abbott Labs (ABT) news for Monday concerning a new five-minute test for the coronavirus from China has ABT stock heading higher.\r\nThe post Abbott Labs News: ABT Stock Surges 7% on 5-Minute Coronavirus Test appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/03/abbott-labs-news-coronavirus-test-sends-abt-stock-up/"}, {"symbol": "ABT", "publishedDate": "2020-03-30 12:18:00", "title": "4 MedTech Stocks Set to Rebound Post Coronavirus-Led Crisis", "image": "https://cdn.snapi.dev/images/v1/d/1/medical26.jpg", "site": "Zacks Investment Research", "text": "Here are some MedTech stocks which are steadily inching toward a trend reversal after registering record declines over the past few weeks.", "url": "https://www.zacks.com/stock/news/845390/4-medtech-stocks-set-to-rebound-post-coronavirus-led-crisis"}, {"symbol": "ABT", "publishedDate": "2020-03-30 12:10:40", "title": "Abbott Labs Surges After FDA Authorizes 5-Minute Coronavirus Test", "image": "https://cdn.snapi.dev/images/v1/5/2/medical23.jpg", "site": "Investors Business Daily", "text": "Shares of Abbott Laboratories stock popped Monday after the medical giant launched a coronavirus test capable of detecting the SARS-CoV-2 virus, which causes Covid-19, within five minutes.\nThe post Abbott Labs Surges After FDA Authorizes 5-Minute Coronavirus Test appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/coronavirus-test-abt-stock-pops-fda-authorization/"}, {"symbol": "ABT", "publishedDate": "2020-03-30 10:54:46", "title": "Big Pharma Advances on COVID-19", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5556442fcoronavirus-sample-gettyjpgw700opresize.jpg", "site": "24/7 Wall Street", "text": "Measures currently being taken against COVID-19 are the only means of containing and suppressing the virus.", "url": "https://247wallst.com/healthcare-business/2020/03/30/big-pharma-advances-on-covid-19/"}, {"symbol": "ABT", "publishedDate": "2020-03-30 09:11:00", "title": "4 Stocks Countering Coronavirus Battle With Testing Kits", "image": "https://cdn.snapi.dev/images/v1/1/n/medical17.jpg", "site": "Zacks Investment Research", "text": "While the market bloodbath is showing no signs of dissipating any time soon, investors might keep an eye on certain genetic testing and medical device companies.", "url": "https://www.zacks.com/stock/news/844809/4-stocks-countering-coronavirus-battle-with-testing-kits"}, {"symbol": "ABT", "publishedDate": "2020-03-30 09:02:00", "title": "New Shutdown Repeal Dates and a Testing Breakthrough Could Be Game-Changers for the Market", "image": "https://cdn.snapi.dev/images/v1/t/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5657122fgettyimages-1206969058jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The U.S. and Germany recently set new dates to examine reopening their economies, and an exciting new test could speed the process along.", "url": "https://www.fool.com/investing/2020/03/30/new-shutdown-repeal-dates-and-a-testing-breakthrou.aspx"}, {"symbol": "ABT", "publishedDate": "2020-03-30 08:19:00", "title": "Why Abbott Laboratories Stock Is on Fire Today", "image": "https://cdn.snapi.dev/images/v1/h/k/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5657302fglobe-coronavirusjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Abbott Lab's portable COVID-19 test kit could be a big winner for the company.", "url": "https://www.fool.com/investing/2020/03/30/why-abbott-laboratories-stock-is-on-fire-today.aspx"}, {"symbol": "ABT", "publishedDate": "2020-03-30 04:41:00", "title": "FDA EUA for Coronavirus Tests Boosts MedTech: 3 Stocks in Focus (Revised)", "image": "https://cdn.snapi.dev/images/v1/8/m/medical15.jpg", "site": "Zacks Investment Research", "text": "These key biotech and molecular diagnostic players banking on the receipt of FDA's EUA for COVID-19 tests are currently outperforming the broader industries they belong to.", "url": "https://www.zacks.com/stock/news/844438/fda-eua-for-coronavirus-tests-boosts-medtech-3-stocks-in-focus-revised"}, {"symbol": "ABT", "publishedDate": "2020-03-29 14:32:50", "title": "My 2 Favorite Medical Device Stocks to Own", "image": "https://cdn.snapi.dev/images/v1/q/9/medical25.jpg", "site": "GuruFocus", "text": "Medical device manufacturers are some of my favorite investments, as the top names in this sector are always on the cutting edge of health care.", "url": "https://www.gurufocus.com/news/1088442/my-2-favorite-medical-device-stocks-to-own"}, {"symbol": "ABT", "publishedDate": "2020-03-28 12:35:00", "title": "FDA Approves New 5 Minute Test to Accelerate U.S. Coronavirus Response", "image": "https://cdn.snapi.dev/images/v1/s/8/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5656742fgettyimages-1205778458jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The FDA has approved a COVID-19 test that can provide results while patients wait.", "url": "https://www.fool.com/investing/2020/03/28/5-minute-coronavirus-test-to-accelerate-testing.aspx"}, {"symbol": "ABT", "publishedDate": "2020-03-28 09:02:28", "title": "Abbott Labs To Launch Point-Of-Care Test That Can Detect Coronavirus Within 5 Minutes", "image": "https://cdn.snapi.dev/images/v1/e/a/abbott-id-now-platform.jpg", "site": "Benzinga", "text": "The FDA has approved a potential game-changing test for the novel coronavirus (COVID-19).", "url": "https://www.benzinga.com/news/20/03/15689743/abbott-labs-to-launch-point-of-care-test-that-can-detect-coronavirus-within-5-minutes"}, {"symbol": "ABT", "publishedDate": "2020-03-27 23:38:23", "title": "A new FDA-authorized COVID-19 test doesn\u2019t need a lab and can produce results in just 5 minutes", "image": "https://cdn.snapi.dev/images/v1/z/k/idnow-left-960x430-1jpgw730.jpg", "site": "TechCrunch", "text": "There\u2019s a new COVID-19 test from healthcare technology maker Abbott that looks to be the fastest yet in terms of producing results, and that can do so on the spot right at point-of-care, without requiring a round trip to a lab.", "url": "https://techcrunch.com/2020/03/27/a-new-fda-authorized-covid-19-test-doesnt-need-a-lab-and-can-produce-results-in-just-5-minutes/"}, {"symbol": "ABT", "publishedDate": "2020-03-27 20:14:17", "title": "Abbott receives approval for test that can detect coronavirus in 5 minutes", "image": "https://cdn.snapi.dev/images/v1/f/l/106464618-1585353328997idnow-inaction3-macro-300dpi-1200x628.jpg", "site": "CNBC", "text": "Abbott on Friday announced it received approval for a test that is capable of delivering positive results of the coronavirus in as little as five minutes.", "url": "https://www.cnbc.com/2020/03/27/abbott-receives-approval-for-test-that-can-detect-coronavirus-in-as-little-as-5-minutes.html"}, {"symbol": "ABT", "publishedDate": "2020-03-27 19:57:14", "title": "Abbott Labs receives FDA approval for rapid COVID-19 test", "image": "https://cdn.snapi.dev/images/v1/l/q/medical12.jpg", "site": "Market Watch", "text": "Abbott Laboratories ABT, -1.65% said late Friday that it received emergency use authorization from the U.S.", "url": "https://www.marketwatch.com/story/guid/20376f86-2eb8-400d-8b09-737ecc2ea0ea"}, {"symbol": "ABT", "publishedDate": "2020-03-27 19:20:21", "title": "U.S. Approves Abbott Labs Five-Minute \u2018Rapid\u2019 Coronavirus Test", "image": "https://cdn.snapi.dev/images/v1/0/l/us-approves-abbott-labs-five-minute-rapid-coronavirus-test.jpg", "site": "Forbes", "text": "Abbott Laboratories won U.S. Food and Drug Administration approval for its molecular test for the Coronavirus strain COVID-19, which the company says can deliver \u201cpositive results in as little as five minutes and negative results in 13 minutes.", "url": "https://www.forbes.com/sites/brucejapsen/2020/03/27/us-approves-abbott-labs-five-minute-rapid-coronavirus-test/"}, {"symbol": "ABT", "publishedDate": "2020-03-27 09:03:00", "title": "FDA EUA for Coronavirus Tests Boosts MedTech: 3 Stocks in Focus", "image": "https://cdn.snapi.dev/images/v1/4/p/medical4.jpg", "site": "Zacks Investment Research", "text": "These key biotech and molecular diagnostic players banking on the receipt of FDA's EUA for COVID-19 tests are currently outperforming the broader industries they belong to.", "url": "https://www.zacks.com/stock/news/838283/fda-eua-for-coronavirus-tests-boosts-medtech-3-stocks-in-focus"}, {"symbol": "ABT", "publishedDate": "2020-03-25 11:40:19", "title": "HRC vs. ABT: Which Stock Is the Better Value Option?", "image": "https://cdn.snapi.dev/images/v1/t/a/medical9-2.jpg", "site": "Zacks Investment Research", "text": "HRC vs. ABT: Which Stock Is the Better Value Option?", "url": "https://www.zacks.com/stock/news/834254/hrc-vs-abt-which-stock-is-the-better-value-option"}, {"symbol": "ABT", "publishedDate": "2020-03-23 08:49:33", "title": "Deep Dive: You can be \u2018practically stealing\u2019 quality stocks now, according to Jefferies", "image": "https://cdn.snapi.dev/images/v1/m/w/mw-ic783-amazon-20200322100729-zhjpguuid7766973c-6c46-11ea-a791-9c8e992d421e.jpg", "site": "Market Watch", "text": "The bank\u2019s analysts identified companies with strong fundamentals that are attractive because of \u2018indiscriminate selling\u2019", "url": "https://www.marketwatch.com/story/guid/96b63db0-6c2b-11ea-a687-9e83803f6b96"}, {"symbol": "ABT", "publishedDate": "2020-03-20 20:44:00", "title": "FDA Warns About Unauthorized Fraudulent COVID-19 Tests", "image": "https://cdn.snapi.dev/images/v1/l/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5646592fcoronavirus-blood-testjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The agency hasn't approved any in-home test kits yet.", "url": "https://www.fool.com/investing/2020/03/20/fda-warns-about-unauthorized-fraudulent-covid-19-t.aspx"}, {"symbol": "ABT", "publishedDate": "2020-03-19 10:20:00", "title": "Abbott Launches Coronavirus Detection Test After FDA Gives EUA", "image": "https://cdn.snapi.dev/images/v1/l/u/medical20.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) launches test for the detection of coronavirus in human, after receiving the EUA.", "url": "https://www.zacks.com/stock/news/823123/abbott-launches-coronavirus-detection-test-after-fda-gives-eua"}, {"symbol": "ABT", "publishedDate": "2020-03-18 22:02:56", "title": "Coronavirus Test-makers Ramp Up Production", "image": "https://cdn.snapi.dev/images/v1/i/k/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5642352fcoronavirus-blood-testjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Multiple companies have gained regulatory approvals in recent days.", "url": "https://www.fool.com/investing/2020/03/18/coronavirus-test-makers-ramp-up-production.aspx"}, {"symbol": "ABT", "publishedDate": "2020-03-18 18:01:44", "title": "Abbott Labs gets FDA green light to ship coronavirus tests", "image": "https://cdn.snapi.dev/images/v1/w/p/medical9.jpg", "site": "Market Watch", "text": "Abbott Laboratories ABT, -0.29% said late Wednesday that it received an emergency authorization from the Food and Drug Administration to ship 150,000 tests for COVID-19, or infection from the SARS-CoV-2 coronavirus.", "url": "https://www.marketwatch.com/story/guid/5fdb970c-a0d7-42ae-b650-1dbcebde37c0"}, {"symbol": "ABT", "publishedDate": "2020-03-18 18:00:02", "title": "U.S. Approves Abbott Labs Coronavirus Test For Hospital Use", "image": "https://cdn.snapi.dev/images/v1/q/n/us-approves-abbott-labs-coronavirus-test-for-hospital-use.jpg", "site": "Forbes", "text": "Abbott Laboratories has won U. S. approval for its molecular test for the Coronavirus strain COVID-19, which will be used by hospitals and academic medical centers to speed diagnostic capabilities for the disease sweeping across the country.", "url": "https://www.forbes.com/sites/brucejapsen/2020/03/18/us-approves-abbott-labs-coronavirus-test-for-hospital-use/"}, {"symbol": "ABT", "publishedDate": "2020-03-18 17:50:09", "title": "Abbott (ABT) Stock Moves -0.29%: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/d/b/medical11.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) closed at $79.26 in the latest trading session, marking a -0.29% move from the prior day.", "url": "https://www.zacks.com/stock/news/821806/abbott-abt-stock-moves-029-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2020-03-13 01:59:50", "title": "Abbott Labs Is Sliding Closer To Attractive Territory", "image": "https://cdn.snapi.dev/images/v1/o/v/medical2.jpg", "site": "Seeking Alpha", "text": "The stock is now attractively priced for long-term investors and will become very attractive if it slides below $65 per share.", "url": "https://seekingalpha.com/article/4331728-abbott-labs-is-sliding-closer-to-attractive-territory"}, {"symbol": "ABT", "publishedDate": "2020-03-12 08:00:00", "title": "Will Abbott Stock Outperform The Broader Market Post Coronavirus?", "image": "https://cdn.snapi.dev/images/v1/l/f/will-abbott-stock-outperform-the-broader-market-post-coronavirus.jpg", "site": "Forbes", "text": "Abbott\u2019s (NYSE: ABT) stock could outperform the broader S&P 500 index post coronavirus and oil price war crisis, going by trends seen during the 2008 slowdown, where it fell 11% from the approximate pre-crisis peak in 2008, and recovered 17% by early 2010.", "url": "https://www.forbes.com/sites/greatspeculations/2020/03/12/will-abbott-stock-outperform-the-broader-market-post-coronavirus/"}, {"symbol": "ABT", "publishedDate": "2020-03-10 10:48:00", "title": "Coronavirus Ails S&P 500 Index, MedTechs Bear the Brunt", "image": "https://cdn.snapi.dev/images/v1/l/o/medical24.jpg", "site": "Zacks Investment Research", "text": "S&P 500 MedTech stocks pull the index further down on COVID-19 situation becoming grimmer.", "url": "https://www.zacks.com/stock/news/806126/coronavirus-ails-sp-500-index-medtechs-bear-the-brunt"}, {"symbol": "ABT", "publishedDate": "2020-03-10 07:44:15", "title": "Abbott Laboratories: A Solid Buy In Uncertain Times", "image": "https://cdn.snapi.dev/images/v1/w/1/medical18.jpg", "site": "Seeking Alpha", "text": "Abbott Laboratories: A Solid Buy In Uncertain Times", "url": "https://seekingalpha.com/article/4330837-abbott-laboratories-solid-buy-in-uncertain-times"}, {"symbol": "ABT", "publishedDate": "2020-03-09 08:00:00", "title": "Can Abbott\u2019s Revenue Continue To Grow In Double-Digits?", "image": "https://cdn.snapi.dev/images/v1/c/q/can-abbotts-revenue-continue-to-grow-in-double-digits.jpg", "site": "Forbes", "text": "We don\u2019t expect Abbott\u2019s (NYSE: ABT) revenue to grow in double-digits in the near term. The company has seen its revenue grow at a CAGR of 12.4% from $20.4 billion in 2015 to $31.9 billion in 2019, but this growth was largely driven by the impact of St Jude Medical as well as Alere acquisitions.", "url": "https://www.forbes.com/sites/greatspeculations/2020/03/09/can-abbotts-revenue-continue-to-grow-in-double-digits/"}, {"symbol": "ABT", "publishedDate": "2020-03-06 08:00:09", "title": "This Medical Giant Was Socked In February \u2014 Is Its Stock A Safe Bet?", "image": "https://cdn.snapi.dev/images/v1/i/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5542982fgettyimages-1146913659jpgw700opresize.jpg", "site": "Investors Business Daily", "text": "ABT stock is one of the biggest diversified medical stocks behind Johnson & Johnson and Roche. As it aims for clearance of its Freestyle Libre 2 system, is it time to buy Abbott stock?", "url": "https://www.investors.com/news/technology/abt-stock-buy-now/"}, {"symbol": "ABT", "publishedDate": "2020-03-05 17:50:07", "title": "Abbott (ABT) Stock Moves -1.91%: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/s/j/medical18.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) closed at $80.52 in the latest trading session, marking a -1.91% move from the prior day.", "url": "https://www.zacks.com/stock/news/798928/abbott-abt-stock-moves-191-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2020-03-05 16:37:00", "title": "Why Abbott Labs Shares Fell 11.6% in February", "image": "https://cdn.snapi.dev/images/v1/d/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5618002fgettyimages-abbottjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Investors are worrying about the impact from the coronavirus on business in China.", "url": "https://www.fool.com/investing/2020/03/05/why-abbott-labs-shares-fell-116-in-february.aspx"}, {"symbol": "ABT", "publishedDate": "2020-03-04 08:34:00", "title": "Coronavirus Spreads Rapidly Worldwide: Medtech Stocks in Focus", "image": "https://cdn.snapi.dev/images/v1/z/4/medical13.jpg", "site": "Zacks Investment Research", "text": "The coronavirus outbreak disrupts manufacturing and supply chain in China, which in turn might have taken a toll on U.S. Medtech stocks.", "url": "https://www.zacks.com/stock/news/796015/coronavirus-spreads-rapidly-worldwide-medtech-stocks-in-focus"}, {"symbol": "ABT", "publishedDate": "2020-03-01 09:03:00", "title": "The Best Dividend Aristocrat You Can Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/2/v/pt-25-193726-o.jpg", "site": "The Motley Fool", "text": "And not just because of its dividend.", "url": "https://www.fool.com/investing/2020/03/01/the-best-dividend-aristocrat-you-can-buy-right-now.aspx"}, {"symbol": "ABT", "publishedDate": "2020-02-28 08:18:00", "title": "Medical Products Industry Outlook: Growth Prospects Bright", "image": "https://cdn.snapi.dev/images/v1/m/i/medical23.jpg", "site": "Zacks Investment Research", "text": "Medical Products Industry Outlook: Growth Prospects Bright", "url": "https://www.zacks.com/commentary/788220/medical-products-industry-outlook-growth-prospects-bright"}, {"symbol": "ABT", "publishedDate": "2020-02-25 08:30:00", "title": "Abbott\u2019s EPS Growth Is 2x Compared To Medtronic\u2019s", "image": "https://cdn.snapi.dev/images/v1/7/n/abbotts-eps-growth-is-2x-compared-to-medtronics.jpg", "site": "Forbes", "text": "Abbott\u2019s (NYSE: ABT) adjusted earnings per share grew at a CAGR of 11% from $2.16 in 2015 to $3.26 in 2019. This was almost 2x the CAGR of 5.1% for Medtronic\u2019s adjusted EPS, which grew from $4.28 in fiscal 2015 to $5.22 in fiscal 2019.", "url": "https://www.forbes.com/sites/greatspeculations/2020/02/25/abbotts-eps-growth-is-2x-compared-to-medtronics/"}, {"symbol": "ABT", "publishedDate": "2020-02-24 09:08:00", "title": "Abbott's Alliance With Insulet to Fortify Diabetic Care Unit", "image": "https://cdn.snapi.dev/images/v1/m/n/medical16.jpg", "site": "Zacks Investment Research", "text": "Both Abbott (ABT) and Insulet will use a pay-as-you-go model to enhance customer acceptance.", "url": "https://www.zacks.com/stock/news/781034/abbotts-alliance-with-insulet-to-fortify-diabetic-care-unit"}, {"symbol": "ABT", "publishedDate": "2020-02-21 16:36:33", "title": "Insulet Partners With Abbott and DexCom On Diabetes", "image": "https://cdn.snapi.dev/images/v1/l/u/medical10.jpg", "site": "GuruFocus", "text": "Insulet Corp. (NASDAQ:PODD) hit its 52-week high on Feb. 19 after announcing formation of two partnerships that further strengthens its leading role in the market for continuous glucose monitoring.", "url": "https://www.gurufocus.com/news/1047218/insulet-partners-with-abbott-and-dexcom-on-diabetes"}, {"symbol": "ABT", "publishedDate": "2020-02-21 11:30:19", "title": "Abbott (ABT) Down 2.5% Since Last Earnings Report: Can It Rebound?", "image": "https://cdn.snapi.dev/images/v1/1/y/medical4.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/777320/abbott-abt-down-25-since-last-earnings-report-can-it-rebound"}, {"symbol": "ABT", "publishedDate": "2020-02-20 15:17:23", "title": "Abbott Presents Data Showing its Glucose Monitor Helps People With Diabetes", "image": "https://cdn.snapi.dev/images/v1/q/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5589962ffsllink-us-960x4301jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The FreeStyle Libre system helped patients in multiple studies performed in different countries across the globe.", "url": "https://www.fool.com/investing/2020/02/20/abbott-presents-data-showing-its-glucose-monitor-h.aspx"}, {"symbol": "ABT", "publishedDate": "2020-02-20 10:01:26", "title": "Abbott Labs Recalls Some Catheters Due to Possible Defects", "image": "https://cdn.snapi.dev/images/v1/8/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5587992fgettyimages-1170269659jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The company issued a Class I recall of recently manufactured lots of two models because of potential balloon deflation problems.", "url": "https://www.fool.com/investing/2020/02/20/abbott-labs-recalls-some-catheters-due-to-possible.aspx"}, {"symbol": "ABT", "publishedDate": "2020-02-19 14:01:00", "title": "Insulet Announces Agreements With Abbott and DexCom", "image": "https://cdn.snapi.dev/images/v1/f/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5587062fblood-sugar-controljpgw700opresize.jpg", "site": "The Motley Fool", "text": "Insulet's wearable insulin pumps will be integrated with blood glucose monitors from both companies.", "url": "https://www.fool.com/investing/2020/02/19/insulet-announces-agreements-with-abbott-and-dexco.aspx"}, {"symbol": "ABT", "publishedDate": "2020-02-19 11:22:50", "title": "Abbott Laboratories: Why Adding More of This Health Care Giant Makes Sense", "image": "https://cdn.snapi.dev/images/v1/d/g/medical10.jpg", "site": "GuruFocus", "text": "Abbott Laboratories (NYSE:ABT) has been one of the best investments to hold over the long term.", "url": "https://www.gurufocus.com/news/1043050/abbott-laboratories-why-adding-more-of-this-health-care-giant-makes-sense"}, {"symbol": "ABT", "publishedDate": "2020-02-18 15:22:00", "title": "Want to Know What Your Heart Defibrillator Is Doing? Abbott Has an App for That", "image": "https://cdn.snapi.dev/images/v1/v/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5585492fdoctor-patient-heartjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Remote monitoring should help doctors and patients identify issues earlier.", "url": "https://www.fool.com/investing/2020/02/18/want-to-know-what-your-heart-defibrillator-is-doin.aspx"}, {"symbol": "ABT", "publishedDate": "2020-02-13 08:00:00", "title": "Better Buy: Abbott Laboratories vs. Novo Nordisk", "image": "https://cdn.snapi.dev/images/v1/c/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5569812fprescription-medicationjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These healthcare stocks can give investors a good mix of dividends and growth.", "url": "https://www.fool.com/investing/2020/02/13/better-buy-abbott-laboratories-vs-novo-nordisk.aspx"}, {"symbol": "ABT", "publishedDate": "2020-02-12 09:20:09", "title": "This Medical Giant Is Lingering In A Buy Zone \u2014 Are Shares A Good Bet?", "image": "https://cdn.snapi.dev/images/v1/a/b/abbottoffice-3.jpg", "site": "Investors Business Daily", "text": "ABT stock is one of the biggest diversified medical stocks behind Johnson & Johnson and Roche. As it aims for clearance of its Freestyle Libre 2 system, is it time to buy Abbott stock?", "url": "https://www.investors.com/news/technology/abt-stock-buy-now/"}, {"symbol": "ABT", "publishedDate": "2020-02-11 07:45:22", "title": "5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech13-13.jpg", "site": "24/7 Wall Street", "text": "For years, one of the most dependable sectors, especially for more conservative investors, was health care, which included the top pharmaceutical and biotech stocks among other holdings.", "url": "https://247wallst.com/healthcare-business/2020/02/11/5-big-dividend-pharmaceutical-stocks-to-buy-as-health-care-could-explode-higher/"}, {"symbol": "ABT", "publishedDate": "2020-02-04 16:52:00", "title": "Abbott's Implantable Heart Pump System Gets FDA's Breakthrough Device Designation", "image": "https://cdn.snapi.dev/images/v1/o/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5562052fgettyimages-1126117038jpgw700opresize.jpg", "site": "The Motley Fool", "text": "This device, which is still in development, could help hundreds of thousands of Americans if approved.", "url": "https://www.fool.com/investing/2020/02/04/abbotts-implantable-heart-pump-system-gets-fdas-br.aspx"}, {"symbol": "ABT", "publishedDate": "2020-02-03 09:51:55", "title": "Why Abbott Laboratories Just Became an Even Better Buy", "image": "https://cdn.snapi.dev/images/v1/b/f/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5557192fcompany-meeting-reportjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The healthcare stock has produced returns of more than 90% in five years and it's still going strong.", "url": "https://www.fool.com/investing/2020/02/03/why-abbott-laboratories-just-became-an-even-better.aspx"}, {"symbol": "ABT", "publishedDate": "2020-01-28 07:26:13", "title": "Abbott's Pending Loss Ushers In Ongoing Prosperity", "image": "https://cdn.snapi.dev/images/v1/f/r/medical14.jpg", "site": "Seeking Alpha", "text": "Abbott's Pending Loss Ushers In Ongoing Prosperity", "url": "https://seekingalpha.com/article/4319431-abbotts-pending-loss-ushers-in-ongoing-prosperity"}, {"symbol": "ABT", "publishedDate": "2020-01-25 09:00:00", "title": "Better Buy: DexCom vs. Abbott Laboratories", "image": "https://cdn.snapi.dev/images/v1/b/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5522752fgettyimages-1077435756jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Both medical device stocks have characteristics investors should consider.", "url": "https://www.fool.com/investing/2020/01/25/better-buy-dexcom-vs-abbott-laboratories.aspx"}, {"symbol": "ABT", "publishedDate": "2020-01-24 14:46:00", "title": "Abbot's Brain Stimulation System Approved to Treat Parkinson's", "image": "https://cdn.snapi.dev/images/v1/r/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5546902fgettyimages-1140748326jpgw700opresize.jpg", "site": "The Motley Fool", "text": "This system now has approval to target all areas of the brain associated with movement disorders.", "url": "https://www.fool.com/investing/2020/01/24/abbots-brain-stimulation-system-approved-to-treat.aspx"}, {"symbol": "ABT", "publishedDate": "2020-01-23 13:27:00", "title": "Abbott's Proclaim XR Neurostimulation Implant Device Said to Reduce Pain", "image": "https://cdn.snapi.dev/images/v1/u/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5544612fdepressionjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The recently launched system has helped the medical device company's struggling neurology business.", "url": "https://www.fool.com/investing/2020/01/23/abbotts-proclaim-xr-neurostimulation-implant-devic.aspx"}, {"symbol": "ABT", "publishedDate": "2020-01-22 16:42:05", "title": "Abbott Laboratories (ABT) CEO Miles White on Q4 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/5/3/transcript34-2.jpg", "site": "Seeking Alpha", "text": "Abbott Laboratories (ABT) CEO Miles White on Q4 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4318424-abbott-laboratories-abt-ceo-miles-white-on-q4-2019-results-earnings-call-transcript"}, {"symbol": "ABT", "publishedDate": "2020-01-22 14:58:09", "title": "Abbott Labs Earnings: ABT Stock Jumps 3% on Q4 Beat", "image": "https://cdn.snapi.dev/images/v1/j/6/medical20.jpg", "site": "InvestorPlace", "text": "Abbott Labs (ABT) earnings for the health care company's fourth quarter of 2019 have ABT stock heading higher on Wednesday.\nThe post Abbott Labs Earnings: ABT Stock Jumps 3% on Q4 Beat appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/01/abbott-labs-earnings-abt-stock-jumps-3-on-q4-beat/"}, {"symbol": "ABT", "publishedDate": "2020-01-22 13:52:00", "title": "Abbott Laboratories Beats Revenue Expectations With Balanced Growth", "image": "https://cdn.snapi.dev/images/v1/p/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5542982fgettyimages-1146913659jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The Dividend Aristocrat also gave strong guidance for 2020.", "url": "https://www.fool.com/investing/2020/01/22/abbott-laboratories-beats-revenue-expectations-wit.aspx"}, {"symbol": "ABT", "publishedDate": "2020-01-22 13:50:00", "title": "Gov. Abbott: Countries are hungry to have success like the US", "image": "https://cdn.snapi.dev/images/v1/m/z/gov-abbott-countries-are-hungry-to-have-success-like-the-us.jpg", "site": "Fox Business", "text": "Gov. Greg Abbott, (R-Texas), discusses Trump at Davos and the \u2018tax exodus\u2019 from high tax states to places like Texas.", "url": "https://www.youtube.com/watch?v=kc-d2NuZrQo"}, {"symbol": "ABT", "publishedDate": "2020-01-22 12:02:34", "title": "Abbott hits all-time high on quarterly revenue beat", "image": "https://cdn.snapi.dev/images/v1/6/n/ab2-2.jpg", "site": "Reuters", "text": "Abbott Laboratories Inc's  shares rose to an all-time high on Wednesday after the device maker beat Wall Street estimates for quarterly sales on higher demand for its nutrition products and generic drugs.", "url": "https://www.reuters.com/article/us-abbott-results/abbott-hits-all-time-high-on-quarterly-revenue-beat-idUSKBN1ZL1OG"}, {"symbol": "ABT", "publishedDate": "2020-01-22 12:01:00", "title": "Here's Why Investors Really Liked Abbott Labs' Q4 Earnings Results", "image": "https://cdn.snapi.dev/images/v1/c/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5542602fman-in-suit-touching-a-hologram-ball-with-dollar-signs-on-itjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The healthcare giant delivered a solid quarterly performance yet again, with sales growth in all of its segments.", "url": "https://www.fool.com/investing/2020/01/22/heres-why-investors-really-liked-abbott-labs-q4-ea.aspx"}, {"symbol": "ABT", "publishedDate": "2020-01-22 11:11:50", "title": "Incoming Abbott CEO says not looking to do any deals", "image": "https://cdn.snapi.dev/images/v1/p/t/pt-25-193726-o-2.jpg", "site": "Reuters", "text": "Abbott Laboratories' incoming Chief Executive Officer Robert Ford said on Wednesday that deal-making was not on the company's agenda.", "url": "https://www.reuters.com/article/us-abbott-results-conference-call/incoming-abbott-ceo-says-not-looking-to-do-any-deals-idUSKBN1ZL2AP"}, {"symbol": "ABT", "publishedDate": "2020-01-22 10:42:00", "title": "Breaking Q4 Earnings News", "image": "https://cdn.snapi.dev/images/v1/j/i/653.jpg", "site": "Zacks Investment Research", "text": "Breaking Q4 Earnings News", "url": "https://www.zacks.com/stock/news/729282/breaking-q4-earnings-news"}, {"symbol": "ABT", "publishedDate": "2020-01-22 10:22:21", "title": "Drug, nutrition product sales power Abbott's revenue beat", "image": "https://cdn.snapi.dev/images/v1/z/h/m02d20200122t2i1479788075rlynxmpeg0l1bnw640.jpg", "site": "Reuters", "text": "Medical device maker Abbott Laboratories Inc  beat quarterly sales estimates on Wednesday, benefiting from higher demand for its nutrition products and generic drug sales.", "url": "https://www.reuters.com/article/us-abbott-results/drug-nutrition-product-sales-power-abbotts-revenue-beat-idUSKBN1ZL1OG"}, {"symbol": "ABT", "publishedDate": "2020-01-22 10:07:00", "title": "Abbott (ABT) Q4 Earnings Match Estimates, Revenues Beat Mark", "image": "https://cdn.snapi.dev/images/v1/q/8/medical14.jpg", "site": "Zacks Investment Research", "text": "We are upbeat about Abbott's (ABT) strong and consistent EPD and Medical Devices performances, organically.", "url": "https://www.zacks.com/stock/news/729187/abbott-abt-q4-earnings-match-estimates-revenues-beat-mark"}, {"symbol": "ABT", "publishedDate": "2020-01-22 08:45:03", "title": "Abbott (ABT) Meets Q4 Earnings Estimates", "image": "https://cdn.snapi.dev/images/v1/h/f/medical10.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) delivered earnings and revenue surprises of 0.00% and 0.63%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/729034/abbott-abt-meets-q4-earnings-estimates"}, {"symbol": "ABT", "publishedDate": "2020-01-22 08:03:33", "title": "Shares of Abbott Labs are up 1%; sales are up 7%", "image": "https://cdn.snapi.dev/images/v1/6/4/medical7.jpg", "site": "Market Watch", "text": "Shares of Abbott Laboratories ABT, +0.82% were up 1% after the company reported sales increases across each of its four businesses in the fourth quarter of 2019.", "url": "https://www.marketwatch.com/story/shares-of-abbott-labs-are-up-on-single-digit-sales-in-2020-01-22"}, {"symbol": "ABT", "publishedDate": "2020-01-22 07:41:27", "title": "Abbott Laboratories Earnings Meet, Sales Top; ABT Stock Rises In Buy Zone", "image": "https://cdn.snapi.dev/images/v1/b/s/medical6-2.jpg", "site": "Investors Business Daily", "text": "Abbott Labs met Q4 earnings per share views while sales topped. ABT stock, already in a buy zone, moved higher early Wednesday.", "url": "https://www.investors.com/news/technology/abt-stock-abt-earnings-q4-2019/"}, {"symbol": "ABT", "publishedDate": "2020-01-21 13:42:28", "title": "Q4 Earnings Preview: Abbott Laboratories", "image": "https://cdn.snapi.dev/images/v1/f/t/microscope-275984-1920-27.jpg", "site": "Benzinga", "text": "On Wednesday, January 22, Abbott Laboratories (NYSE: ABT) will report its last quarter's earnings.", "url": "https://www.benzinga.com/news/earnings-previews/20/01/15157168/earnings-preview-abbott-laboratories"}, {"symbol": "ABT", "publishedDate": "2020-01-21 07:00:00", "title": "What To Expect From Abbott\u2019s Full-Year 2019 Earnings", "image": "https://cdn.snapi.dev/images/v1/v/1/what-to-expect-from-abbotts-full-year-2019-earnings.jpg", "site": "Forbes", "text": "Abbott will release its Q4 and full-year 2019 results on Wednesday, January 22. For full-year 2019, Trefis estimates that the company will report: Revenues of $31.8 billion, reflecting 4.1% y-o-y growth, primarily driven by the company\u2019s medical devices segment.", "url": "https://www.forbes.com/sites/greatspeculations/2020/01/21/what-to-expect-from-abbotts-full-year-2019-earnings/"}, {"symbol": "ABT", "publishedDate": "2020-01-20 09:13:00", "title": "Can Abbott (ABT) Q4 Earnings Ride on Growth in All Lines?", "image": "https://cdn.snapi.dev/images/v1/b/t/medical17.jpg", "site": "Zacks Investment Research", "text": "Abbott's (ABT) imminent quarterly results are expected to reflect a solid performance by the Established Pharmaceuticals Division (EPD) business alike the last reported quarter.", "url": "https://www.zacks.com/stock/news/726455/can-abbott-abt-q4-earnings-ride-on-growth-in-all-lines"}, {"symbol": "ABT", "publishedDate": "2020-01-19 07:03:00", "title": "Better Buy: Abbott Laboratories vs. AbbVie", "image": "https://cdn.snapi.dev/images/v1/u/5/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5536262fbusinessman-scratching-head-with-left-and-right-arrowsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Which stock wins in a matchup between these two healthcare siblings?", "url": "https://www.fool.com/investing/2020/01/19/better-buy-abbott-laboratories-vs-abbvie.aspx"}, {"symbol": "ABT", "publishedDate": "2020-01-18 07:00:00", "title": "Where Will Abbott Laboratories Be in 5 Years?", "image": "https://cdn.snapi.dev/images/v1/9/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5521162fgettyimages-1176943904jpgw700opresize.jpg", "site": "The Motley Fool", "text": "What does the future hold for this well-regarded Dividend Aristocrat?", "url": "https://www.fool.com/investing/2020/01/18/where-will-abbot-laboratories-be-in-5-years.aspx"}, {"symbol": "ABT", "publishedDate": "2020-01-17 06:51:46", "title": "3 Big Stock Charts for Friday: IBM, Abbott Labs, and FuelCell Energy", "image": "https://cdn.snapi.dev/images/v1/l/t/ysny27-1.jpg", "site": "InvestorPlace", "text": "Friday's big stock charts feature three names that could be set up for a big move \u2014 and have upcoming earnings reports as a catalyst.\r\nThe post 3 Big Stock Charts for Friday: IBM, Abbott Labs, and FuelCell Energy appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/01/3-big-stock-charts-for-friday-ibm-abbott-labs-and-fuelcell-energy/"}, {"symbol": "ABT", "publishedDate": "2020-01-15 12:30:34", "title": "Abbott (ABT) Reports Next Week: Wall Street Expects Earnings Growth", "image": "https://cdn.snapi.dev/images/v1/a/q/medical23.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/719419/abbott-abt-reports-next-week-wall-street-expects-earnings-growth"}, {"symbol": "ABT", "publishedDate": "2020-01-13 12:30:00", "title": "How Much Does Abbott Spend On SG&A?", "image": "https://cdn.snapi.dev/images/v1/b/6/how-much-does-abbott-spend-on-sga.jpg", "site": "Forbes", "text": "Abbott spent $6.5 billion on selling, general & administrative (SG&A) expense in 2014, and the figure increased to $9.7 billion in 2018, driven by acquisitions, growth in sales, and the launch of new products. As a percentage of revenue, SG&A largely hovered in the range of 32% and 33%.", "url": "https://www.forbes.com/sites/greatspeculations/2020/01/13/how-much-does-abbott-spend-on-sga/?ss=markets"}, {"symbol": "ABT", "publishedDate": "2020-01-08 10:18:39", "title": "Abbott Laboratories CFO to retire in February", "image": "https://cdn.snapi.dev/images/v1/1/j/medical25.jpg", "site": "Market Watch", "text": "Abbott Laboratories ABT, +0.40% disclosed Wednesday that Chief Financial Officer Brian Yoor has said he will retire, effective Feb.", "url": "https://www.marketwatch.com/story/abbott-laboratories-cfo-to-retire-in-february-2020-01-08"}, {"symbol": "ABT", "publishedDate": "2020-01-08 10:00:09", "title": "This Medical Giant Tried To Break Out \u2014 Should You Buy ABT Stock Now?", "image": "https://cdn.snapi.dev/images/v1/v/l/medical13.jpg", "site": "Investors Business Daily", "text": "ABT stock is one of the biggest diversified medical stocks behind Johnson & Johnson and Roche. As it aims for clearance of its Freestyle Libre 2 system, is it time to buy Abbott stock?", "url": "https://www.investors.com/news/technology/abt-stock-buy-now/"}, {"symbol": "ABT", "publishedDate": "2020-01-08 09:23:00", "title": "Abbott's Less-Invasive Surgery for Heart Pump Gets FDA Nod", "image": "https://cdn.snapi.dev/images/v1/3/c/medical26.jpg", "site": "Zacks Investment Research", "text": "Abbott's (ABT) less invasive approach for heart surgery for its heart pump gets the FDA clearance, thus paving the way for avoiding open heart surgeries.", "url": "https://www.zacks.com/stock/news/708050/abbotts-less-invasive-surgery-for-heart-pump-gets-fda-nod"}, {"symbol": "ABT", "publishedDate": "2020-01-07 07:03:00", "title": "3 Top Medical Device Stocks to Buy in January", "image": "https://cdn.snapi.dev/images/v1/i/1/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5525372fmedical-technologyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These medical device stocks should be poised for a happy new year.", "url": "https://www.fool.com/investing/2020/01/07/3-top-medical-device-stocks-to-buy-in-january.aspx"}, {"symbol": "ABT", "publishedDate": "2020-01-02 09:10:00", "title": "Better Buy: Abbott Laboratories vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/i/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5521882fgettyimages-1162383808jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These two healthcare giants have a lot going for them. But which one is better?", "url": "https://www.fool.com/investing/2020/01/02/better-buy-abbott-laboratories-vs-pfizer.aspx"}, {"symbol": "ABT", "publishedDate": "2019-12-31 07:30:00", "title": "How Does Abbott\u2019s Revenue And Other Key Metrics Compare With That of Boston Scientific?", "image": "https://cdn.snapi.dev/images/v1/v/1/how-does-abbotts-revenue-and-other-key-metrics-compare-with-that-of-boston-scientific.jpg", "site": "Forbes", "text": "Abbott and Boston Scientific are both engaged in the medical devices business. Abbott generates 3x the revenue when compared to Boston Scientific.", "url": "https://www.forbes.com/sites/greatspeculations/2020/12/31/how-does-abbotts-revenue-and-other-key-metrics-compare-with-that-of-boston-scientific/"}, {"symbol": "ABT", "publishedDate": "2019-12-30 10:30:00", "title": "How Much Revenue Does Abbott Generate From The United States?", "image": "https://cdn.snapi.dev/images/v1/a/5/how-much-revenue-does-abbott-generate-from-the-united-states.jpg", "site": "Forbes", "text": "Abbott (NYSE: ABT) generates its revenue from sales of medical devices across the globe. The company generated $11 billion in sales in the United States, accounting for over one-third of its total revenue in 2018.", "url": "https://www.forbes.com/sites/greatspeculations/2020/12/30/how-much-revenue-does-abbott-generate-from-the-united-states/"}, {"symbol": "ABT", "publishedDate": "2019-12-29 09:00:00", "title": "The 3 Best Healthcare Stocks to Buy for 2020", "image": "https://cdn.snapi.dev/images/v1/z/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5518912f2020-with-0s-formed-by-heart-and-a-stethoscopejpgw700opresize.jpg", "site": "The Motley Fool", "text": "These three healthcare stocks have all the ingredients needed to cook up great returns in the new year.", "url": "https://www.fool.com/investing/2019/12/29/the-3-best-healthcare-stocks-to-buy-for-2020.aspx"}, {"symbol": "ABT", "publishedDate": "2019-12-19 07:00:00", "title": "This Dividend Aristocrat Just Gave Shareholders a Great Gift", "image": "https://cdn.snapi.dev/images/v1/n/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5512542f50-bill-box-wrapped-with-red-bowjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Abbott Labs just reached a milestone that very few companies have been able to achieve.", "url": "https://www.fool.com/investing/2019/12/19/this-dividend-aristocrat-just-gave-shareholders-a.aspx"}, {"symbol": "ABT", "publishedDate": "2019-12-16 11:13:20", "title": "2 Stocks You Can Keep Forever: ABT & KO", "image": "https://cdn.snapi.dev/images/v1/s/t/stocks18-1.jpg", "site": "The Motley Fool", "text": "These are stocks investors can buy today and forget about.", "url": "https://www.fool.com/investing/2019/12/16/2-stocks-you-can-keep-forever.aspx"}, {"symbol": "ABT", "publishedDate": "2019-12-15 07:31:00", "title": "Here's a Blue-Chip Stock You'd Probably Never Guess Would Profit From Marijuana Legalization", "image": "https://cdn.snapi.dev/images/v1/y/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5508082fcannabis-leaf-with-gaveljpgw700opresize.jpg", "site": "The Motley Fool", "text": "Hint: Its market cap is over $150 billion, and the company was founded when Grover Cleveland was president.", "url": "https://www.fool.com/investing/2019/12/15/heres-a-blue-chip-stock-youd-probably-never-guess.aspx"}, {"symbol": "ABT", "publishedDate": "2019-12-13 10:54:16", "title": "Abbott Labs raises quarterly dividend by 12.5% to 36 cents a share", "image": "https://cdn.snapi.dev/images/v1/e/i/medical28.jpg", "site": "Market Watch", "text": "Abbott Laboratories ABT, +0.12% said Friday its board has approved a 12.5% increase in its quarterly dividend to 36 cents a share.", "url": "https://www.marketwatch.com/story/abbott-labs-raises-quarterly-dividend-by-125-to-36-cents-a-share-2019-12-13-10915416"}, {"symbol": "ABT", "publishedDate": "2019-12-08 09:00:00", "title": "Is Abbott Laboratories (ABT) Stock a Buy?", "image": "https://cdn.snapi.dev/images/v1/r/i/jnj-4.jpg", "site": "The Motley Fool", "text": "Here's how the healthcare giant scores on growth prospects, dividend, and valuation.", "url": "https://www.fool.com/investing/2019/12/08/is-abbott-laboratories-stock-a-buy.aspx"}, {"symbol": "ABT", "publishedDate": "2019-12-05 09:00:09", "title": "Abbott Is One Of The Biggest Medical Stocks \u2014 Should You Buy ABT Stock Now?", "image": "https://cdn.snapi.dev/images/v1/e/b/medical2.jpg", "site": "Investors Business Daily", "text": "ABT stock is one of the biggest diversified medical stocks behind Johnson & Johnson and Roche. As it aims for clearance of its Freestyle Libre 2, is it time to buy Abbott stock?", "url": "https://www.investors.com/news/technology/abt-stock-buy-now/"}, {"symbol": "ABT", "publishedDate": "2019-12-01 07:00:00", "title": "3 Stocks to Buy Ahead of the Next Market Crash: ABT, BMY & DG", "image": "https://cdn.snapi.dev/images/v1/k/k/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5493002fbusinessman-with-needle-close-to-stock-chart-in-a-bubblejpgw700opresize.jpg", "site": "The Motley Fool", "text": "These stocks are great picks to own regardless of which turns the market takes.", "url": "https://www.fool.com/investing/2019/12/01/3-stocks-to-buy-ahead-of-the-next-market-crash.aspx"}, {"symbol": "ABT", "publishedDate": "2019-11-30 08:00:00", "title": "Better Buy: Abbott Laboratories vs. Johnson & Johnson", "image": "https://cdn.snapi.dev/images/v1/p/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5490702fbusinessman-scratching-head-with-left-and-right-arrowsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Which stock wins in a matchup between these two healthcare giants?", "url": "https://www.fool.com/investing/2019/11/30/better-buy-abbott-laboratories-vs-johnson-johnson.aspx"}, {"symbol": "ABT", "publishedDate": "2019-11-28 08:14:00", "title": "Digital Diabetes Management Gains Momentum: 3 Stocks in Focus", "image": "https://cdn.snapi.dev/images/v1/s/i/medical18.jpg", "site": "Zacks Investment Research", "text": "With digital diabetes management space rapidly gaining momentum, patients with diabetes can look forward to better and improved outcomes.", "url": "https://www.zacks.com/stock/news/644821/digital-diabetes-management-gains-momentum-3-stocks-in-focus"}, {"symbol": "ABT", "publishedDate": "2019-11-19 10:07:46", "title": "Mairs and Power Sells UPS, Abbott Labs and more", "image": "https://cdn.snapi.dev/images/v1/v/d/medical20.jpg", "site": "GuruFocus", "text": "The investment firm\u00a0Mairs and Power (Trades, Portfolio) sold shares of the following stocks during the third quarter.", "url": "https://www.gurufocus.com/news/987207/mairs-and-power-sells-ups-abbott-labs"}, {"symbol": "ABT", "publishedDate": "2019-11-18 17:16:02", "title": "Heart disease study finds limited benefits for stents", "image": "https://cdn.snapi.dev/images/v1/m/q/heart-disease-study-finds-limited-benefits-for-stents.jpg", "site": "CNBC Television", "text": "Heart disease study found that stents and bypass surgery were not more effective than medicine. CNBC's Meg Tirrell reports.", "url": "https://www.youtube.com/watch?v=1AAXEwtDChk"}, {"symbol": "ABT", "publishedDate": "2019-11-17 17:00:00", "title": "3  Dividend Aristocrats to Buy and Hold Forever.", "image": "https://cdn.snapi.dev/images/v1/w/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5479842f100-bills-forming-infinity-symboljpgw700opresize.jpg", "site": "The Motley Fool", "text": "Retired investors will especially like these reliable and solid dividend stocks.", "url": "https://www.fool.com/investing/2019/11/17/3-dividend-aristocrats-to-buy-and-hold-forever.aspx"}, {"symbol": "ABT", "publishedDate": "2019-11-15 09:30:19", "title": "Abbott (ABT) Up 2.1% Since Last Earnings Report: Can It Continue?", "image": "https://cdn.snapi.dev/images/v1/9/y/medical3.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/621404/abbott-abt-up-21-since-last-earnings-report-can-it-continue"}, {"symbol": "ABT", "publishedDate": "2019-11-13 11:23:07", "title": "Abbott CEO Miles White Steps Down", "image": "https://cdn.snapi.dev/images/v1/n/0/pedialyte.jpg", "site": "Benzinga", "text": "After nearly 21 years at Abbott Laboratories (NYSE: ABT), CEO Miles White is preparing for his departure.", "url": "https://www.benzinga.com/news/19/11/14797935/abbott-ceo-miles-white-steps-down"}, {"symbol": "ABT", "publishedDate": "2019-11-13 10:37:52", "title": "Medtech Giant Elects New CEO As 21-Year Veteran Steps Down", "image": "https://cdn.snapi.dev/images/v1/1/8/18abcoc-1.jpg", "site": "Investors Business Daily", "text": "Abbott Laboratories announced Wednesday that Chief Operating Officer Robert Ford would succeed Chief Executive Officer Miles White in March. Abbott stock dipped a fraction in early trading.", "url": "https://www.investors.com/news/technology/abbott-stock-news-robert-ford-succeed-miles-white-ceo/"}, {"symbol": "ABT", "publishedDate": "2019-11-13 07:58:08", "title": "Abbott Laboratories CEO Miles White to step down after 2 decades in charge", "image": "https://cdn.snapi.dev/images/v1/o/n/medical9.jpg", "site": "Market Watch", "text": "Abbott Laboratories ABT, +0.69% said Wednesday that Chief Executive Miles White will step down on March 31, 2020, after 21 years in the role.", "url": "https://www.marketwatch.com/story/abbott-laboratories-ceo-miles-white-to-step-down-after-2-decades-in-charge-2019-11-13"}, {"symbol": "ABT", "publishedDate": "2019-11-13 07:56:41", "title": "Abbott Labs CEO Miles White Stepping Down After Two Decades", "image": "https://cdn.snapi.dev/images/v1/6/t/medical8.jpg", "site": "Forbes", "text": "Abbott Laboratories chief executive Miles White is stepping down effective next year after 21 years at the helm of the diversified healthcare company.", "url": "https://www.forbes.com/sites/brucejapsen/2019/11/13/abbott-labs-ceo-miles-white-stepping-down-after-two-decades/"}, {"symbol": "ABT", "publishedDate": "2019-11-06 09:42:00", "title": "Medical Products' Nov 7 Earnings Roster: ABC, CAH & More", "image": "https://cdn.snapi.dev/images/v1/e/t/etf15.jpg", "site": "Zacks Investment Research", "text": "Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.", "url": "https://www.zacks.com/stock/news/606407/medical-products-nov-7-earnings-roster-abc-cah-more"}, {"symbol": "ABT", "publishedDate": "2019-11-05 06:06:58", "title": "Abbott Laboratories: Predictability In Q4", "image": "https://cdn.snapi.dev/images/v1/s/a/medical25.jpg", "site": "Seeking Alpha", "text": "Abbott Laboratories: Predictability In Q4", "url": "https://seekingalpha.com/article/4302473-abbott-laboratories-predictability-q4"}, {"symbol": "ABT", "publishedDate": "2019-10-30 12:09:00", "title": "Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More", "image": "https://cdn.snapi.dev/images/v1/1/4/14medstin-1.jpg", "site": "Zacks Investment Research", "text": "Earnings and revenues for the Medical Instruments sector in the third quarter are likely to have declined sequentially. Read to know how a few companies from the sector might have fared in the period.", "url": "https://www.zacks.com/stock/news/593569/medical-instruments-oct-31-earnings-roster-idxx-abmd-more"}, {"symbol": "ABT", "publishedDate": "2019-10-28 07:10:59", "title": "How Much Can Abbott\u2019s Revenue Grow In The Coming Years?", "image": "https://cdn.snapi.dev/images/v1/m/q/medical19.jpg", "site": "Forbes", "text": "Abbott is a diversified healthcare conglomerate with a global presence. The firm operates in four main segments: Medical Devices, Diagnostics, Nutritional, and Established Pharmaceuticals.", "url": "https://www.forbes.com/sites/greatspeculations/2019/10/28/how-much-can-abbotts-revenue-grow-in-the-coming-years/"}, {"symbol": "ABT", "publishedDate": "2019-10-27 07:00:00", "title": "Better Buy: Abbott Laboratories vs.  Novo Nordisk", "image": "https://cdn.snapi.dev/images/v1/a/d/ab6-6.jpg", "site": "The Motley Fool", "text": "Which stock wins in a battle between these two healthcare giants?", "url": "https://www.fool.com/investing/2019/10/27/better-buy-abbott-laboratories-vs-novo-nordisk.aspx"}, {"symbol": "ABT", "publishedDate": "2019-10-23 09:20:00", "title": "Medical Products' Oct 24 Earnings Roster: BAX, CERN & More", "image": "https://cdn.snapi.dev/images/v1/6/5/653.jpg", "site": "Zacks Investment Research", "text": "Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.", "url": "https://www.zacks.com/stock/news/578727/medical-products-oct-24-earnings-roster-bax-cern-more"}, {"symbol": "ABT", "publishedDate": "2019-10-16 15:49:53", "title": "5 Top Stock Trades for Thursday: ADBE, NFLX, ABT, NOW & WDAY", "image": "https://cdn.snapi.dev/images/v1/y/s/ysny27-1.jpg", "site": "InvestorPlace", "text": "Adobe, Netflix, ServiceNow, Workday and Abbott Labs were our top stock trades from Wednesday. Here's a look at the charts.", "url": "https://investorplace.com/2019/10/5-top-stock-trades-for-thursday-adbe-nflx-abt/"}, {"symbol": "ABT", "publishedDate": "2019-10-16 14:42:11", "title": "Abbott Laboratories (ABT) CEO Miles White on Q3 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/u/r/transcript47.jpg", "site": "Seeking Alpha", "text": "Abbott Laboratories (ABT) CEO Miles White on Q3 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4296862-abbott-laboratories-abt-ceo-miles-white-q3-2019-results-earnings-call-transcript"}, {"symbol": "ABT", "publishedDate": "2019-10-16 12:00:00", "title": "3 Things You'll Want to Know About Abbott Labs' Q3 Results", "image": "https://cdn.snapi.dev/images/v1/j/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5425532fbusinessman-pointing-to-dollar-sign-imagesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Here's a quick rundown on how the healthcare giant performed.", "url": "https://www.fool.com/investing/2019/10/16/3-key-things-youll-want-to-know-about-abbott-labs.aspx"}, {"symbol": "ABT", "publishedDate": "2019-10-16 11:17:00", "title": "Abbott (ABT) Meets Q3 Earnings Estimates, Lowers EPS Guidance", "image": "https://cdn.snapi.dev/images/v1/s/h/medical14.jpg", "site": "Zacks Investment Research", "text": "We are optimistic about Abbott's (ABT) strong and consistent EPD and Medical Devices performance organically.", "url": "https://www.zacks.com/stock/news/567712/abbott-abt-meets-q3-earnings-estimates-lowers-eps-guidance"}, {"symbol": "ABT", "publishedDate": "2019-10-16 09:36:02", "title": "Abbott Labs trims profit forecast after revenue miss", "image": "https://cdn.snapi.dev/images/v1/v/t/m02d20191016t2i1441465394rlynxmpef9f10cw640.jpg", "site": "Reuters", "text": "Medical device maker Abbott Laboratories  fell just short of Wall Street estimates for quarterly revenue on Wednesday and trimmed the upper end of its full-year earnings forecast.", "url": "https://www.reuters.com/article/us-abbott-results/abbott-labs-trims-profit-forecast-after-revenue-miss-idUSKBN1WV1HQ"}, {"symbol": "ABT", "publishedDate": "2019-10-16 08:54:35", "title": "Abbott Stock Dives On Shy Third-Quarter Sales, But Earnings Meet Views", "image": "https://cdn.snapi.dev/images/v1/j/n/medical13.jpg", "site": "Investors Business Daily", "text": "Abbott earnings of 84 cents per share met expectations in the third quarter, but $8.08 billion in sales was just light of estimates. Abbott stock slipped in premarket trading on Wednesday.", "url": "https://www.investors.com/news/technology/abbott-earnings-abbott-stock-q3-2019/"}, {"symbol": "ABT", "publishedDate": "2019-10-16 08:45:04", "title": "Abbott (ABT) Meets Q3 Earnings Estimates", "image": "https://cdn.snapi.dev/images/v1/h/l/medical24.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) delivered earnings and revenue surprises of 0.00% and -0.23%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/567220/abbott-abt-meets-q3-earnings-estimates"}, {"symbol": "ABT", "publishedDate": "2019-10-16 07:47:03", "title": "Abbott Laboratories Reports Mixed Q3 Earnings", "image": "https://cdn.snapi.dev/images/v1/0/z/medical12.jpg", "site": "Benzinga", "text": "Abbott Laboratories (NYSE: ABT) reported third-quarter earnings of 84 cents per share, which met the analyst consensus estimate.", "url": "https://www.benzinga.com/news/earnings/19/10/14601833/abbott-laboratories-reports-mixed-q3-earnings"}, {"symbol": "ABT", "publishedDate": "2019-10-16 07:44:08", "title": "Abbott Labs stock falls after profit matches expectations, sales comes up a bit shy", "image": "https://cdn.snapi.dev/images/v1/r/i/pt-25-193726-o.jpg", "site": "Market Watch", "text": "Shares of Abbott Laboratories ABT, +2.71% fell 2.7% in premarket trading Wednesday, after medical device, diagnostics and drug maker reported a third-quarter profit that was in line with expectations, while sales came up a bit shy.", "url": "https://www.marketwatch.com/story/abbott-labs-stock-falls-after-profit-matches-expectations-sales-comes-up-a-bit-shy-2019-10-16"}, {"symbol": "ABT", "publishedDate": "2019-10-15 10:37:00", "title": "Can Structural Heart Strength Aid Abbott (ABT) Q3 Earnings?", "image": "https://cdn.snapi.dev/images/v1/g/t/medical9.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) has been growing popular with developments in its flagship, market leading device for the treatment of mitral regurgitation, MitraClip.", "url": "https://www.zacks.com/stock/news/565764/can-structural-heart-strength-aid-abbott-abt-q3-earnings"}, {"symbol": "ABT", "publishedDate": "2019-10-15 10:06:11", "title": "Medical Devices Stock Rockets After Snagging An Abbott Partnership", "image": "https://cdn.snapi.dev/images/v1/4/h/medical6.jpg", "site": "Investors Business Daily", "text": "Tandem Diabetes stock popped Tuesday on a partnership deal with medical behemoth Abbott Laboratories in diabetes treatment. The medical technology firms will integrate their medical devices.", "url": "https://www.investors.com/news/technology/tandem-diabetes-stock-rockets-diabetes-treatment-deal-abbott/"}, {"symbol": "ABT", "publishedDate": "2019-10-15 09:10:00", "title": "Abbott Forms Alliance With Omada Health for Diabetes Care", "image": "https://cdn.snapi.dev/images/v1/r/n/medical4.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) collaborates with Omada Health to revolutionize diabetes care by expanding technological access.", "url": "https://www.zacks.com/stock/news/565703/abbott-forms-alliance-with-omada-health-for-diabetes-care"}, {"symbol": "ABT", "publishedDate": "2019-10-15 08:28:00", "title": "Abbott Labs gets authorization for $3 billion in additional buybacks", "image": "https://cdn.snapi.dev/images/v1/f/t/abbottoffice-1.jpg", "site": "Market Watch", "text": "Abbott Laboratories Inc. ABT, +0.24% said in a Tuesday filing that its board had authorized an additional $3 billion in share repurchases.", "url": "https://www.marketwatch.com/story/abbott-labs-gets-authorization-for-3-billion-in-additional-buybacks-2019-10-15"}, {"symbol": "ABT", "publishedDate": "2019-10-14 11:43:00", "title": "Can Balanced Segmental Growth Aid Abbott (ABT) Q3 Earnings?", "image": "https://cdn.snapi.dev/images/v1/t/7/medical1.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) is steadily gaining prominence for developments in its flagship, sensor-based continuous glucose monitoring (CGM) system of FreeStyle Libre.", "url": "https://www.zacks.com/stock/news/564047/can-balanced-segmental-growth-aid-abbott-abt-q3-earnings"}, {"symbol": "ABT", "publishedDate": "2019-10-10 09:49:00", "title": "Five Dividend Aristocrats Where Analysts See Capital Gains", "image": "https://cdn.snapi.dev/images/v1/a/s/asset-management32.jpg", "site": "Forbes", "text": "To become a \"Dividend Aristocrat,\" a dividend paying company must accomplish an incredible feat: consistently increase shareholder dividends every year for at least 20 consecutive years.", "url": "https://www.forbes.com/sites/dividendchannel/2019/10/10/5-dividend-aristocrats-where-analysts-see-capital-gains-14/"}, {"symbol": "ABT", "publishedDate": "2019-10-09 10:30:48", "title": "Abbott (ABT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release", "image": "https://cdn.snapi.dev/images/v1/h/f/medical2.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/556156/abbott-abt-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release"}, {"symbol": "ABT", "publishedDate": "2019-10-05 07:03:00", "title": "3 Great Dividend Stocks That Aren't Founder-Led", "image": "https://cdn.snapi.dev/images/v1/x/0/wd2e-3.jpg", "site": "The Motley Fool", "text": "The stocks of companies with CEOs who are founders can be big winners. But so can the stocks of companies that aren't led by their founders.", "url": "https://www.fool.com/investing/2019/10/05/3-great-dividend-stocks-that-arent-founder-led.aspx"}, {"symbol": "ABT", "publishedDate": "2019-10-02 09:48:00", "title": "Abbott (ABT) Gets FDA Nod for New Troponin-I Blood Test", "image": "https://cdn.snapi.dev/images/v1/l/k/medical5.jpg", "site": "Zacks Investment Research", "text": "The regulatory go-ahead for Abbott's (ABT) ARCHITECT STAT High Sensitivity Troponin-I blood test is a major stride forward in its commitment for detecting patients suspected of having a heart attack.", "url": "https://www.zacks.com/stock/news/545891/abbott-abt-gets-fda-nod-for-new-troponin-i-blood-test"}, {"symbol": "ABT", "publishedDate": "2019-10-01 11:08:33", "title": "4 Healthcare Stocks to Buy Now", "image": "https://cdn.snapi.dev/images/v1/h/e/healthcare1600c-768x432.jpg", "site": "InvestorPlace", "text": "There's a lot in the news this week, from talks of an impeachment to a potential trade war resolution. Buy these healthcare stocks to benefit.", "url": "https://investorplace.com/2019/10/4-healthcare-stocks-to-buy-now/"}, {"symbol": "ABT", "publishedDate": "2019-10-01 09:14:00", "title": "Abbott (ABT) Gets FDA Nod for Spinal Cord Stimulation System", "image": "https://cdn.snapi.dev/images/v1/z/u/medical26.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) is upbeat about the latest clearance in its neuromodulation product portfolio.", "url": "https://www.zacks.com/stock/news/544418/abbott-abt-gets-fda-nod-for-spinal-cord-stimulation-system"}, {"symbol": "ABT", "publishedDate": "2019-09-30 13:56:20", "title": "Abbott Labs, Homebuilders and US Bancorp in the trader blitz", "image": "https://cdn.snapi.dev/images/v1/p/v/abbott-labs-homebuilders-and-us-bancorp-in-the-trader-blitz.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders take investors through some of the day's biggest movers.", "url": "https://www.youtube.com/watch?v=9DOJHaoFtv0"}, {"symbol": "ABT", "publishedDate": "2019-09-30 05:20:00", "title": "What\u2019s Fueling Abbott\u2019s Stock Price Growth?", "image": "https://cdn.snapi.dev/images/v1/a/e/pt-25-193270-o.jpg", "site": "Forbes", "text": "Abbott Labs\u2019 share price has more than doubled over the last three years. This can be attributed to steady growth in its revenues, margin expansion, price to earnings multiple growth, and lower share count.", "url": "https://www.forbes.com/sites/greatspeculations/2019/09/30/whats-fueling-abbotts-stock-price-growth/"}, {"symbol": "ABT", "publishedDate": "2019-09-26 17:50:19", "title": "Abbott (ABT) Stock Moves -0.24%: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/9/x/medical14.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) closed at $82.66 in the latest trading session, marking a -0.24% move from the prior day.", "url": "https://www.zacks.com/stock/news/537532/abbott-abt-stock-moves-024-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2019-09-23 07:22:22", "title": "3 Big Stock Charts for Monday: MSCI, Macerich and Abbott Laboratories", "image": "https://cdn.snapi.dev/images/v1/z/b/medical9.jpg", "site": "InvestorPlace", "text": "The stock charts of MAC, ABT and MSCI are positioned to start the new trading week in clearly defined situations. Here are levels to watch.", "url": "https://investorplace.com/2019/09/3-big-stock-charts-for-monday-msci-macerich-and-abbott-laboratories/"}, {"symbol": "ABT", "publishedDate": "2019-09-18 07:57:00", "title": "Abbott Receives European Nod for Pediatric Heart Devices", "image": "https://cdn.snapi.dev/images/v1/w/8/medical8.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) aims to offer better treatment options for the most vulnerable patient population.", "url": "https://www.zacks.com/stock/news/524246/abbott-receives-european-nod-for-pediatric-heart-devices"}, {"symbol": "ABT", "publishedDate": "2019-09-17 08:38:00", "title": "Abbott Partners With Sanofi to Upgrade Diabetes Management", "image": "https://cdn.snapi.dev/images/v1/l/o/medical2.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) collaborates with Sanofi to revolutionize diabetes care through technological advancements.", "url": "https://www.zacks.com/stock/news/522662/abbott-partners-with-sanofi-to-upgrade-diabetes-management"}, {"symbol": "ABT", "publishedDate": "2019-09-16 08:29:00", "title": "Abbott's (ABT) FreeStyle Libre Gains Canadian Reimbursement", "image": "https://cdn.snapi.dev/images/v1/9/9/medical4.jpg", "site": "Zacks Investment Research", "text": "With this reimbursement approval, Abbott's (ABT) FreeStyle Libre becomes the first sensor-based glucose monitoring system to be listed by any provincial health plan in Canada.", "url": "https://www.zacks.com/stock/news/520824/abbotts-abt-freestyle-libre-gains-canadian-reimbursement"}, {"symbol": "ABT", "publishedDate": "2019-09-11 09:30:00", "title": "Abbott Sees Hammer Chart Pattern: Time to Buy?", "image": "https://cdn.snapi.dev/images/v1/7/j/medical10.jpg", "site": "Zacks Investment Research", "text": "Abbott Laboratories has been struggling lately, but the selling pressure may be coming to an end soon.", "url": "https://www.zacks.com/stock/news/512991/abbott-sees-hammer-chart-pattern-time-to-buy"}, {"symbol": "ABT", "publishedDate": "2019-09-10 11:09:00", "title": "Five Dividend Aristocrats: Where Analysts See Capital Gains", "image": "https://cdn.snapi.dev/images/v1/e/t/etf45.jpg", "site": "Forbes", "text": "To become a \"Dividend Aristocrat,\" a dividend paying company must accomplish an incredible feat: consistently increase shareholder dividends every year for at least 20 consecutive years.", "url": "https://www.forbes.com/sites/etfchannel/2019/09/10/5-dividend-aristocrats-where-analysts-see-capital-gains-40/"}, {"symbol": "ABT", "publishedDate": "2019-09-09 11:27:00", "title": "Abbott (ABT) Launches Pivotal Trial TRILUMINATE in the US", "image": "https://cdn.snapi.dev/images/v1/v/3/medical28.jpg", "site": "Zacks Investment Research", "text": "Given the lack of an alternative therapy to replace tricuspid regurgitation surgery, Abbott (ABT) should be at an advantage in this space.", "url": "https://www.zacks.com/stock/news/509662/abbott-abt-launches-pivotal-trial-triluminate-in-the-us"}, {"symbol": "ABT", "publishedDate": "2019-09-03 07:02:00", "title": "Five Cancer-Fighting Stocks to Add to Your Portfolio", "image": "https://cdn.snapi.dev/images/v1/s/t/stocks-1-6.jpg", "site": "Zacks Investment Research", "text": "Cancer-fighting stocks receive a boost from advance research and development. These five stocks can add value to your portfolio.", "url": "https://www.zacks.com/stock/news/499386/5-cancer-fighting-stocks-to-add-to-your-portfolio"}, {"symbol": "ABT", "publishedDate": "2019-08-29 22:56:35", "title": "Top 5 Recession Stocks", "image": "https://cdn.snapi.dev/images/v1/1/6/16stre-1.jpg", "site": "Investopedia", "text": "What makes these stocks so resilient? And how did they perform during the last crisis?", "url": "https://www.investopedia.com/articles/investing/041015/top-5-recession-stocks.asp"}, {"symbol": "ABT", "publishedDate": "2019-08-27 08:56:00", "title": "Here's Why You Should Add Abbott (ABT) to Your Portfolio", "image": "https://cdn.snapi.dev/images/v1/s/p/medical3.jpg", "site": "Zacks Investment Research", "text": "Investors continue to be optimistic about Abbott (ABT) on its balanced segmental performances.", "url": "https://www.zacks.com/stock/news/490967/heres-why-you-should-add-abbott-abt-to-your-portfolio"}, {"symbol": "ABT", "publishedDate": "2019-08-27 08:54:00", "title": "Abbott's (ABT) TRACK-TBI Study Reveals Encouraging Results", "image": "https://cdn.snapi.dev/images/v1/w/3/medical4.jpg", "site": "Zacks Investment Research", "text": "This study outcome should be a crucial step forward for Abbott Laboratories (ABT) in its endeavor to boost TBI diagnosis and treatment.", "url": "https://www.zacks.com/stock/news/490800/abbotts-abt-track-tbi-study-reveals-encouraging-results"}, {"symbol": "ABT", "publishedDate": "2019-08-26 09:30:11", "title": "Has Abbott Laboratories (ABT) Outpaced Other Medical Stocks This Year?", "image": "https://cdn.snapi.dev/images/v1/h/a/medical24.jpg", "site": "Zacks Investment Research", "text": "Is  (ABT) Outperforming Other Medical Stocks This Year?", "url": "https://www.zacks.com/stock/news/489317/has-abbott-laboratories-abt-outpaced-other-medical-stocks-this-year"}, {"symbol": "ABT", "publishedDate": "2019-08-26 09:00:07", "title": "Abbott (ABT) Upgraded to Buy: What Does It Mean for the Stock?", "image": "https://cdn.snapi.dev/images/v1/v/o/medical20.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).", "url": "https://www.zacks.com/stock/news/489199/abbott-abt-upgraded-to-buy-what-does-it-mean-for-the-stock"}, {"symbol": "ABT", "publishedDate": "2019-08-25 07:30:00", "title": "3 Fantastic Stocks for Low-Risk Investors", "image": "https://cdn.snapi.dev/images/v1/h/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5374752frisk-measurement-with-caliperjpgw700opresize.jpg", "site": "The Motley Fool", "text": "There's no such thing as a no-risk stock. But these three stocks should be much less risky than most.", "url": "https://www.fool.com/investing/2019/08/25/3-fantastic-stocks-for-low-risk-investors.aspx"}, {"symbol": "ABT", "publishedDate": "2019-08-22 11:45:00", "title": "Abbott's Libre Adoption a Positive, Rhythm Management a Woe", "image": "https://cdn.snapi.dev/images/v1/y/j/medical22.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) is steadily riding high on a healthy growth track within its Diabetes Care business.", "url": "https://www.zacks.com/stock/news/483012/abbotts-libre-adoption-a-positive-rhythm-management-a-woe"}, {"symbol": "ABT", "publishedDate": "2019-08-21 10:05:00", "title": "3 Top Diabetes Stocks to Watch in August", "image": "https://cdn.snapi.dev/images/v1/n/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5369452fdiabetesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These three diabetes-oriented companies should be on your radar right now.", "url": "https://www.fool.com/investing/2019/08/21/3-top-diabetes-stocks-to-watch-in-august.aspx"}, {"symbol": "ABT", "publishedDate": "2019-08-16 09:30:19", "title": "Abbott (ABT) Down 4.4% Since Last Earnings Report: Can It Rebound?", "image": "https://cdn.snapi.dev/images/v1/9/p/medical17.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/473393/abbott-abt-down-44-since-last-earnings-report-can-it-rebound"}, {"symbol": "ABT", "publishedDate": "2019-08-13 07:05:00", "title": "5 Stocks -Trading Near 52-Week High With More Room to Run", "image": "https://cdn.snapi.dev/images/v1/s/t/stock-market-3.jpg", "site": "Zacks Investment Research", "text": "Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.", "url": "https://www.zacks.com/stock/news/468278/5-stocks-trading-near-52-week-high-with-more-room-to-run"}, {"symbol": "ABT", "publishedDate": "2019-08-09 18:15:03", "title": "Abbott Laboratories (ABT) Executive Vice President & CFO Brian B Yoor Sold $3..", "image": "https://cdn.snapi.dev/images/v1/f/x/medical22.jpg", "site": "GuruFocus", "text": "Executive Vice President & CFO of Abbott Laboratories (30-Year Financial, Insider Trades) Brian B Yoor (insider trades) sold 43,763 shares of ABT on 08/08/2019 at an average price of $85.77 a share.", "url": "https://www.gurufocus.com/news/925827/abbott-laboratories-abt-executive-vice-president--cfo-brian-b-yoor-sold-38-million-of-shares"}, {"symbol": "ABT", "publishedDate": "2019-08-04 18:52:14", "title": "Abbott: A Long-Term Hold Based On The Business Outlook", "image": "https://cdn.snapi.dev/images/v1/b/z/medical19.jpg", "site": "Seeking Alpha", "text": "Uptrend in stock price is justified by the company outlook.", "url": "https://seekingalpha.com/article/4281503-abbott-long-term-hold-based-business-outlook?source=feed_tag_long_ideas"}, {"symbol": "ABT", "publishedDate": "2019-07-27 12:20:00", "title": "10 Biggest Cancer-Fighting Stocks", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5193592fabt-earnings-41719.jpg", "site": "The Motley Fool", "text": "The fight against cancer is a big battle. And these 10 companies are among the biggest combatants you can invest in.", "url": "https://www.fool.com/investing/2019/07/27/10-biggest-cancer-fighting-stocks.aspx"}, {"symbol": "ABT", "publishedDate": "2019-07-27 12:17:00", "title": "10 Biggest Medical Device Stocks", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5312752fmedical-devices-in-hospital-roomjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Market caps for these medical device stocks are big. Most of them have been big winners, too.", "url": "https://www.fool.com/investing/2019/07/27/10-biggest-medical-device-stocks.aspx"}, {"symbol": "ABT", "publishedDate": "2019-07-18 14:05:03", "title": "Final Trades: Abbott Labs, Goldman Sachs, Disney, United Airlines & Silver", "image": "https://cdn.snapi.dev/images/v1/t/f/tfr2-1.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders give their top stocks to watch for the second half.", "url": "https://www.youtube.com/watch?v=yDyjLwzjW2M"}, {"symbol": "ABT", "publishedDate": "2019-07-18 10:33:23", "title": "Abbott Labs Rises Following the Release of 2nd-Quarter Numbers", "image": "https://cdn.snapi.dev/images/v1/e/j/biotech13-3.jpg", "site": "GuruFocus", "text": "Shares of Abbott Laboratories (NYSE:ABT) moved 3.13% higher to $85.76 at close on Wednesday after the company posted second-quarter results for fiscal 2019.", "url": "https://www.gurufocus.com/news/910935/abbott-labs-rises-following-the-release-of-2ndquarter-numbers"}, {"symbol": "ABT", "publishedDate": "2019-07-18 09:00:06", "title": "Abbott (ABT) Upgraded to Strong Buy: What Does It Mean for the Stock?", "image": "https://cdn.snapi.dev/images/v1/z/g/medical14.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).", "url": "https://www.zacks.com/stock/news/444280/abbott-abt-upgraded-to-strong-buy-what-does-it-mean-for-the-stock"}, {"symbol": "ABT", "publishedDate": "2019-07-18 08:58:56", "title": "Final Trades: Abbott, TLT, SPY & GDX", "image": "https://cdn.snapi.dev/images/v1/f/t/ft623-1.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders share their final trades of the day including ABT, GDX, and more", "url": "https://www.youtube.com/watch?v=vNt5ig8L9-w"}, {"symbol": "ABT", "publishedDate": "2019-07-17 15:59:00", "title": "Abbott (ABT) Tops Q2 Earnings Estimates, Lifts EPS Guidance", "image": "https://cdn.snapi.dev/images/v1/n/y/medical12.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) registers strong Cardiovascular and Neuromodulation sales on double-digit growth in Electrophysiology, Heart Failure and Structural Heart.", "url": "https://www.zacks.com/stock/news/444027/abbott-abt-tops-q2-earnings-estimates-lifts-eps-guidance"}, {"symbol": "ABT", "publishedDate": "2019-07-17 15:41:23", "title": "Abbott Laboratories (ABT) CEO Miles White on Q2 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/f/t/transcript3.jpg", "site": "Seeking Alpha", "text": "Abbott Laboratories (ABT) CEO Miles White on Q2 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4275546-abbott-laboratories-abt-ceo-miles-white-q2-2019-results-earnings-call-transcript?source=feed_sector_transcripts"}, {"symbol": "ABT", "publishedDate": "2019-07-17 15:41:03", "title": "5 Top Stock Trades for Thursday (July 18)", "image": "https://cdn.snapi.dev/images/v1/w/d/wd2e-3.jpg", "site": "InvestorPlace", "text": "Tesla, Teva, Abbott Labs, Invitae and the gold ETF were are top stock trades on Wednesday. Let's look at the setups heading into Thursday.", "url": "https://investorplace.com/2019/07/5-top-stock-trades-for-thursday-tsla-gld-abt/"}, {"symbol": "ABT", "publishedDate": "2019-07-17 13:53:45", "title": "Textron, United Airlines and more in the Blitz", "image": "https://cdn.snapi.dev/images/v1/p/q/textron-united-airlines-and-more-in-the-blitz.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders discuss today's big movers, including Textron, United Airlines, Abbott Labs, Comerica, and Bank of America.", "url": "https://www.youtube.com/watch?v=ZlrNcQohzok"}, {"symbol": "ABT", "publishedDate": "2019-07-17 13:13:52", "title": "Abbott Laboratories Earnings: ABT Stock Surges on Guidance, Q2 Beat", "image": "https://cdn.snapi.dev/images/v1/e/m/medical11-2.jpg", "site": "InvestorPlace", "text": "Abbott Laboratories earnings for the company's second quarter of 2019 has ABT stock heading higher Wednesday on positive results.\nThe post Abbott Laboratories Earnings: ABT Stock Surges on Guidance, Q2 Beat appeared first on InvestorPlace.", "url": "https://investorplace.com/2019/07/abbott-laboratories-earnings-have-abt-stock-up/"}, {"symbol": "ABT", "publishedDate": "2019-07-17 12:19:54", "title": "Abbott hits record high as diabetes device fuels profit beat", "image": "https://cdn.snapi.dev/images/v1/p/t/ab2-2.jpg", "site": "Reuters", "text": "Abbott Laboratories  beat analysts' estimates for quarterly profit and lifted its full-year earnings forecast on Wednesday, boosted by a near 64% jump in sales of its blood sugar monitoring device.", "url": "https://www.reuters.com/article/us-abbott-results/abbott-hits-record-high-as-diabetes-device-fuels-profit-beat-idUSKCN1UC1D7"}, {"symbol": "ABT", "publishedDate": "2019-07-17 08:55:03", "title": "Abbott (ABT) Q2 Earnings Surpass Estimates", "image": "https://cdn.snapi.dev/images/v1/i/v/medical30.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) delivered earnings and revenue surprises of 2.50% and -0.10%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/443606/abbott-abt-q2-earnings-surpass-estimates"}, {"symbol": "ABT", "publishedDate": "2019-07-17 08:07:39", "title": "Abbott Laboratories Reports Q2 Earnings Beat", "image": "https://cdn.snapi.dev/images/v1/a/b/abo23-3.jpg", "site": "Benzinga", "text": "Abbott Laboratories (NYSE: ABT) reported quarterly earnings of 82 cents per share, which beat the analyst consensus estimate of 8 cents.", "url": "https://www.benzinga.com/news/earnings/19/07/14086892/abbott-laboratories-reports-q2-earnings-beat"}, {"symbol": "ABT", "publishedDate": "2019-07-17 08:01:00", "title": "US-India Trade Tensions Rise: 3 Stocks in the Line of Fire", "image": "https://cdn.snapi.dev/images/v1/e/t/etf32-35.jpg", "site": "Zacks Investment Research", "text": "As India moves toward self-sufficiency, U.S. MedTech bigwigs fret over possible losses.", "url": "https://www.zacks.com/stock/news/443560/us-india-trade-tensions-rise-3-stocks-in-the-line-of-fire"}, {"symbol": "ABT", "publishedDate": "2019-07-17 07:57:11", "title": "Abbott stock rises after earnings beat, full-year guidance boost", "image": "https://cdn.snapi.dev/images/v1/w/6/medical27.jpg", "site": "Market Watch", "text": "Shares of Abbott Laboratories ABT, -0.78% gained 0.8% in premarket trade Wednesday after the medical-device maker reported second-quarter earnings that topped Wall Street expectations and raised full-year guidance, though the company missed expectations for revenue.", "url": "https://www.marketwatch.com/story/abbott-stock-rises-after-earnings-beat-full-year-guidance-boost-2019-07-17"}, {"symbol": "ABT", "publishedDate": "2019-07-17 07:48:00", "title": "Abbott Earnings Narrowly Top; Health Care Giant Raises Guidance", "image": "https://cdn.snapi.dev/images/v1/w/y/medical26.jpg", "site": "Investors Business Daily", "text": "Abbott Laboratories earnings beat second-quarter earnings views. The health care giant raised full-year guidance.", "url": "https://www.investors.com/news/technology/abbott-earnings-abbott-stock-q2-2019/"}, {"symbol": "ABT", "publishedDate": "2019-07-16 07:45:00", "title": "Abbott MitraClip G4 Gets FDA Nod, Valve Repair Options Expand", "image": "https://cdn.snapi.dev/images/v1/u/b/medical11.jpg", "site": "Zacks Investment Research", "text": "The FDA approval for MitraClip G4 is expected to enhance Abbott's (ABT) cardiac treatment portfolio.", "url": "https://www.zacks.com/stock/news/442877/abbott-mitraclip-g4-gets-fda-nod-valve-repair-options-expand"}, {"symbol": "ABT", "publishedDate": "2019-07-15 10:26:00", "title": "Will Abbott's (ABT) Q2 Earnings Gain From Overall Growth?", "image": "https://cdn.snapi.dev/images/v1/m/o/pt-25-193726-o.jpg", "site": "Zacks Investment Research", "text": "Abbott's (ABT) consistent rise on a strong Diabetes Care business performance is seen over the last few quarters.", "url": "https://www.zacks.com/stock/news/442478/will-abbotts-abt-q2-earnings-gain-from-overall-growth"}, {"symbol": "ABT", "publishedDate": "2019-07-15 09:12:00", "title": "ABT or BIO: Which Stock Has Better Potential Right Now?", "image": "https://cdn.snapi.dev/images/v1/l/k/medical1.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) scores higher than Bio-Rad (BIO) in terms of valuation and one-year price performance.", "url": "https://www.zacks.com/stock/news/442319/abt-or-bio-which-stock-has-better-potential-right-now"}, {"symbol": "ABT", "publishedDate": "2019-07-12 15:46:29", "title": "4 Healthcare Stocks That Are Feeling Sick \u00a0", "image": "https://cdn.snapi.dev/images/v1/j/n/jnj-4.jpg", "site": "InvestorPlace", "text": "These healthcare stocks are breaking down on the charts. Investors should be careful before stepping into these four.", "url": "https://investorplace.com/2019/07/4-healthcare-stocks-that-are-feeling-sick/"}, {"symbol": "ABT", "publishedDate": "2019-07-10 13:16:00", "title": "The 10 Biggest Healthcare Stocks", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5301712fbusinessman-pointing-to-healthcare-iconsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "How big does a company's market cap need to be to make the top 10 list of healthcare stocks? $111 billion.", "url": "https://www.fool.com/investing/2019/07/10/the-10-biggest-healthcare-stocks.aspx?source=iedfolrf0000001"}, {"symbol": "ABT", "publishedDate": "2019-06-26 15:45:00", "title": "How Does Abbott's Established Pharmaceuticals Business Compare With Its Peers?", "image": "https://cdn.snapi.dev/images/v1/8/n/medical23.jpg", "site": "Forbes", "text": "Abbott Labs\u2019 (NYSE:ABT) established pharmaceuticals business offers a broad line of branded pharmaceuticals, manufactured worldwide, and marketed and sold outside the U.S. The major products sold through this segment include Creon, Brufen, Biaxin, Influvac, and Duphaston, among others.", "url": "https://www.forbes.com/sites/greatspeculations/2019/06/26/how-does-abbotts-established-pharmaceuticals-business-compare-with-its-peers/"}, {"symbol": "ABT", "publishedDate": "2019-06-26 09:30:58", "title": "Abbott: Long-Term Hold", "image": "https://cdn.snapi.dev/images/v1/a/b/abbottoffice-2.jpg", "site": "Seeking Alpha", "text": "Abbott has a diversified portfolio of healthcare products that are highly regarded in the market.", "url": "https://seekingalpha.com/article/4272188-abbott-long-term-hold?source=feed_tag_long_ideas"}, {"symbol": "ABT", "publishedDate": "2019-06-18 07:12:00", "title": "Abbott Labs Stock Just Hit an All-Time High: Buy, Sell, or Hold?", "image": "https://cdn.snapi.dev/images/v1/i/v/ab6-6.jpg", "site": "The Motley Fool", "text": "This healthcare giant is hot. But will Abbott's sizzle fizzle or get even hotter?", "url": "https://www.fool.com/investing/2019/06/18/abbott-labs-stock-just-hit-an-all-time-high-buy-se.aspx?source=iedfolrf0000001"}, {"symbol": "ABT", "publishedDate": "2019-06-17 07:40:00", "title": "Abbott (ABT) Hits New 52-Week High on Solid Growth Drivers", "image": "https://cdn.snapi.dev/images/v1/s/7/medical28.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) gains from expansion of product portfolio and several regulatory clearances.", "url": "https://www.zacks.com/stock/news/430392/abbott-abt-hits-new-52-week-high-on-solid-growth-drivers"}, {"symbol": "ABT", "publishedDate": "2019-06-13 14:00:00", "title": "3 Top Diabetes Stocks to Watch in June", "image": "https://cdn.snapi.dev/images/v1/w/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5287162fdiabetesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These three diabetes stocks have a lot going on this month.", "url": "https://www.fool.com/investing/2019/06/13/3-top-diabetes-stocks-to-watch-in-june.aspx?source=iedfolrf0000001"}, {"symbol": "ABT", "publishedDate": "2019-06-12 13:40:39", "title": "Final trades: Abbott, United, Coca-Cola & (IEF) Bonds", "image": "https://cdn.snapi.dev/images/v1/f/t/ftus72.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders give their top stocks to watch for the second half.", "url": "https://www.youtube.com/watch?v=eWieEAbhKuY"}, {"symbol": "ABT", "publishedDate": "2019-06-12 08:28:15", "title": "Traders Look to Buy Global Health Care Stocks", "image": "https://cdn.snapi.dev/images/v1/1/4/14ghl.jpg", "site": "Investopedia", "text": "The patterns forming on the long-term charts suggest that the global health care sector could be poised for a prolonged move higher.", "url": "https://www.investopedia.com/traders-look-to-buy-global-health-care-stocks-4690339"}, {"symbol": "ABT", "publishedDate": "2019-06-11 11:58:53", "title": "How Abbott's New Continuous Glucose Monitor Can Change The Company", "image": "https://cdn.snapi.dev/images/v1/n/j/medical1.jpg", "site": "Seeking Alpha", "text": "New data released by Abbott on the FreeStyle Libre Continuous Glucose Monitor shows it lowers blood sugar levels across the board by nearly a full percentage point in diabetics.", "url": "https://seekingalpha.com/article/4269631-abbotts-new-continuous-glucose-monitor-can-change-company?source=feed_tag_long_ideas"}, {"symbol": "ABT", "publishedDate": "2019-06-10 16:20:34", "title": "Five Health Care Stocks Gurus Are Buying", "image": "https://cdn.snapi.dev/images/v1/2/0/20heal.jpg", "site": "GuruFocus", "text": "According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.", "url": "https://www.gurufocus.com/news/891970/5-health-care-stocks-gurus-are-buying"}, {"symbol": "ABT", "publishedDate": "2019-06-09 07:00:00", "title": "Where Will Abbott Laboratories Be in 10 Years?", "image": "https://cdn.snapi.dev/images/v1/a/v/ab2-2.jpg", "site": "The Motley Fool", "text": "Expect the healthcare giant to hew to the principles that lifted it to where it stands now.", "url": "https://www.fool.com/investing/2019/06/09/where-will-abbott-laboratories-be-in-10-years.aspx?source=iedfolrf0000001"}, {"symbol": "ABT", "publishedDate": "2019-06-04 11:47:00", "title": "Abbott (ABT) Grows on EPD Amid Rhythm Management Challenges", "image": "https://cdn.snapi.dev/images/v1/t/q/medical10.jpg", "site": "Zacks Investment Research", "text": "We are optimistic about the steady growth trend in Abbott's (ABT) EPD and Medical Devices segments on an organic basis.", "url": "https://www.zacks.com/stock/news/424732/abbott-abt-grows-on-epd-amid-rhythm-management-challenges"}, {"symbol": "ABT", "publishedDate": "2019-05-29 17:50:16", "title": "Abbott (ABT) Stock Moves -0.05%: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/r/s/medical17.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Abbott (ABT) closed at $75.67, marking a -0.05% move from the previous day.", "url": "https://www.zacks.com/stock/news/421836/abbott-abt-stock-moves-005-what-you-should-know"}, {"symbol": "ABT", "publishedDate": "2019-05-29 11:07:00", "title": "The Companies Leading On Health For Communities And Families", "image": "https://cdn.snapi.dev/images/v1/h/e/he72-2.jpg", "site": "Forbes", "text": "To show how business can and must cultivate a Culture of Health, JUST Capital has released new analysis, with support from Robert Wood Johnson Foundation, evaluating how companies perform on core issues of community health.", "url": "https://www.forbes.com/sites/justcapital/2019/05/29/the-companies-leading-on-health-for-communities-and-families/"}, {"symbol": "ABT", "publishedDate": "2019-05-20 08:24:37", "title": "Watch a CIO explain where investors can find value in the market amid trade tensions", "image": "https://cdn.snapi.dev/images/v1/m/q-4/watch-a-cio-explain-where-investors-can-find-value-in-the-market-amid-trade-tensions.jpg", "site": "CNBC Television", "text": "Chris Zaccarelli, chief investment officer at Independent Advisor Alliance, joins \"Squawk Box\" to discuss where investors can find value in the markets as they continue to digest the news surrounding the U.S.", "url": "https://www.youtube.com/watch?v=7ccje80mZLc"}, {"symbol": "ABT", "publishedDate": "2019-05-17 09:30:23", "title": "Why Is Abbott (ABT) Up 3.6% Since Last Earnings Report?", "image": "https://cdn.snapi.dev/images/v1/f/9/medical9.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/415647/why-is-abbott-abt-up-36-since-last-earnings-report"}, {"symbol": "ABT", "publishedDate": "2019-05-13 14:22:17", "title": "Is Abbott heading to new highs? The desk answers viewer questions", "image": "https://cdn.snapi.dev/images/v1/a/b/abb22.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions on Abbott Labs.", "url": "https://www.youtube.com/watch?v=wfSoj3u8dY8"}, {"symbol": "ABT", "publishedDate": "2019-05-08 13:51:43", "title": "Abbott Laboratories: A Solid Business For An Attractive Valuation", "image": "https://cdn.snapi.dev/images/v1/h/i/jnj-1.jpg", "site": "Seeking Alpha", "text": "Abbott is a diversified company benefiting from a leadership position in its main markets.", "url": "https://seekingalpha.com/article/4261544-abbott-laboratories-solid-business-attractive-valuation?source=feed_tag_long_ideas"}, {"symbol": "ABT", "publishedDate": "2019-05-06 09:30:10", "title": "Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?", "image": "https://cdn.snapi.dev/images/v1/a/b/abo23-2.jpg", "site": "Zacks Investment Research", "text": "Is  (ABT) Outperforming Other Medical Stocks This Year?", "url": "https://www.zacks.com/stock/news/409125/is-abbott-laboratories-abt-stock-outpacing-its-medical-peers-this-year"}, {"symbol": "ABT", "publishedDate": "2019-04-26 17:55:00", "title": "Three Dividend Aristocrats to Buy and Hold Forever.", "image": "https://cdn.snapi.dev/images/v1/a/r/ari2.jpg", "site": "The Motley Fool", "text": "If you're looking for reliable dividend payers, these stocks are for you.", "url": "https://www.fool.com/investing/2019/04/26/3-dividend-aristocrats-to-buy-and-hold-forever.aspx?source=iedfolrf0000001"}, {"symbol": "ABT", "publishedDate": "2019-04-24 13:35:53", "title": "Final Trades: Boeing, Abbott Labs, EWJ, Amarin & Disney", "image": "https://cdn.snapi.dev/images/v1/b/o/bo3-2.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders give their top stocks to watch for the second half.", "url": "https://www.youtube.com/watch?v=qxJ2VXcwCAs"}, {"symbol": "ABT", "publishedDate": "2019-04-23 07:40:34", "title": "Why 5 Lagging Health Care Giants May Be Incredible Buys Now", "image": "https://cdn.snapi.dev/images/v1/h/c/hc2-3.jpg", "site": "24/7 Wall Street", "text": "While the overall stock market has been very strong year to date, with sectors like technology outperforming, the health care sector, which encompasses everything from pharmaceuticals to biotech to medical devices and more, has been absolutely wretched, lagging the S&P 500 by a huge 9%.", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/_dbktYH2jm0/"}, {"symbol": "ABT", "publishedDate": "2019-04-18 13:40:53", "title": "A Diabetes Treatment Revolution Could Bolster These Medtech Firms", "image": "https://cdn.snapi.dev/images/v1/a/4/a42.jpg", "site": "Investors Business Daily", "text": "Medical device companies like Abbott, Medtronic and Tandem Diabetes are jockeying for a piece of the diabetes treatment market, which could be worth north of $2 trillion by 2030.", "url": "https://feedproxy.google.com/~r/InternetTechnologyRss/~3/o8bBVTYfcH8/"}, {"symbol": "ABT", "publishedDate": "2019-04-18 12:10:00", "title": "Dividend Growth Stocks With Upside To Analyst Targets", "image": "https://cdn.snapi.dev/images/v1/p/t/pt-1168-50007-o.jpg", "site": "Forbes", "text": "if the analysts are correct, these are five dividend growth stocks that could produce capital gains in addition to their growing dividend payments.", "url": "https://www.forbes.com/sites/etfchannel/2019/04/18/5-dividend-growth-stocks-with-upside-to-analyst-targets-42/"}, {"symbol": "ABT", "publishedDate": "2019-04-18 11:18:42", "title": "An Abbott Labs Analyst's 5 Reasons To Own The Stock: 'Near-Perfect For This Environment'", "image": "https://cdn.snapi.dev/images/v1/a/b/abbottoffice-1.jpg", "site": "Benzinga", "text": "Health care company Abbott Laboratories (NYSE: ABT) has had a strong start to the year with forecast-beating\u00a0first-quarter results and in-line full-year guidance.", "url": "https://feeds.benzinga.com/~r/benzinga/~3/KO2U1rqx7YU/an-abbott-labs-analysts-5-reasons-to-own-the-stock-near-perfect-for-this-environmen"}, {"symbol": "ABT", "publishedDate": "2019-04-17 15:02:00", "title": "Abbott Labs Starts 2019 Off by Beating Expectations", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5193592fabt-earnings-41719.jpg", "site": "The Motley Fool", "text": "The big healthcare company reported strong earnings growth in Q1.", "url": "https://www.fool.com/investing/2019/04/17/abbott-labs-starts-2019-off-by-beating-expectation.aspx?source=iedfolrf0000001"}, {"symbol": "ABT", "publishedDate": "2019-04-17 13:18:04", "title": "Abbott Laboratories (ABT) CEO, Miles White on Q1 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/r/s/transcript37.jpg", "site": "Seeking Alpha", "text": "Abbott Laboratories (ABT) CEO, Miles White on Q1 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4254989-abbott-laboratories-abt-ceo-miles-white-q1-2019-results-earnings-call-transcript?source=feed_sector_transcripts"}, {"symbol": "ABT", "publishedDate": "2019-04-17 11:07:14", "title": "Jim Cramer's Thoughts on Abbott Earnings", "image": "https://cdn.snapi.dev/images/v1/t/h/the2.jpg", "site": "The Street", "text": "Jim Cramer on Abbot Laboratories.", "url": "https://www.youtube.com/watch?v=bP88Vfv7F6I&t=208s"}, {"symbol": "ABT", "publishedDate": "2019-04-17 09:05:02", "title": "Abbott (ABT) Surpasses Q1 Earnings and Revenue Estimates", "image": "https://cdn.snapi.dev/images/v1/e/q/medical11.jpg", "site": "Zacks Investment Research", "text": "Abbott (ABT) delivered earnings and revenue surprises of 3.28% and 0.91%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/382575/abbott-abt-surpasses-q1-earnings-and-revenue-estimates"}, {"symbol": "ABT", "publishedDate": "2019-04-17 08:02:10", "title": "Abbott Labs' stock gains after profit and sales top forecasts, guidance is in line", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech13-3.jpg", "site": "Market Watch", "text": "Shares of Abbott Laboratories  gained 0.8% in premarket trade Wednesday, after the health-care company reported first-quarter earnings that beat expectations.", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/gUkgu46920g/story.aspx"}, {"symbol": "ABT", "publishedDate": "2019-04-17 07:57:53", "title": "Abbott Earnings, Sales Top First-Quarter Views", "image": "https://cdn.snapi.dev/images/v1/a/b/ab6-6.jpg", "site": "Investors Business Daily", "text": "Abbott earnings and sales topped first-quarter views for the medical products giant. Abbott stock rose modestly early Wednesday.", "url": "https://feedproxy.google.com/~r/InternetTechnologyRss/~3/vXBRvWE9oL8/"}, {"symbol": "ABT", "publishedDate": "2019-04-16 15:06:00", "title": "What To Expect From Abbott In Q1?", "image": "https://cdn.snapi.dev/images/v1/p/t/pt-25-193726-o.jpg", "site": "Forbes", "text": "Abbott Labs is expected to publish its Q1 2019 results on April 17. This note details Trefis\u2019 forecasts for Abbott, as well as some of the key trends we will be watching when the company reports earnings.", "url": "https://www.forbes.com/sites/greatspeculations/2019/04/16/what-to-expect-from-abbott-in-q1/"}, {"symbol": "ABT", "publishedDate": "2019-04-16 11:31:52", "title": "Abbott Labs: Earnings Charts this Week", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech28.jpg", "site": "Zacks Investment Research", "text": "Which large cap earnings reports should you be watching this week?", "url": "https://www.youtube.com/watch?v=WMzHDlaXQE4&t=109s"}, {"symbol": "ABT", "publishedDate": "2019-04-15 08:35:00", "title": "Will Abbott's Steady Overall Growth Aid Q1 Earnings?", "image": "https://cdn.snapi.dev/images/v1/a/b/ab2-2.jpg", "site": "Zacks Investment Research", "text": "At the end of 2018, Abbott (ABT) posts some encouraging data, buoying investors' optimism on its Diabetes Care segment.", "url": "https://www.zacks.com/stock/news/380433/will-abbotts-abt-steady-overall-growth-aid-q1-earnings"}, {"symbol": "ABT", "publishedDate": "2019-03-26 15:34:00", "title": "What Are Abbott Laboratories' Key Sources of Revenue?", "image": "https://cdn.snapi.dev/images/v1/p/t/pt-25-193270-o.jpg", "site": "Forbes", "text": "Abbott Labs generates its revenues from Medical Devices, Nutritionals, Diagnostics, and Generic Pharmaceuticals business.", "url": "https://www.forbes.com/sites/greatspeculations/2019/03/26/what-are-abbott-laboratories-key-sources-of-revenue/"}, {"symbol": "ABT", "publishedDate": "2019-03-25 10:54:00", "title": "Abbott's New CE Mark to Boost Core Laboratory Diagnostics Arm", "image": "https://cdn.snapi.dev/images/v1/a/b/abott6.jpg", "site": "Zacks Investment Research", "text": "Abbott's (ABT) Alinity m diagnostics system and assays will provide increased flexibility and time efficiency while catering to the rising demand for infectious disease testing.", "url": "https://www.zacks.com/stock/news/364189/abbotts-new-ce-mark-to-boost-core-laboratory-diagnostics-arm"}, {"symbol": "ABT", "publishedDate": "2019-03-19 10:04:04", "title": "3 Blue Chip Stocks That Just Hit 52-Week Highs: Are They Buys?", "image": "https://cdn.snapi.dev/images/v1/s/t/stocks-1-6.jpg", "site": "The Motley Fool", "text": "Two medical-device makers and one big drugmaker are on a roll. But can their momentum continue?", "url": "https://www.fool.com/investing/2019/03/19/3-blue-chip-stocks-that-just-hit-52-week-highs-are.aspx?source=iedfolrf0000001"}, {"symbol": "ABT", "publishedDate": "2019-03-10 09:31:31", "title": "Better Buy: Abbott Laboratories (ABT)  vs. Johnson & Johnson (JNJ)", "image": "https://cdn.snapi.dev/images/v1/j/n/jnj-1.jpg", "site": "The Motley Fool", "text": "Which stock wins in a matchup between these two healthcare giants?", "url": "https://www.fool.com/investing/2019/03/10/better-buy-abbott-laboratories-vs-johnson-johnson.aspx?source=iedfolrf0000001"}, {"symbol": "ABT", "publishedDate": "2019-02-27 19:00:00", "title": "The desk answers your questions: How does Abbvie look here?", "image": "https://cdn.snapi.dev/images/v1/j/p/jppztxwvgoev-4.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions on Rio Tinto, Abbvie, ON Semiconductor and eBay.", "url": "https://www.youtube.com/watch?v=JppZtxWVGoE&t=110s"}, {"symbol": "ABT", "publishedDate": "2019-02-20 19:00:00", "title": "There's plenty of growth to go around in tech", "image": "https://cdn.snapi.dev/images/v1/z/w/zwiep7oq3om.jpg", "site": "CNBC Television", "text": "Lew Piantedosi, portfolio manager at Eaton Vance, and Jeff Richards, managing partner at GGV Capital, join CNBC's \"Squawk Alley\" to discuss the performance of some of the major tech players in the markets.", "url": "https://www.youtube.com/watch?v=ZWIep7OQ3OM"}, {"symbol": "ABT", "publishedDate": "2019-02-18 19:00:00", "title": "Final Trades: Abbott Labs, Gilead, Equinix & CVS", "image": "https://cdn.snapi.dev/images/v1/k/c/kc8-po-xgbe.jpg", "site": "CNBC Television", "text": "ABT, GILD, CVS, FINAL TRADES", "url": "https://www.youtube.com/watch?v=kC8-Po-XGBE"}, {"symbol": "ABT", "publishedDate": "2019-02-10 19:00:00", "title": "Final trades: Abbott Labs", "image": "https://cdn.snapi.dev/images/v1/a/b/abibzeuvf9iv-1.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders & Mad Money host Jim Cramer give their top stocks to watch for the second half.", "url": "https://www.youtube.com/watch?v=ABIBZEuvf9I&t=0s"}, {"symbol": "ABT", "publishedDate": "2019-01-21 19:00:00", "title": "Final Trades: Abbot Labs, JPMorgan, UnitedHealth & Chipotle", "image": "https://cdn.snapi.dev/images/v1/s/t/sttmyunek0k.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders give their top picks to watch for the second half.", "url": "https://www.youtube.com/watch?v=sTTMyUNek0k"}, {"symbol": "ABT", "publishedDate": "2019-01-16 19:00:00", "title": "Here's Yana Barton's 2019 stock picks", "image": "https://cdn.snapi.dev/images/v1/j/u/judzrjbrhhc.jpg", "site": "CNBC Television", "text": "Yana Barton, Eaton Vance portfolio manager, joins the 'Fast Money Halftime Report' team to discuss what stocks are on her 2019 playbook.", "url": "https://www.youtube.com/watch?v=juDZrjBrhHc"}, {"symbol": "ABT", "publishedDate": "2019-01-01 19:00:00", "title": "Stocks under pressure on first trading day of the year", "image": "https://cdn.snapi.dev/images/v1/n/w/nw-zh4i8o-y.jpg", "site": "CNBC Television", "text": "The 'Fast Money Halftime Report' team discuss markets on the first trading day of the new year.", "url": "https://www.youtube.com/watch?v=NW_ZH4i8O_Y"}, {"symbol": "ABT", "publishedDate": "2018-11-12 19:00:00", "title": "Chartmaster says amid the market sell-off these are the best names to buy", "image": "https://cdn.snapi.dev/images/v1/u/x/uxmsotqbrwc.jpg", "site": "CNBC Television", "text": "Carter Worth, Cornerstone Macro, on quality bear-market stocks to buy. With CNBC's Joe Kernen and the Fast Money traders, Pete Najarian, Steve Grasso, Brian Kelly and Tim Seymour.", "url": "https://www.youtube.com/watch?v=uXmsOTQBrWc"}, {"symbol": "ABT", "publishedDate": "2018-11-07 19:00:00", "title": "The future of the health-care industry", "image": "https://cdn.snapi.dev/images/v1/u/6/u6rlgkkgeoe.jpg", "site": "CNBC Television", "text": "Fred Hassan, former Shering-Plough CEO, and Bill George, former Medtronic CEO, join 'Squawk on the Street' to discuss the impact on health-care stocks after news that the sector was the top issue for midterm voters.", "url": "https://www.youtube.com/watch?v=U6rLgKKgeOE"}, {"symbol": "ABT", "publishedDate": "2018-10-16 20:00:00", "title": "IBM, Home Depot weigh on Dow; Netflix gaps up on earnings; UAL takes flight $HD $IBM $NFLX $ABT", "image": "https://cdn.snapi.dev/images/v1/t/r/trlhojggtzy.jpg", "site": "Investors Business Daily", "text": "Ken Shreve & Alissa Coram\u00b4s analyses stock\u00b4s behavior..", "url": "https://www.youtube.com/watch?v=trLHoJGGtzY"}, {"symbol": "ABT", "publishedDate": "2018-09-26 20:00:00", "title": "The traders take their position on Delphi Technologies and Gilead", "image": "https://cdn.snapi.dev/images/v1/3/u/3ur-xx6-zig.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders take viewer questions on Delphi Technologies and Gilead.", "url": "https://www.youtube.com/watch?v=3UR-XX6_ZIg"}, {"symbol": "ABT", "publishedDate": "2018-09-25 20:00:00", "title": "The trade on Abbott Labs, how oil will impact American Airlines & more", "image": "https://cdn.snapi.dev/images/v1/f/i/fixdaaeeqga.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders take viewer questions on Abbott Labs, American Airlines, and E*Trade.", "url": "https://www.youtube.com/watch?v=FIxDAaEeqGA"}, {"symbol": "ABT", "publishedDate": "2018-08-22 20:00:00", "title": "Four movers in the blitz", "image": "https://cdn.snapi.dev/images/v1/f/l/fln-dzl8x-8.jpg", "site": "CNBC Television", "text": "Four big movers in the blitz.", "url": "https://www.youtube.com/watch?v=Fln-dzl8X-8"}, {"symbol": "ABT", "publishedDate": "2018-08-16 20:00:00", "title": "Portfolio Manager: watch these 4 stocks", "image": "https://cdn.snapi.dev/images/v1/s/r/srpqwccyybw.jpg", "site": "CNBC Television", "text": "Eaton Vance Portfolio Manager Yana Barton makes the bull case for 3 stocks.", "url": "https://www.youtube.com/watch?v=SRPqwCcYyBw"}, {"symbol": "ABT", "publishedDate": "2018-07-31 20:00:00", "title": "Should investors give up on the tech sector?", "image": "https://cdn.snapi.dev/images/v1/b/f/bfmt-3rrnha.jpg", "site": "Fox Business", "text": "FBN's Charles Payne on how the U.S.-China trade talks have helped stocks and why he believes that the technology sector isn't dead.", "url": "https://www.youtube.com/watch?v=bfmt-3rrNhA"}]